The present disclosure relates to a prosthetic heart valve. Specifically, the present disclosure relates to a prosthetic heart valve for a transcatheter delivered endoprosthesis used in the treatment of a stenotic cardiac valve and/or a cardiac valve insufficiency.
The present disclosure also relates to a transcatheter delivered endoprosthesis that includes a prosthetic heart valve and a stent for positioning and anchoring of the prosthetic heart valve at the implantation site in the heart of a patient. Specifically, the present disclosure also relates to a collapsible and expandable prosthesis incorporating a prosthetic heart valve and a stent that can be delivered to the implant site using a catheter for treatment of a stenosis (narrowing) of a cardiac valve and/or a cardiac valve insufficiency.
The expression “narrowing (stenosis) of a cardiac valve and/or cardiac valve insufficiency” may include a functional defect of one or more cardiac valves, which is either genetic or has developed. A cardiac defect of this type might affect each of the four heart valves, although the aortic and mitral valves are affected much more often than the right-sided part of the heart (pulmonary and tricuspid valves). The functional defect can result in narrowing (stenosis), inability to close (insufficiency) or a combination of the two (combined vitium). This disclosure relates to a prosthetic heart valve as well as a transcatheter delivered endoprosthesis that includes a prosthetic heart valve and an expandable stent capable of being implanted transluminally in a patient's body and enlarged radially after being introduced by transcatheter delivery for treating such a heart valve defect.
The human heart has four valves which control the blood flow circulating through the human body. On the left side of the heart are the mitral valve, located between the left atrium and the left ventricle, and the aortic valve, located between the left ventricle and the aorta. Both of these valves direct the oxygenated blood, coming from the lungs into the aorta for distribution through the body. The tricuspid valve, located between the right atrium and the right ventricle, and the pulmonary valve, located between the right ventricle and the pulmonary artery, however, are situated on the right side of the heart and direct deoxygenated blood, coming from the body, to the lungs.
The native heart valves are passive structures that open and close in response to differential pressures induced by the pumping motions of the heart. They consist of moveable leaflets designed to open and close in response to the said differential pressure. Normally, the mitral valve has two leaflets and the tricuspid valve has at least two, preferably three leaflets. The aortic and pulmonary valves, however, have normally at least two, preferably three leaflets, also often referred to as “cusps” because of their half-moon like appearance. In the present disclosure, the terms “leaflet” and “cusps” have the same meaning.
Heart valve diseases are classified into two major categories, named stenosis and insufficiency. In the case of a stenosis, the native heart valve does not open properly, whereby insufficiency represents the opposite effect showing deficient closing properties. Medical conditions like high blood pressure, inflammatory and infectious processes can lead to such cardiac valve dysfunctions. Either way in most cases the native valves have to be treated by surgery. In this regard, treatment can either include reparation of the diseased heart valve with preservation of the patient's own valve or the valve could be replaced by a mechanical or biological substitutes also referred to as prosthetic heart valves. Particularly for aortic heart valves, however, it is frequently necessary to introduce a heart valve replacement.
In principle, there are two possibilities of treating the diseased heart valve, when inserting a prosthetic heart valve: The first way includes extracting at least major parts of the diseased heart valve. The second alternative way provides leaving the diseased heart valve in place and pressing the diseased leaflets aside to create space for the prosthetic heart valve.
Biological or mechanical prosthetic heart valves are typically surgically sewn into the cardiac valve bed through an opening in the chest after removal of the diseased cardiac valve. This operation necessitates the use of a heart-lung machine to maintain the patient's circulation during the procedure and cardiac arrest is induced during implantation of the prosthesis. This is a risky surgical procedure with associated dangers for the patient, as well as a long post-operative treatment and recovery phase. Such an operation can often not be considered with justifiable risk in the case of polypathic patients.
Minimally-invasive forms of treatment have been developed recently which are characterized by allowing the procedure to be performed under local anesthesia. One approach provides for the use of a catheter system to implant a self-expandable stent to which is connected a collapsible heart valve. Such a self-expandable endoprosthesis can be guided via a catheter system to the implantation site within the heart through an inguinal artery or vein. After reaching the implantation site, the stent with the prosthetic heart valve affixed thereto can then be unfolded.
An increasing number of patients suffer from stenosis (narrowing) of cardiac valve and/or cardiac valve insufficiency. In this regard, the issue concerning the provision of long term durability is involved with developing prosthetic heart valves. Each of the four major heart valves open and close about 100,000 times a day and stability requirements for replacements valves are particularly high.
Moreover, there is the danger that—due to the dynamic fluid pressure from blood flow through the prosthetic heart valve, the leaflet material, or the threads (e.g. sutures) used in fastening the prosthetic heart valve to the stent may tear or break. These component failures over the course of time may result in loss of overall valve function.
On the basis of the problems outlined above and other issues with current transcatheter technologies, certain embodiments of the present disclosure address the issue of providing a prosthetic heart valve, as well as a self-expandable endoprosthesis for treating a narrowed cardiac valve or a cardiac valve insufficiency which realizes optimum long term durability, excellent hemodynamics (e.g. low pressure gradients and minimal regurgitation), minimization of paravalvular leakage, accurate device alignment and positioning, no coronary obstruction, prevention of device migration and avoidance of heart block. In addition, the disclosure provides an improved attachment of a prosthetic heart valve to a corresponding collapsible stent structure, thereby distributing stress loads over a greater surface area and thus reducing the potential for stress concentration points throughout the prosthetic heart valve, resulting in improved durability.
In this regard and as it will be described later in detail, the disclosure provides a prosthetic heart valve for a transcatheter delivered endoprosthesis used in the treatment of a stenosis (narrowing) of a cardiac valve and/or a cardiac valve insufficiency. The prosthetic heart valve comprises at least two leaflets, a skirt portion, and a transition area representing a junction between the leaflets and the skirt portion. Each of the at least two leaflets of the prosthetic heart valve consists of natural tissue or synthetic material and has a first opened position for opening the patient's heart chamber and a second closed position for closing the patient's heart chamber, the at least two leaflets being able to switch between their first and second position in response to the blood flow through the patient's heart. The skirt portion consists of natural tissue or synthetic material and is used for mounting of the prosthetic heart valve to a stent. The transition area, which represents a junction between the at least two leaflets of the prosthetic heart valve and the skirt portion, progresses approximately in a U-shaped manner, similar to a cusp shape of a natural aortic or pulmonary heart valve, thereby reducing stresses within the heart valve material during opening and closing motion of the at least two leaflets.
The expression “natural tissue” as used herein means naturally occurring tissue, i.e. biological tissue obtained from the patient, from another human donor, or from a nonhuman animal. On the other hand, the herein used expression “natural tissue” shall also cover tissue fabricated by tissue engineering in the laboratory, for example, from combinations of engineered extracellular matrices (“scaffolds”), cells, and biologically active molecules.
As it will be described in detail later on, in some embodiments of the present disclosure, the prosthetic heart valve either comprises xenografts/homografts or synthetic, nonbiological, non-thrombogenic materials. Homografts are either human donor valves, e.g., heart valves, or replacements made of human tissue, e.g., pericardial tissue. In contrast, xenografts describe valves received from animals, e.g., heart valves, or made of animal tissue, e.g., pericardial tissue, typically porcine or bovine respectively. These natural tissues normally contain tissue proteins (i.e., collagen and elastin) acting as a supportive framework and determining the pliability and firmness of the tissue.
It is conceivable to increase the stability of said natural tissues by applying chemical fixation. That is, the natural tissue may be exposed to one or more chemical fixatives (i.e. tanning agents) that form cross-linkages between the polypeptide chains within the protein structures of the natural tissue material. Examples of these chemical fixative agents include: formalaldehyde, glutaraldehyde, dialdehyde starch, hexamethylene diisocyanate and certain polyepoxy compounds.
So far, a major problem with the implantation of conventional biological prosthetic heart valves is that the natural tissue material can become calcified, resulting in undesirable stiffening or degradation of the prosthetic heart valve.
Even without calcification, high valve stresses can lead to mechanical failure of components of the heart valve. In order to overcome problems with mechanical failure and potential stress induced calcification that limit valve durability, some embodiments of the disclosure describe an improved construction of the prosthetic heart valve, the design of the disclosed prosthetic heart valve is suited for reducing stresses, and reducing the potential for calcification to improve durability of the heart valve.
In addition, the disclosure provides an improved attachment of a prosthetic heart valve to a corresponding collapsible stent structure, thereby distributing stress loads over a greater surface area and thus reducing the potential for stress concentration points throughout the prosthetic heart valve, resulting in improved durability.
In some embodiment of the disclosure, the prosthetic heart valve may be made of one piece of flat pericardial tissue. This pericardial tissue can either be extracted from an animal's heart (xenograft) or a human's heart (homograft). Subsequently, the extracted tissue may be cut by a laser cutting system, a die press, a water jet cutting system or by hand with a variety of cutting instruments in order to form a pattern representing each of the at least two leaflets or in another embodiment individual leaflets. This pattern may also include the skirt portion in some embodiments. The skirt portion represents an area of the prosthetic heart valve that is used for connecting the prosthetic heart valve to a stent, for example, by means of sutures. Current prosthetic heart valves consist of separated leaflets and skirt portions, wherein the separated leaflets and skirt portions are sewn together by the time the biological heart valve is connected to the stent. According to the “one piece” embodiment described herein, however, the leaflets are integrally formed with the leaflet support portion, that is the prosthetic heart valve is made of one piece of flat pericardial tissue.
The pattern of the prosthetic heart valve, which represents each of the at least two and preferably three leaflets and the skirt portion, shall substantially be constructed like a native aortic or pulmonary heart valve. To this end, the pattern is preferably designed so as to form leaflets in the aforementioned cusp manner, having three half-moon shaped leaflets like the aortic or pulmonary heart valve. The leaflets can be designed in various shapes such as the geometry of an ellipse, U-shape or substantially oval. In this regard, preferably each of the three different leaflets is formed in such a manner that all of them have the same extent; however, it is also conceivable to design them in different sizes.
The shaping of the leaflets into said pattern, for minimizing stresses in the closed position of the prosthetic heart valve, can be achieved in several ways. Most importantly, the mechanical properties of the leaflets of the prosthetic heart valve are influenced by the free margin and the shape of the supported edges. To this end, in an advantageous embodiment disclosed herein, the leaflets are formed into a predetermined 3D shape, by means of a cross-linking the flat tissue on a mandrel. Subsequently, potentially occurring excess material is trimmed off by means of a laser, knife, or water jet respectively to form the edges of the 3D shape. Between the leaflets and the skirt portion, the valve pattern shows a transition area progressing in a substantial U-shaped manner, similar to the cusp shape of a natural aortic or pulmonary heart valve.
In another embodiment of the present disclosure, the lower end section of the prosthetic heart valve exhibits a tapered or flared shape. Such a tapered or flared shape may be advantageous regarding the attachment of the prosthetic heart valve to a corresponding stent. As will be explained in more detail hereinafter, a corresponding stent may comprise a tapered or flared lower end section in order to improve the anchoring of the stent at the implantation site. As a consequence, it may be useful to construct the lower end section of the prosthetic heart valve in a tapered or flared shape, so as to prevent paravalvular leakage between the stent and the blood vessel.
According to another embodiment of the present disclosure, the leaflets may have a cuspidal geometry, which is formed in an elliptically, u-shaped or oval manner. Such a cuspdial geometry reduces the potential for stress concentrations and therefore minimizes the potential for areas of wear and calcium deposition. In another embodiment of the present disclosure all three leaflets are shaped to the same extent, absorbing loads equally throughout the cardiac cycle. However, it is conceivable to assemble a device with leaflets of varying designs.
With reference to another embodiment of the present disclosure, the leaflet portion of the prosthetic heart valve is designed to provide redundant coaptation for potential annular distortion. In particular, redundant coaptation means that each of the leaflets covers more than one third of the inner diameter of the respective stent, in the closed position of the valve. The redundant coaptation may reduce stress on the leaflets and provides reliable closure of the heart chamber in the second closed position of the leaflets, even in the case of an annular distortion. That is, the prosthetic heart valve of the present disclosure is capable of preventing regurgitation even if the size of the heart valve annulus has been altered (annular distortion).
In another embodiment of the present disclosure, the prosthetic heart valve comprises a plurality of fastening holes provided along the progression of the bendable transition area. These fastening holes are preferably introduced into the tissue of the prosthetic heart valve before the valve is attached to the corresponding stent. This plurality of fastening holes may reduce the time needed for attachment of the prosthetic heart valve to the retaining arches of the corresponding stent.
According to another aspect of the present disclosure, the prosthetic heart valve is designed for collapsing and delivering in a catheter. To this end, the prosthetic heart valve can be designed in such a way as to fit inside the corresponding stent structure. Furthermore, it is conceivable that the design of the prosthetic heart valve comprises certain folds in order to allow for collapsing to very small diameters.
In another embodiment of the invention, the tissue material of the prosthetic heart valve has a thickness of 160 μm to 300 μm, preferably from 220 μm to 260 μm. However, it should be noted that the thickness may be dependent on the tissue material of the prosthetic heart valve. In general, the thickness of bovine tissue is thicker than the thickness of porcine tissue.
The blood vessels and heart valve orifices of the individual patients can have significantly varying diameter, accordingly, the prosthetic heart valve may have a diameter ranging form 19 mm to 28 mm. Thus, the prosthetic heart valve of the present disclosure is adapted to fit to the individual characteristics of individual patient's heart anatomy.
In another embodiment of the present disclosure, the bendable transition area of the prosthetic heart valve is attached to retaining arches of the stent by means of sutures, having a diameter larger than the diameter of the sutures used for attachment of the prosthetic heart valve to an annular collar of the stent. Due to this, the prosthetic heart valve can be reliably attached to the stent without adding too much bulk to the stent, in order to collapse the endoprosthesis to a small diameter.
The disclosure also provides a transcatheter delivered endoprosthesis having a prosthetic heart valve affixed to a stent. The stent provides retaining arches which are configured once in the expanded state to be in a gradually uniform U-shape. The transition area of the tissue is attached to the retaining arches of the stent in a number of possible embodiments. The purpose of the retaining arches is to control the motion of the leaflets during the opening and closing phases of the valve in a manner which minimizes the stresses associated with the cyclic motion.
In general, current transcatheter prosthetic heart valves consist of separated leaflets and skirt portions, wherein the separated leaflets and skirt portions are sewn together by the time the biological heart valve is connected to the stent. Hence, with the conventional prosthetic heart valves, additional suture lines are necessary, causing stress concentration and reduced flexibility of the heart valve, thus leading to earlier calcification of the prosthetic heart valves.
In order to reduce or minimize stress concentration and to enhance flexibility of the heart valve, in some embodiments as disclosed herein the leaflets are integrally formed with the skirt portion. For example, a single piece of pericardium may be used for forming the prosthetic heart valve. As an alternative, the skirt portion may consist of multiple pieces of tissue, e.g. three pieces of tissue, which are sewn together by the time the biological heart valve is connected to the stent, wherein the leaflets are integrally formed with the tissue material of the pieces which together form the skirt portion. For example, three individual tissue panels may be utilized to construct the valve portion of the prosthetic heart valve. Whether a single piece of pericardium or three panels are used, the tissue structure is sutured to the stent structure to create the desired U-shape of the leaflets. This U-shape helps distribute the load on the leaflets throughout the cardiac cycle, but especially when in the closed position.
By avoiding that the leaflets must be sewn to the skirt portion(s), greater strength and durability of the heart valve assembly may be provided, as the strength and integrity of a uniform piece of tissue is improved from separate pieces of tissue sewn together. Additionally, the advantages of not having a seam include reduced assembly time (less suturing), less overall bulk when collapsing the prosthesis for small catheter delivery and more flexible leaflets at the transition area that could improve leaflet motion and hemodynamics.
The natural tissue material used for the manufacture of prosthetic heart valves typically contains connective tissue proteins (i.e., collagen and elastin) that act as supportive framework of the tissue material. In order to strengthen this compound of tissue proteins, a chemical fixation process may be performed, linking the proteins together. This technique usually involves the exposure of the natural tissue material to one or more chemical fixatives that form the cross-linkages between the polypeptide chains of the collagen molecules. In this regard, it is conceivable to apply different cross-linking techniques for different parts of the prosthetic heart valve tissue. For instance, the leaflets of the prosthetic heart valve could be treated by a different chemical fixative agent than the skirt portion in order to obtain diverse rigidity within the prosthetic heart valve.
In addition, it is conceivable to have leaflets and a skirt which are not integral. In this case, different cross-linking techniques may be applied to the leaflets and the skirt.
Examples of chemical fixative agents conceivably used for cross-linking of the prosthetic heart valve, according to the present disclosure include: aldehydes, (e.g. formaldehyde, glutaraldehyde, dialdehyde starch, para formaldehyde, glyceroaldehyde, glyoxal acetaldehyde, acrolein), diisocyanates (e.g., hexamethylene diisocyanate), carbodiimides, photooxidation, and certain polyepoxy compounds (e.g., Denacol-810,-512).
According to some of the disclosed embodiments, the prosthetic heart valve is mounted to the inner surface of a support stent. This arrangement facilitates protection of the prosthetic heart valve material during collapse and deployment. This is because the prosthetic heart valve is not in contact with the inner wall of the implantation catheter, and thus may not get stuck on the inner surface thereof. On this account, damage to the prosthetic heart valve is avoided. Also, such an endoprosthesis can be collapsed to a smaller diameter compared with a prosthetic heart valve mounted to the outer surface of the stent, hence providing the possibility to use smaller catheters.
On the other hand, it is conceivable to mount the prosthetic heart valve to the outer surface of a support stent. That is, the skirt portion could be in direct contact with the diseased native heart valve and could be attached to the stent by means of sutures. Mounting the prosthetic heart valve to the outer surface of the stent supports the load transfer from the leaflet to the stent. This greatly reduces stresses on the leaflets during closing and consequently improves the durability thereof. Also, it is possible to design the valve to obtain improved hemodynamics in the case of mounting the skirt portion and commissures to the outer surface of the stent. Additionally, the heart valve material which is in direct contact with the diseased native heart valve provides a good interface for sealing against leakage (i.e., paravalvular leakage), tissue in-growth and attachment. The stent designs for this endoprosthesis uniquely accommodate this valve embodiment and advantages, whereas for cage-like transcatheter delivered stent designs this is not possible.
The prosthetic heart valve can be made from pericardial tissue, for example, human pericardial tissue, preferably animal pericardial tissue, whereby bovine or porcine pericardial tissue is preferred. However, it is conceivable to employ kangaroo, ostrich, whale or any other suitable xeno- or homograft tissue of any feasible dimension.
Preferably, porcine tissue thicknesses of 220 to 260 μm after fixation shall be used to manufacture the biological prosthetic heart valves. Of course, this example is not a limitation of the possible kinds of tissues and their dimensions. Rather, it is conceivable to employ kangaroo, ostrich, whale or any other suitable xeno- or homograft tissue of any feasible dimension.
Many aspects of the disclosed prosthetic heart valve embodiments may become clear considering the structure of a corresponding stent to which the prosthetic heart valve may be attached in order to form a transcatheter delivered endoprosthesis used in the treatment of a stenosis (narrowing) of a cardiac valve and/or a cardiac valve insufficiency.
According to an aspect of the disclosure, a stent suitable for implantation with the aforementioned prosthetic heart valve may comprise positioning arches configured to be positioned within the pockets of the patient's native heart valve. Furthermore, the stent may comprise retaining arches. In detail, for each positioning arch one retaining arch may be provided. In the implanted state of the stent, the respective head portions of the positioning arches are positioned within the pockets of the patient's native heart valve such that the positioning arches are located on a first side of a plurality of native heart valve leaflets. On the other hand, in the implanted state of the stent, the retaining arches of the stent are located on a second side of the native heart valve leaflets opposite the first side. In this respect, the positioning arches on the one hand and the retaining arches on the other hand clamp the native heart valve leaflets in a paper-clip manner.
Hence, the positioning arches of the stent are designed to engage in the pockets of the native (diseased) cardiac valve which allows accurate positioning of the stent and a prosthetic heart valve affixed to the stent. Furthermore, in the implanted state, each positioning arch co-operates with a corresponding retaining arch resulting in clipping of the native leaflet between the two arches. In this way, the positioning and retaining arches hold the stent in position and substantially eliminate axial rotation of the stent
In a preferred embodiment, the positioning arch may be formed such as to have a substantially convex shape. In this way, the shape of each positioning arch provides an additional clipping force against the native valve leaflet.
The at least one retaining arch of the stent may be connected to a corresponding positioning arch by a connecting web. The retaining arch may extend substantially parallel to the positioning arch, thus having essentially the same shape. The shape of the retaining arch basically represents a U-shape with a small gap at its lower end. This gap is surrounded by a connection portion which originates during the fabrication of the tip of the positioning arches. The connection portion may be similar to a U- or V-shape and links the two sides of a retaining arch.
Along the retaining arches of the stent, a plurality of fastening holes and optionally one or more notches may be provided. Preferably, these fastening holes and notches are longitudinally distributed at given positions along the retaining arches and guide at least one thread or thin wire to fasten the tissue components of the prosthetic heart valve to the stent, thereby enabling a precise positioning of the tissue components on the stent. The means provided for fastening the tissue components of the biological prosthetic heart valve to the retaining arches of the stent (thread or thin wire) is guided by way of the fastening holes and notches to ensure accurate repeatable securement of the bioprosthetic heart valve within the stent structure. This accurate securement of the biological prosthesis substantially reduces the potential for longitudinal displacement of the biological prosthetic heart valve relative to the stent.
According to another embodiment of the present disclosure, the aforementioned plurality of retaining arches are provided with one or more fastening notches which can be used to fix the bendable transition area to the stent. To this end, the retaining arches may be segmented by a plurality of bending edges forming said fastening notches and defining bending points of the retaining arches. The fastening notches simplify the attachment of the bendable transition area of the prosthetic heart valve to the retaining arches.
In another aspect of the stent which is suitable for implantation with a biological prosthetic heart valve as disclosed herein, the retaining arches are cut from the material portion of a small metal tube in an shape that when expanded essentially form the U-shaped structure corresponding to the aforementioned progression of the transition area.
At the lower end of the stent, an annular collar may be provided. The annular collar may serve as a supporting body through which the radial forces, developing due to the self-expansion, are transmitted to the vascular wall. Attached to the annular collar is the skirt portion of the biological prosthetic heart valve. Typically, this attachment is implemented by means of suturing.
The intent of the self expanding annular collar in combination with the attached skirt region of the valve is to provide sufficient radial forces so as to seal and prevent paravalvular leakage. In addition, the collar aids in anchoring the prosthesis in the annulus to prevent migration. This collar may incorporate a flared or tapered structure to further enhance securement.
As mentioned above, a prosthetic heart valve can be attached to a corresponding stent in order to provide a transcatheter delivered endoprosthesis which can be used in the treatment of a stenosis (narrowing) of a cardiac valve and/or a cardiac valve insufficiency.
A prosthetic heart valve made from pericardial tissue material may be attached to the retaining arches and annular collar of the afore-mentioned stent by means of braided multi-filament polyester sutures. These sutures may have any suitable diameter, typically about 0.07 mm.
In order to increase the strength of the connection of biological prosthetic heart valve to the stent, however, it is conceivable to increase the size of the multi-filament sutures, for example, up to 0.2 mm. In this way, it is possible that the fundamental bond between the transition area of the prosthetic heart valve and the retaining arches of the stent exhibits additional stability. On the other hand, the remaining sutures shall be kept as thin as possible to enable collapsing of the endoprosthesis to a small diameter.
A common running stitch pattern may be used to obtain said bonding. According to the disclosure, the stitch pattern is preferably a locking stitch or a blanket stitch respectively. Of course, any other suitable stitch pattern (i.e. overlocking stitch, slipstitch or topstitch) is also possible.
Considering the stress concentration due to direct stitching in the heart valve material, another aspect of the disclosure may provide that the material of the prosthetic heart valve is reinforced to improve its suture retention force. To this end, laser cut suturing holes may be introduced into the prosthetic heart valve tissue with the laser cutting process strengthening the tissue area around the cut hole. Predefined laser cutting holes might also ease the suturing process itself and reduce stresses on the material of the prosthetic heart valve due to the penetration of the needle during stitching.
In another embodiment of the present disclosure, the connection of the prosthetic heart valve material to a stent may be reinforced by means of reinforcement elements. Such reinforcement elements are intended to reduce stress concentrations in the material of the prosthetic heart valve that may occur from direct stitching in the valve material. In particular, the reinforcement elements might reduce stress concentration in the tissue material of the prosthetic heart valve at the connection between the bendable transition area and the retaining arches of the stent. The reinforcement elements may be placed between an inner suture and the prosthetic heart valve material, thus distributing aforementioned stresses, caused by the stitching, over a larger area of the valve material. These reinforcement elements can be used at discrete locations or continuously along the path of the stitching. For example, they can be placed opposite to the retaining arches of the stent on the other side of the prosthetic heart valve material.
Reinforcement elements may be applied in order to avoid direct contact between knots of the sutures and the tissue of the prosthetic heart valve, thereby reducing abrasion of the prosthetic heart valve tissue due to rubbing against said sutures. To reduce direct contact between the heart valve tissue and the stent structure or any other metallic component of the endoprosthesis, reinforcement elements can further be used to prevent the tissue of the prosthetic heart valve from directly contacting the stent structure or any other metallic component respectively.
In this regard, it is also conceivable to locate reinforcement elements along the entire surface of the prosthetic heart valve. Preferably, such reinforcement elements could also be located at or near the upper edge of the leaflets. These upper edges, building the commissures of the endoprosthesis, are exposed to an increased tension, which are more likely to tear during the operation of the prosthetic heart valve.
Moreover, it is also feasible to place said reinforcement elements inside the tissue of the prosthetic heart valve, instead of a mere attachment on the surface of the prosthetic heart valve. In this regard, it may be advantageous to have a layer of tissue or synthetic material of different mechanical properties inside the aforementioned prosthetic heart valve. This alternative embodiment may be especially useful in order to reinforce the leaflets of the prosthetic heart valve in order to increase their ability to yield mechanical stresses occurring during the operation of the endoprosthesis.
Reinforcement elements can be used at discrete locations or continuously along the path of the stitching. For example, they can be placed opposite to the retaining arches of the stent on the other side of the prosthetic heart valve material.
The reinforcement elements may be folded or formed in such a way that round edges are formed. These round edges are designed to reduce or avoid abrasion of the valve material during opening and closing of the prosthetic heart valve.
With regard to a further embodiment of the present disclosure, the reinforcement elements comprise at least one inner cushion, which is mounted to the inner surface of the bendable transition area of the prosthetic heart valve. This inner cushion is arranged essentially opposite the retaining arches and/or to the commissure attachment region of the stent. Opposite in this context means that the inner cushion is mounted on an opposite side of the prosthetic heart valve. The inner cushion is designed to reduce the stress concentrations in the tissue that occur from direct stitching in the tissue. In more detail, the inner cushion prevents the prosthetic heart valve tissue from directly contacting knots of the suture. Due to this, wear of the heart valve tissue is reduced, as said knots do not rub on the surface of the tissue, during opening and closing of the heart valve.
In a further embodiment, the at least one inner cushion may be a pledget made of one or multiple layer materials. The inner cushion may consist of materials, for examples, like polyester velour, PTFE, pericardial tissue or any other material suitable for forming round edges, distributing or buffering stresses in the valve material, due to the sutures. On this account, the material of the inner cushion can be made from flat sheets or fabrics such as knits or woven constructions. It is to be noted that the reinforcement elements can be applied in order to span between stent struts, in particular across a gap, located at the lower end of the retaining arches, to help support the valve material across said gap.
In an alternative implementation, the reinforcement elements may consist of a wire rail placed at the inner surface of the bendable transition area of the prosthetic heart valve, essentially opposite the retaining arch of the stent. The wire rail may be secured in place using a stitch pattern meant to accommodate the wire rail and the valve material to the stent. In comparison to the inner cushion mentioned above, such a wire rail could be easier to attach to the material of the prosthetic heart valve. Furthermore the already rounded shape of the rail does not require the wire rail to be folded in order to obtain rounded edges for prevention of valve material abrasion.
It is preferable that said wire rail is made of Nitinol in order to allow collapsing of the reinforcement element simultaneously with the stent structure.
Moreover, in another realisation, the reinforcement elements may be essentially of the same size and form as the retaining arches of the stent, hence forming an inner attachment rail. The reinforcement elements, however, shall be of thinner material than the retaining arches. This is due to the fact that thick material may limit the ability of the endoprosthesis to be collapsed to a small size.
In particular, the inner attachment rail may have the same fastening holes and notches longitudinally distributed at given locations as the retaining arches of the stent. Again, the attachment rail may be placed on the inner surface of the bendable transition area of the prosthetic heart valve, opposite to the retaining arches of the stent. Thus, the material of the prosthetic heart valve may be clamped in between the stent and the reinforcement element, which are connected through sutures. The reinforcement element thus may act as an inner attachment rail for the leaflets of the prosthetic heart valve to bend over and evenly distribute stress loads affecting the valve material over a large attachment rail rather than individual suture points.
Although most embodiments of the disclosure use sutures to fix the reinforcement element or valve material to the stent, it is conceivable to use different attachment methods like welding, soldering, locking fixture and rivets. For instance, these methods could be used to attach the aforementioned inner attachment rail to the retaining arches of the stent. This would result in clamping the prosthetic heart valve material in between the inner surface of the stent and the outer surface of the reinforcement element without penetrating the valve material with needles of suture.
Another alternative attachment concept includes a reinforcing element attached to the back side of the prosthetic heart valve material. This concept may be suitable for attachment in a high stress area of a commissure attachment region on top of the retaining arches, which is described in more detail below. This concept involves creating a strengthened region by folding the prosthetic heart valve material and wrapping it with the reinforcing element. Thus, the reinforcement element forms an outer wrapping element which is mounted to the outer surface of the bendable transition area of the prosthetic heart valve, at the commissure attachment region of the stent. The reinforced bendable transition area of the prosthetic heart valve can then be securely attached to the retaining arches of the stent or the commissure attachment region of the stent.
The aforementioned outer wrapping element of the reinforcing element is preferably made of a polymer material such as PTFE or a PET fabric or sheet. However, it could also be a more rigid U-shaped clip or bendable material that can pinch the folded valve material. One advantage this concept has over the other reinforcing elements is that the reinforcing material is not placed on the inner surface of the prosthetic heart valve, hence does not disrupt the blood flow or potentially be a site for thrombus formation.
The outer wrapping element of the reinforcing element may also provide an opening buffer to keep the valve leaflet material from opening too wide and hitting the stent, which would cause wear of the valve material. Similar to the rounded edges of the other reinforcement elements, these buffers should be rounded, smooth or soft to avoid wear when the open valve material hits them. The buffer should be small enough to not significantly over restrict leaflet material opening.
An especially beneficial embodiment of the present invention includes an attachment concept with reinforcement elements attached to the inner surface and to the outer surface of the transition area of the prosthetic heart valve. This configuration optimally prevents stress concentration and resulting wear of the prosthetic heart valve.
In particular, a first reinforcement element is connected to the outer surface of the bendable area of the prosthetic heart valve, preferably lining the retaining arches and the commissure attachment region over their entire length. The said reinforcement element, which is connected to the outer surface of the prosthetic heart valve, can be made of animal pericardial tissue, such as the one used for the prosthetic heart valve itself. Of course, it is conceivable to use any other suitable material for the reinforcement element, such as synthetic materials or even homograft (human) tissue. The reinforcement element, connected to the outer surface of the prosthetic heart valve, has several advantages, such as preventing any rubbing and wear between the leaflet and the stent at the retaining arches or commissure attachment region respectively. Even if the attachment is tightly sutured, the tissue will have strain cycles at the surface during opening and closing motion of the leaflets, which can cause wear against the stent from micro movements. Furthermore, the reinforcement element allows for an additional spring-like compression to tighten the attachment of the leaflet to the stent, providing a more durable attachment than the one achieved by suturing the leaflets to a rigid surface. Also, the reinforcement element serves as a bumper during opening to limit full opening and reduce the accompanied shock affecting the prosthetic heart valve at opening.
In another embodiment, the reinforcement element, which is connected to the outer surface of the prosthetic heart valve, extends along the retaining arches and along the commissure attachment region, having a wider surface than the surface of the retaining arches or the surface of the commissure attachment region respectively. For this reason, the reinforcement element provides a surface, sufficient to cover the retaining arches and the commissure attachment region completely. Thus, abrasion or wear of the tissue at the retaining arches or commissure attachment region respectively is avoided reliably.
Concerning the attachment of the aforementioned reinforcement element another advantageous embodiment includes wrapping the reinforcement element around the retaining arches and the commissure attachment region and securing this connection by means of wrapping and stitching. That is to say that the reinforcement element is secured firmly to the retaining arches or commissure attachment region respectively, providing a stable surface for attachment of the prosthetic heart valve.
With regard to the reinforcement element, which is connected to the inner surface of the transition area of the prosthetic heart valve, in another realisation, the reinforcement element consists of a folded strip of porcine pericardium and is attached to the transition area and stent by means of sutures. This folded strip of porcine pericardium allows the sutures to spread out the compressive forces that secure the leaflet tissue. A tight suture attachment is required to avoid any movement or slipping under physiological loads. If attached tightly, the loads from the leaflet will be at least partially transferred to the stent through friction and not directly to the sutures at the needle holes. This minimizes the stress concentration by spreading out the stresses, especially at the commissure attachment region. Also, the strip of porcine pericardium serves as a bumper to absorb the impact of the tissue during closing and reduces the dynamic stresses transferred to the sutures. Of course, it is conceivable to use different materials to implement the reinforcement element, which is connected to the inner surface of the prosthetic heart valve, such as wires, brackets, synthetic materials or even homograft (human) tissue. In order to reduce or prevent leakage during closed state of the prosthetic heart valve, however, the aforementioned reinforcement element has to be constructed with a minimal size, so as to avoid the formation of a gap in between the closed leaflets.
According to another embodiment of the present invention, the reinforcement elements are wrapped in tissue to avoid wear of the prosthetic heart valve tissue during operation. This is especially advantageous in the case of the implementation of rigid reinforcement elements, such as wires or brackets. The tissue, wrapped around the reinforcement elements, provides a soft contact surface for the prosthetic heart valve tissue and hence prevents it from rubbing and reduces wear.
In addition to the reinforcement elements, other stent structures may also be wrapped in tissue or any other suitable synthetic cover. That is, in order to avoid abrasion of the prosthetic heart valve against the stent structure (e.g. retaining arches), the stent may be wrapped in tissue or any other suitable material. In accordance with this particular embodiment of the present disclosure, the heart valve tissue may not be sutured directly to the metallic stent structure but to the tissue or synthetic material covering it. This could provide a closer contact between the prosthetic heart valve and the stent so as to reliably prevent paravalvular leakage.
Yet another modification of the present disclosure includes exposing the prosthetic heart valve material surface and structure to polymeric material in order to reinforce it. Materials according to this embodiment could be cyanoacrylates or polyepoxides which imply excellent bonding of body tissue and could even be used for suture-less surgery.
In a similar realisation the bendable transition portion of the prosthetic heart valve material includes a layering of various materials with differing mechanical properties used to improve the durability of the prosthetic heart valve. To this end, layer materials with very high suture retention strength overlapping the valve material in regions of very high stress load may be applied. As to that, material layers with high suture retention in lower parts of the transition area of the prosthetic heart valve may be provided, whereas the upper parts of the transition area shall be designed to be flexible for improving the durability of the valve. Examples for such layer materials will be explained in more detail, with reference to the “reinforcement elements” below.
With regard to another embodiment of the present disclosure, an attachment for the prosthetic heart valve material that reduces the concentration of stresses at the bendable transition portion is disclosed. In this embodiment, the bendable transition portion of the prosthetic heart valve is attached to the retaining arches of the stent by folding the valve material from the outside of the stent through slotts provided along the retaining arches. As mentioned previously, the edges of the slotted retaining arches may be rounded and smooth to avoid abrading or wearing of the valve material. In this design, there is some material thickness on the outside of the stent, which could impinge on the anchoring of the stent at the position of the diseased natural prosthetic heart valve.
To accommodate this issue, a thinning of the retaining arches relative to the rest of the stent structure could be conducted. This would also allow for a recess when the stent is compressed so that the collapsed prosthesis does not require a larger delivery catheter.
According to an alternative embodiment of the present disclosure, the prosthetic heart valve is assembled with three separate pieces of pericardial tissue. According to this, the three separate pieces of pericardial tissue are advantageous regarding the thickness of the prosthetic heart valve tissue. When using a one piece flat tissue in order to form the prosthetic heart valve, the thickness of the leaflets can vary and result in less desirable valve performance, unsymmetrical valve opening and closure or less desirable hemodynamics, such as a short durability or insufficient leaflet closure. Therefore, three smaller pieces of pericardial tissue provide the possibility to form prosthetic heart valve with more uniform thicknesses and mechanical properties.
To this end, another embodiment of the present disclosure includes that each of the three separate pieces has a flat tissue pattern in an essentially T-shirt like shape, exhibiting sleeves for connection between the adjacent pieces. As mentioned previously, the adjacent pieces can be constructed, as to reinforce the contiguous edges of the adjacent pieces. To accomplish this, the sleeves of adjacent pieces can be folded to the outside and sutured together to reinforce the joining connection. Attaching this reinforced area to the stent commissure attachment region helps to more uniformly distribute leaflet stresses supported by the commissure attachment.
In order to further improve the reinforcement of the contiguous edges of the separate pieces, in another embodiment of the present invention, the reinforcement elements consist of outer wrapping elements, wrapped around the sleeves of the three separate pieces, in order to reinforce the prosthetic heart valve and attach it to the commissure attachment region of the stent. That is, an outer wrapping element can be used in order to further improve the durability of the prosthetic heart valve. In this regard, the outer wrapping element can consist of a piece of pericardial tissue or a synthetic material respectively. Also, the outer wrapping element is used to attach the reinforced prosthetic heart valve to the commissure attachment region of the stent by means of sutures. Therefore, the stresses due to the suturing between the stent and the prosthetic heart valve is mainly introduced into the material of the reinforcement element, avoiding high stress concentrations in the prosthetic heart valve.
The following will make reference to the attached drawings in describing preferred embodiments of the prosthetic heart valve, a corresponding stent and a transcatheter delivered endoprosthesis according to the present disclosure in greater detail.
Shown are:
The leaflets 102 of the prosthetic heart valve 100 are adapted to be moveable from a first opened position for opening the heart chamber and a second closed position for closing the heart chamber. In particular, in the implanted state of the prosthetic heart valve 100, the leaflets 102 may switch between their first and second position in response to the blood flow through the patient's heart. During ventricular systole, pressure rises in the left ventricle of the patient's heart. When the pressure in the left ventricle of the patient's heart rises above the pressure in the aorta the leaflets 102 of prosthetic heart valve 100 opens, allowing blood to exit the left ventricle into the aorta. When ventricular systole ends, pressure in the left ventricle rapidly drops. When the pressure in the left ventricle decreases, the aortic pressure forces the leaflets 102 of the prosthetic heart valve 100 to close.
During the opening phase the leaflets pivot about a bendable transition area 104, as depicted in
In the exemplary embodiment depicted in
As can be seen from
Another aspect shown by
Between the leaflets 102 and the skirt portion 103, the valve pattern shows the bendable transition area 104 progressing in a substantial U-shaped manner, similar to the cusp-shape of a natural aortic or pulmonary heart valve.
As can be derived from
Although not depicted in
The bendable transition area 104 shown in
As the size and diameter of different blood vessels of different patients varies to a certain extent, it may be advantageous to provide prosthetic heart valves 100 of different designs. In particular, tissue material with a thickness of 160 μm to 300 μm, more preferably 220 μm to 260 μm may be used, depending on the particular tissue material used to manufacture the prosthetic heart valve. Furthermore, the prosthetic heart valve 100, according to the present disclosure, may have a diameter ranging form 19 mm to 28 mm.
Reference is made in the following to
As can be seen from the illustrations according to
For adapting the prosthetic heart valve 100 to a corresponding stent 10 so that the valvular leaflets 102 are properly formed and prosthetic heart valve is properly fitted to the stent structure, the pattern of the flat-tissue material of the prosthetic heart valve 100 shall be cut so as to incorporate the leaflet structures, the annular skirt portion 103 and the transition area 104 in between them. In other words, after the prosthetic heart valve material is sewn into its cylindrical or conical shape, the valve exhibits a flared portion at the lower end. This flared geometry fits the structure of the stent 10 and is constructed to optimally fit the vascular wall at the implantation site of the diseased heart valve.
In the exemplary embodiment of the transcatheter delivered endoprosthesis 1 depicted in
Upon assembly of this tissue pattern (see
As has been described in more detail with reference to
Accordingly, the lower part of leaflet support portion 103 of the prosthetic heart valve 100 affixed to the stent 10 also exhibits an extended diameter in order to accommodate the flared shape of the annular collar 40.
The prosthetic heart valve 100 is fixed to the stent 10 by means of sutures, threads or wires 101 which are attached to the skirt portion 103 and/or the transition area 104 of the prosthetic heart valve 100. The skirt portion 103 serves for keeping the prosthetic heart valve 100 in a predefined position relative to the stent 10.
As will be described in more detail below, a suitable stent 10, to which the prosthetic heart valve 100 may be attached for forming an endoprosthesis 1, may include an annular collar 40 arranged to a lower section of stent 10. The annular collar 40 of the stent 10 serves as an additional anchoring measure to hold the transcatheter delivered endoprosthesis 1 in a desired location at the site of the diseased heart valve.
As can be seen from the illustrations in
Moreover, a common running stitch pattern may be used to obtain said bonding. According to the disclosure, the stitch pattern is preferably a locking stitch or a blanket stitch respectively. Of course, any other suitable stitch pattern (i.e. overlocking stitch, slipstitch or topstitch) is also possible.
As indicated by
In the exemplary embodiment of the transcatheter delivered endoprosthesis 1 depicted in
The scope of the present disclosure will become more clear by considering some of the possible embodiments of a stent 10 with the prosthetic heart valve 100 attached thereto thereby forming an endoprosthesis. Hence, reference is made in the following to
In particular,
On the other hand,
The stent 10 depicted in
In addition, the stent 10 according to the exemplary embodiment has a total of three positioning arches 15a, 15b, 15c, which undertake the function of automatic positioning of the stent 10. Each of the positioning arches 15a, 15b, 15c has a radiused head portion 20, which engages in the pockets of the native heart valve being treated during positioning of the stent 10 at the implantation site in the heart.
The exemplary embodiment of the stent 10 also includes radial arches 32a, 32b, 32c. In particular, the stent 10 has three radial arches 32a, 32b, 32c, with each arch 32a, 32b, 32c located between the two arms 15a, 15a′, 15b, 15b′, 15c, 15c′ of each positioning arch 15a, 15b, 15c. Each radial arch 32a, 32b, 32c has a shape that is roughly inverse to each positioning arch 15a, 15b, 15c and extends in the opposite direction to each one of the positioning arches 15a, 15b, 15c.
In addition, the stent 10 according to the exemplary embodiment depicted in
In addition to the commissure attachment regions 11b, the stent 10 also comprises second lower leaflet attachment regions 11c for additional fastening of the tissue component(s) of a prosthetic heart valve 100 (see
The stent 10 may also be provided with leaflet guard arches, wherein one leaflet guard arch may be provided in between each positioning arch 15a, 15b, 15c. The structure and function of the leaflet guard arches will be described later with reference to
The exemplary embodiment of the sent 10 is characterized by a specific structure of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c. In detail, in the expanded state of the stent 10, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c have a shape similar to a prosthetic heart valve 100. Furthermore, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c are provided with a number of lower leaflet attachment regions 11c, each having a number of additional fastening holes 12a or eyelets provided for fastening the tissue component(s) of a prosthetic heart valve 100. These additional fastening holes 12a or eyelets provide attachment points for the bendable transition area 104 of a prosthetic heart valve 100 attached to the stent 10.
As will be described in more detailed below, in an alternative embodiment, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c may be provided with a number of fastening notches which can be used to fix the bendable transition area 104 to stent 10. Thus, in this alternative embodiment, there are no additional fastening holes 12a needed along the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c.
According to the stent designs of the embodiments depicted in
This specific design of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c has valve durability advantages. The so formed arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c serve for supporting the skirt portion 103 and edge of the leaflets 102 of a prosthetic heart valve 100 attached to the stent 10.
As depicted, for example, in
In detail and as depicted in the cutting pattern shown in
When manufacturing the stent 10, the stent structure and in particular the structure of the retaining arches 16a, 16b, 16c is programmed such that the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c have a curved shape in the expanded state of the stent 10. The shape of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c is such defined that the arms follow the shape of the transition area 104 of a prosthetic heart valve 100 to be affixed to the stent 10 (see
Hence, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c of the stent 10, onto which the transition area 104 of a prosthetic heart valve 100 is sewn or sewable, will change their shape when the stent 10 expands, wherein the retaining arches 16a, 16b, 16c are curved in the expanded state of the stent 10, but relatively straight when the stent 10 is collapsed.
As can be seen, for example, in
The stent 10 depicted in
In the embodiment depicted in
Hence, as shown in the exemplary embodiment of the transcatheter delivered endoprosthesis 1 depicted in
To reduce longitudinal displacement of the prosthetic heart valve 100 relative to the stent 10, the stent 10 comprises a plurality of fastening portions in the form of lower leaflet attachment regions 11c, essentially extending in the longitudinal direction L of stent 10. In addition, the stent 100 is provided with commissure attachment regions 11b. By means of the lower leaflet attachment regions 11c and the commissure attachment regions 11b (both acting as fastening portion), the tissue components of the prosthetic heart valve 100 are affixed to the stent 10.
In detail, the prosthetic heart valve 100 is fastened to the stent 10 by means of sutures 101, threads or a thin wire which is guided through fastening holes 12a, 12c of the lower leaflet attachment regions 11c and the commissure attachment regions 11b respectively. This allows fixing of the tissue components of the prosthetic heart valve 100 to the stent 10 at a predefined position relative to the stent 10.
Alternatively, as will be described with reference to
It can further be seen from the
On the other hand, it is conceivable to mount the prosthetic heart valve 100 to the outer surface of a support stent 1. That is, the skirt portion 102 could be in direct contact with the diseased native heart valve and could be attached to the stent 10 by means of sutures. Mounting the prosthetic heart valve 100 to the outer surface of the stent 10 supports the load transfer from the leaflet 102 to the stent 1. This greatly reduces stresses on the leaflets 102 during closing and consequently improves the durability thereof. Also, it is possible to design the valve to obtain improved hemodynamics in the case of mounting the skirt portion and commissures to the outer surface of the stent. Additionally, the heart valve material which is in direct contact with the diseased native heart valve provides a good interface for sealing against leakage (i.e., paravalvular leakage), tissue in-growth and attachment.
The material for the prosthetic heart valve 100 and, in particular the material for the leaflets 102 of the prosthetic heart valve 100 can be made from synthetics, animal valves or other animal tissues such as pericardium. The animal tissues can be from a number of types of animals. Preferably, the leaflet material of the prosthetic heart valve 100 is from either bovine or porcine pericardium, but other animals can also be considered, for example equine, kangaroo, etc.
Reference is made in the following to
The reinforcement elements 107.1 to 107.8 can be at discrete locations or continuously along the path of the stitching. For example, they can be placed opposite to the retaining arches of the stent on the other side of the prosthetic heart valve material. The depicted reinforcement elements 107.1 to 107.8 are applied in order to strengthen the attachment to the stent and reduce stress concentrations in the leaflet material that would occur by suturing directly to the bendable transition portion 104 or leaflet support portion 103 respectively. Further to this, the reinforcement elements 107.1 to 107.8 may avoid direct contact between knots of the sutures and the tissue of the prosthetic heart valve. Also, direct contact between the heart valve tissue and the stent structure or any other metallic component of the endoprosthesis can be avoided by the reinforcement elements.
The reinforcement elements 107.1 to 107.8 are preferably designed with rounded edges to avoid abrasion of the valve tissue during opening and closing of the prosthetic heart valve 100.
In more detail,
According to this exemplary embodiment, the connection of the prosthetic heart valve tissue to the stent 10 is reinforced by means of at least one reinforcement element in the form of a inner cushion 107.1 which is intended to reduce stress concentrations in the tissue material of the prosthetic heart valve 100, said that stress concentrations may occur from direct stitching in the tissue material of the prosthetic heart valve 100. The at least one reinforcement element in the form of the inner cushion 107.1 is placed between a suture 101.1 and the tissue material of the prosthetic heart valve 100. In this respect, any stress caused by the suture 101.1 is distributed over a larger area of the tissue material of the prosthetic heart valve 100. The at least one reinforcement element in the form of the inner cushion 107.1 is placed opposite to the corresponding retaining arch 16a, 16b, 16c of the stent 10 on the other side of the tissue material of the prosthetic heart valve 100. That is, the at least one reinforcement element in the form of the inner cushion 107.1 is mounted to the inner surface of the bendable transition area 104 of the prosthetic heart valve 100. The at least one inner cushion 107.1 representing a first embodiment of the reinforcement elements may be folded in such a way that at least one round edge 108 is formed. This at least one round edge 108 is designed to avoid abrasion of tissue material of the leaflets 102 during opening and closing of the prosthetic heart valve 100.
The reinforcement element in the form of the inner cushion 107.1 may be made of one or multiple layer materials, consisting of materials like polyester velour, PTFE, pericardial tissue, or any other material suitable for forming round edges, distributing or buffering stresses in the tissue material of the prosthetic heart valve 100. The reinforcement element in the form of the inner cushion 107.1 can be applied to span across the gap formed between the lower end of two neighbouring arms 16a′, 16a″; 16b′, 16b″; 16c′, 16c″ of one retaining arches 16a, 16b, 16c (see
Reference is further made to
Again, the reinforcement element may be made of one or multiple layer materials and consisting of materials like polyester velour, PTFE, pericardial tissue or any other material suitable for forming round edges. As shown in
Moreover, the inner attachment rail 107.4 is placed on the inner surface of the tissue material of the prosthetic heart valve 100, opposite to the retaining arches 16a, 16b, 16c. Thus the prosthetic heart valve 100 is clamped in between the retaining arches 16a, 16b, 16c and the inner attachment rail 107.4, wherein the retaining arches 16a, 16b, 16c and the inner attachment rail 107.4 are connected by means of sutures 101.1.
In an alternative embodiment, however, the connection between retaining arches 16 and the inner attachment rail 107.4 may utilize rivets, welding or soldering, so as to clamp the biological prosthetic heart valve tissue without penetrating it with needles or suture. In turn, it is preferable, that the inner attachment rail 107.4 may be made of Nitinol, in order to allow simultaneously collapsing with the stent 10.
Of course, the edges of the inner attachment rail 107.4 may be rounded in order to prevent abrasion of the leaflets 102. In addition, the inner attachment rail 107.4 could be wrapped in tissue or synthetic material to further reduce the potential wear during the contact with the leaflet material upon the heart valve operation.
As depicted in
The outer wrapping element 107.5 is attached the commissure attachment region 11b by means of sutures 101.1. Additional lateral sutures 101.2 are provided to press the outer wrapping element 107.5 onto the outer surface of the bendable transition area 104 of the prosthetic heart valve 100.
The outer wrapping element 107.5 is preferably made of a polymer material such as PTFE, PET fabric or sheet or a piece of pericardial tissue. However, it could also be a more rigid u-shaped clip or bendable material that can pinch the folded tissue material of the prosthetic heart valve 100 without the use of additional lateral sutures 101.2. In addition, this outer wrapping element 107.5 acts as a bumper to limit the opening of the leaflets 102 in order to prevent them from hitting stent 10.
The dashed lines in
One embodiment might include thinning the retaining arches 16a, 16b, 16c on the outer surface relative to the rest of the stent structure, to accommodate the tissue material on the outside surface. This would also allow for a recess when the stent 10 is compressed so that the collapsed prosthesis does not require a larger delivery catheter.
In detail,
The 4 mm wide porcine pericardium outer reinforcement element 107.6 may be folded in half and sutured using a fine clinging suture 101.4 (e.g. a 8-0 suture) with a running stitch very close to the free edges. The sutured outer reinforcement element 107.6 is then placed along the inner surface of the retaining arches 16a, 16b, 16c and/or the commissure attachment region lib with a 8-0 running stitch placed along the stent surface. The outer reinforcement element 107.6 is sutured to the stent to line the inner surface using 6-0 surrounding sutures 101.3 and zig-zag crossing stitches that wrap around the commissure attachment region 11b and/or the retaining arches 16a, 16b, 16c (not through the eyelets).
With regards to the inner reinforcement element 107.7, the material is preferably a strip of 200 μm porcine pericardium, which is about 3.5 mm wide and cut and overlapped or rolled to three layers. The length of the piece of tissue depends on whether only the commissure attachment region 11b or the retaining arches 16a, 16b, 16c are reinforced. For only the commissure attachment region 11b, three short segments of about 5 mm are needed. The strip is held in the overlapped or rolled shape by clinging sutures 101.4 with an 8-0 running stitch. The inner reinforcement element 107.7 may be constructed such as to exhibit minimal size to avoid causing too big of a cavity 109 in between the leaflets 102 during closure of the prosthetic heart valve 100. The inner reinforcement element 107.7 is secured on the inner surface of the bendable transition area 104 of the prosthetic heart valve 100 and to the stent 10 through the eyelets 12a. Preferably, 4-0 sutures 101.1 with a locking stitch on the outer diameter are used for this purpose. These sutures 101.1 are the most critical in the assembly and need to be very tight with no slack and locking. Instead of a single 4-0 suture 101.1, it is contemplated that two 6-0 sutures for redundancy and similar overall total strength are used. Furthermore, the 4-0 sutures 101.1 hold the outer reinforcement element 107.6 in place.
When opening and closing the leaflets 102 of the prosthetic heart valve 100, the outer reinforcement element 107.6 acts as a bumper to absorb shocks which affect the leaflets 102 during opening. In turn, the inner reinforcement element 107.7 spreads out the compressive forces induced by the sutures 101.1, thus avoiding stress concentration at the transition area 104 of the prosthetic heart valve 100.
In the following, reference is made to
In contrast to the exemplary embodiment shown in
The endoprosthesis 1 according to the exemplary embodiment illustrated by
In the structure of the stent 10 according to the embodiment depicted in
Each leaflet guard arch 50a, 50b, 50c has a substantially U-shaped or V-shaped structure which is closed to the lower end 2 of the stent 10. In particular, each leaflet guard arch 50a, 50b, 50c has a shape that is roughly similar to the shape of the positioning arch 15a, 15b, 15c and each leaflet guard arch 50a, 50b, 50c is arranged within the arms of the corresponding positioning arch 15a, 15b, 15c. Furthermore, each of the leaflet guard arches 50a, 50b, 50c extends in the same direction as the positioning arch 15a, 15b, 15c.
The leaflet guard arches 50a, 50b, 50c are preferably programmed so that they extend in a radial direction outside the circumference of the stent 10 when the stent 10 is in its expanded state. In this way, an increased contact force can be applied to the leaflets of the native (diseased) cardiac valve when the stent 10 is in its expanded and implanted state. This, in turn, allows an increased security in the fixing of the stent 10 in situ.
When the stent 10 is in its expanded and implanted state, the leaflet guard arches 50a, 50b, 50c actively keep the diseased leaflets, i.e. the leaflets of the native cardiac valve, from impinging the leaflets 102 of a prosthetic heart valve 100 attached to the stent 10, when the positioning arches 15a, 15b, 15c are placed outside the native leaflets. In addition, the leaflet guard arches 50a, 50b, 50c may also provide additional anchoring and securing against migration.
An alternative embodiment of a stent 10 is shown in
In contrast to the first embodiment of a stent 10 depicted in
In more detail,
Thus, the stent 10 according to the second stent embodiment comprises a plurality of positioning arches 15a, 15b, 15c and a plurality of retaining arches 16a, 16b, 16c. Each of the plurality of positioning arches 15a, 15b, 15c is configured to be positioned within a plurality of pockets of the patient's native heart valve and positioned on a first side of a plurality of native heart valve leaflets. On the other hand, each of the plurality of retaining arches 16a, 16b, 16c is configured to be positioned on a second side of the plurality of native heart valve leaflets opposite the first side.
Furthermore, a plurality of leaflet guard arches 50a, 50b, 50c are provided, each interspaced between the two arms 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of one of the plurality of positioning arches 15a, 15b, 15c. In addition, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c are preferably provided with a plurality of bending edges 33 in order to divide each arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ into a plurality of arm segments, wherein the structure of the stent 10 is programmed such that the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c have a curved shape at least in the expanded state of the stent 10. In particular, the shape of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c shall be such defined that the arms follow the shape of the bendable transition area 104 of the prosthetic heart valve 100 to be affixed to the stent 10.
In detail and as depicted in the flat roll-out view shown in
When manufacturing the stent 10, the stent structure and in particular the structure of the retaining arches 16a, 16b, 16c is programmed such that the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ have a curved shape in the expanded state of the stent 10. The shape of the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ is such defined that the arms follow the shape of the leaflets of a prosthetic heart valve 100 to be affixed to the stent 10 (cf.
Hence, the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″, onto which the prosthetic heart valve 100 is sewn or sewable, will change their shape when the stent 10 expands, wherein the retaining arches 16a, 16b, 16c are curved in the expanded state of the stent 10, but relatively straight when the stent 10 is collapsed. Thus, when in the expanded state, the retaining arches 16a, 16b, 16c of the stent 10 are adapted to fit to the shape of the bendable transition area 104 of the prosthetic heart valve 100. In detail, in their expanded state, the retaining arches 16a, 16b, 16c are adapted to progress in an essentially u-shaped manner, similar to the shape of a natural aortic or pulmonary heart valve, for reducing tissue stresses during the opening and closing motion of the leaflets 102.
As can be seen, for example, in
According to the design of the second stent embodiment, the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c are not provided with fastening holes 12a, as it is the case, for example, in the first embodiment of the stent (
A comparison with, for example, the flat roll-out view pursuant to
Moreover, by using the bending edges 33 provided in the retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ as fastening notches for fixing a heart valve prosthesis to the stent 10, a greater number of attachment points compared with the number of fastening holes 12a can be generated. In this regard, high stress concentrations at each single attachment point can be effectively avoided. Furthermore, the fastening notches provide space and allow for the sutures 101 to be protected during collapsing of the valve 100 into the catheter. Therefore, adjacent members of the stent 10 do not impinge on and damage the sutures 101 used to attach the prosthetic heart valve 100 to the retaining arches 16a, 16b, 16c, during collapsing and deployment of the prosthetic heart valve 100.
In addition, in the second embodiment of the stent, the attachment points (bending edges 33) to be used for fixing a heart valve prosthesis to the retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the stent 10 are more uniformly distributed along the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″, thereby providing a more uniform fixation of a heart valve prosthesis to the stent. Hence, the risk of an axial displacement of the heart valve prosthesis relative to the stent may be further reduced. Each individual bending edge 30 provided in the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ thereby serves to guide a thread or thin wire with which the tissue component(s) of the prosthetic heart valve is affixed or sewn to the corresponding retaining arch arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the stent 10. In detail, the means (thread or thin wire) provided for fastening the tissue component(s) of the prosthetic heart valve to the respective retaining arch arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ is guided by way of the bending edge 33 acting as fastening notch so that a longitudinal displacement of the prosthetic heart valve relative to the stent 10 is substantially minimized. This also allows exact positioning of the prosthetic heart valve relative the stent 10.
In addition, the stent 10 according to the second stent embodiment may further include at least one auxiliary arch 18a, 18b, 18c interspaced between two adjacent retaining arches 16a, 16b, 16c, wherein the at least one auxiliary arch 18a, 18b, 18c includes a first arm 18a′, 18b′, 18c′ connected at a first end thereof to a first retaining arch 16a, 16b, 16c and a second arm 18a″, 18b″, 18c″ connected at a first end thereof to a second retaining arch 16a, 16b, 16c, and wherein the first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the at least one auxiliary arch 18a, 18b, 18c each include respective second ends connected to an annular collar 40 which is arranged at the lower end section of the stent body. As in the previously described stent design (first stent embodiment), this at least one collar 40 serves as an additional anchoring measure for a stent cut from a portion of a tube by using the cutting pattern depicted in
In detail, the respective first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the at least one auxiliary arch 18a, 18b, 18c are part of a strut or web structure which is provided between the first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of two adjacent auxiliary arches 18a, 18b, 18c in order to support the prosthetic heart valve 100 to be affixed to the stent 10 (see, for example,
The terms “strength” or “resistance to deformation” as used herein may be used to denote any of a number of different properties associated with the reinforcement members. For example, the terms may be used to refer to properties of the material from which the reinforcement members are made, such as the yield strength, the modulus of elasticity, the modulus of rigidity, or the elongation percentage. Similarly, the terms may be used to refer to the hardness of the reinforcement members. Hardness may be characterized as the “durometer” of the material, in reference to the apparatus used to measure the hardness of the material. The terms may also be used to denote geometric characteristics of the reinforcement members, such as the thickness of the reinforcement members. The terms “strength” or “resistance to deformation” may also be used to characterize any combination of the above properties as well as additional properties and/or characteristics.
The strength or resistance to deformation of the area between the first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of two adjacent auxiliary arches 18a, 18b, 18c can be increased in any number of ways. As can be seen from
It is also conceivable that a reinforcement web is provided in order to increase the strength or resistance to deformation of the area between the first and second arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of two adjacent auxiliary arches 18a, 18b, 18c. This reinforcement web may also be composed by a plurality of reinforcement elements (e.g. struts or strut-like members) which are interconnected to each other thereby forming a rhomboidal pattern.
The strength or resistance to deformation of the area between the first and second arms 18a′, 18a″, 18b°, 18b′, 18c′, 18c″ of two adjacent auxiliary arches 18a, 18b, 18c can be increased, for example, by increasing the thickness of the reinforcement members, by eliminating stress concentration risers in the design of the stent 10, or by changing other aspects of the geometry of the reinforcement members. The strength can also be increased by changing the material properties of the stent 10 and/or the reinforcement members. For example, the reinforcement members can be made from a number of different materials, preferably shape memory materials, each having a different level of hardness. In this regard, it is conceivable to vary the stoichiometric composition of the material used for forming the stent and the reinforcement members such as to adapt the material properties of the stent 10 and/or the reinforcement members to the specific needs of each stent application. It is also conceivable to use different materials, for example nitinol and a shape-memory polymer, for forming the stent and the reinforcement members. In this manner, the selection of the reinforcement members can be tailored to the specific needs of each stent application. For example, in regions where a high external force is expected, reinforcement members having a high hardness may be preferred. The strength may also be increased by combining material properties with geometric changes.
As can be seen from
In addition, this structure of the lattice cells 70 formed by a plurality of struts in the area between the adjacent arms of two neighbouring retaining arches 16a, 16b, 16c may provide uniform stent structure which may minimize blood leakage in the implanted stage of the stent 10 having a heart valve prosthesis attached thereto.
The upper end sections of the respective struts which are forming the structure of the lattice cells 70 are connected to the respective arms of the retaining arches 16a, 16b, 16c. Preferably, the upper end sections of the struts comprise a widened diameter in order to strengthen the connection between the upper end sections of the struts and the arms of the retaining arches 16a, 16b, 16c.
The already mentioned annular collar 40, which is provided at the lower end section of the stent body, is connected with the stent body via the retaining arches 16a, 16b, 16c on the one hand and the second ends of the respective arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the at least one auxiliary arch 18a, 18b, 18c on the other hand, wherein these arms 18a′, 18a″, 18b′, 18b″, 18c′, 18c″ of the at least one auxiliary arch 18a, 18b, 18c are part of the structure of the lattice cells 70. In particular, the stent 10 according to the second embodiment is provided with an annular collar 40 which is shortened in its length by having only a single row of cells.
As can be seen from the flat roll-out view pursuant to
In order to further improve securing of the position of an implanted and expanded endoprosthesis 1 and preventing antegrade migration, the stent 10 according to the second stent embodiment is provided with a flared or tapered section with a radius shape at its lower end section 2. In detail and as depicted in
The stent 10 depicted in
As depicted in
If the implanted and expanded stent together with a prosthetic heart valve affixed thereto extend too far below the annulus of the heart, there may be the risk that the implanted endoprosthesis consisting of the stent 10 on the one hand and the prosthetic heart valve 100 on the other hand contacts the nerve bundles and heart block. The nerve bundles may enter at a location approximately 6 to 10 mm below the annulus of the heart.
In order to avoid the lower end section 2 of the implanted stent 10 touching the atrioventricular node, the stent 10 pursuant to the second stent embodiment is provided with an annular collar 40 which is shortened in its length by having only a single row of cells. In this regard, the total height of the stent 10 and thus the total height of the endoprosthesis 1 to be implanted into the body of the patient are reduced.
Moreover, in the programming process during which the shape of the desired (expanded) stent structure is fixed, the supporting webs 41 of the annular collar 40 may be programmed so that—when the stent 10 of the second embodiment is in its expanded state—only the upper section of the annular collar 40 extends in a radial direction outside the circumference of the stent 10, whereas the lower end section of the annular collar 40 bended relative to the upper section of the annular collar 40 in the radial direction inside the circumference of the stent 10. The lower end section of the annular collar 40 may be bent such that it extends, for example, approximately parallel to the longitudinal direction L of the stent 10. In this way, an increased contact force (radial force) is applied by the upper section of the annular collar 40 to the wall of the blood vessel into which the stent 10 is deployed, whereas the risk is reduced that the lower end section of the annular collar 40 can touch the atrioventricular node.
It is important to note, that the stent 10 according to the second stent embodiment comprises a number of notches 12e uniformly distributed around the lower end section of the annular collar 40. These notches 12e can be used for fixing a heart valve prosthesis (not shown in
A comparison with, for example, the flat roll-out view pursuant to
Hence, by providing notches 12e instead of eyelets 12f as additional fastening means at the lower end section of the annular collar 40, a greater number of notches 12e compared with the number of eyelets 12f can be generated. In detail, according to the second stent embodiment, the lower end sections of every supporting web 41 of the annular collar 40 is provided with a corresponding notch 12e acting as additional fastening means. In contrast, in the first embodiment of the stent (
In this regard, the stent design according to the second stent embodiment differs from the first stent design in that at the lower end section of every supporting web 41 of the annular collar 40 an additional fastening means is provided. This is due to the fact that, in the second embodiment of the stent 10, notches 12e are used as additional fastening means.
Hence, in the second stent embodiment, the additional fastening means to be used for fixing a heart valve prosthesis to the stent 10 are more uniformly distributed around the lower end section of the annular collar 40, thereby providing a more uniform fixation of a prosthetic heart valve to the stent. Hence, the risk of an axial displacement of the heart valve prosthesis relative to the stent may be further reduced. Each individual notch 12e provided at the lower end section of the annular collar 40 thereby serves to guide a thread or thin wire with which the tissue component(s) of the prosthetic heart valve is affixed or sewn to the lower end section of the annular collar 40 of the stent 10. In detail, the means (thread or thin wire) provided for fastening the tissue component(s) of the prosthetic heart valve 100 to the lower end section of the annular collar 40 is guided by way of the notches 12e so that a longitudinal displacement of the prosthetic heart valve relative to the stent 10 is substantially minimized. This also allows positioning of the prosthetic heart valve relative the stent 10. To this end, as can be seen in
Moreover, by using corresponding notches 12e for the secure and defined fixing of the tissue component(s) of the prosthetic heart valve to the lower end section of the annular collar 40 of the stent 10, the means (threads or thin wires) used to fasten the tissue component(s) to the stent 10 are effectively prevented from being squeezed and thus degraded when the stent 10 with the prosthetic heart valve affixed thereto, i.e. the endoprosthesis 1, is compressed and brought into its collapsed shape such as to be ready for being inserted into a catheter system which is used for implanting the endoprosthesis 1. In this regard, the risk of structural deterioration in the threads or thin wires used to fasten the tissue component(s) of the prosthetic heart valve 100 to the stent 10 is reduced.
The cross-sectional shape of the notches 12e may be adapted to the cross-sectional shape of the thread or thin wire used to fasten the tissue component(s) of the prosthetic heart valve 100. This allows fixing of the tissue component(s) of the prosthetic heart valve 100 to the stent 10 at a precise predefined position relative to the stent 10. Because the fastening holes 12 are adapted to the thickness and/or the cross-sectional shape of the thread or thin wire used to affix the prosthetic heart valve 100 to the stent 10, relative movement between the stent 10 and the tissue component(s) of the prosthetic heart valve 100 due to the peristaltic motion of the heart can be effectively prevented when the endoprosthesis 1 is implanted. In the fully expanded and implanted state of the endoprosthesis 1, the tissue component(s) of the prosthetic heart valve 100 is/are thus fastened to the stent 10 with minimal play, based on which friction-induced wear of the thread or thin wire used to affix the prosthetic heart valve is minimized. As shown in, for example, in
As can be seen, in particular from
Referring to the flat roll-out view shown in
On the other hand, each leaflet guard arch 50a, 50b, 50c has a substantially U-shaped or V-shaped structure which is closed to the lower end 2 of stent. Again, each leaflet guard arch 50a, 50b, 50c has a shape that is roughly similar to the shape of the positioning arch 15a, 15b, 15c in between the corresponding leaflet guard arch 50a, 50b, 50c is arranged. Furthermore, each leaflet guard arch 50a, 50b, 50c extends in the same direction as the positioning arch 15a, 15b, 15c.
In the stent design of the second stent embodiment, each arm of a leaflet guard arch 50a, 50b, 50c merges at about the mid-point of the length of an arm of a radial arch 32a, 32b, 32c into the arm of an opposing radial arch 32a, 32b, 32c. According to the stent design of the second stent embodiment, the leaflet guard arches 50a, 50b, 50c project in the longitudinal direction L of the stent and have a reduced length such that the positioning arches 15a, 15b, 15c can deploy during the expansion of the stent 10 and the leaflet guard arches 50a, 50b, 50c do not interfere during deployment.
The positioning arches 15a, 15b, 15c disposed on the stent 10 and also the retaining arches 16a, 16b, 16c may be curved in convex and arched fashion in the direction to the lower end section of the stent; i.e. toward the lower end 2 of the stent, whereby such a rounded form may reduce injuries to the artery as well as facilitate the unfolding during the self-expansion. Such a design may enable an easier insertion of the positioning arches 15a, 15b, 15c into the pockets of the native cardiac valve without correspondingly injuring the neighbouring tissue or blood vessels.
Although not explicitly illustrated in the flat roll-out view according to
When the stent is in its expanded and implanted state, the leaflet guard arches 50a, 50b, 50c actively keep the diseased leaflets, i.e. the leaflets of the native cardiac valve, from impinging the leaflet tissue of the prosthetic heart valve 100 attached to the stent 10, when the positioning arches 15a, 15b, 15c are placed outside the native leaflets. In addition, the leaflet guard arches 50a, 50b, 50c may also provide additional anchoring and securing against migration. This feature may be unique compared to the cage known from the prior art stent designs which are not provided with positioning arches to push the diseased leaflets out of the way.
As can be seen from the roll-out view depicted in
In the programming process during which the shape of the desired (expanded) stent structure is fixed, the radial arches 32a, 32b, 32c are programmed so that they extend in a radial direction outside the circumference of the stent 10 when the stent 10 is in its expanded state. In this way an increased contact force can be applied to the vessel wall by the upper end region of the stent 10. This, in turn, allows an increased security in the fixing of the stent 10 in situ, thereby reducing the likelihood of migration of the stent 10. Therefore, in its expanded state, in addition to the clamping effect of the positioning arches 15a, 15b, 15c and in addition to the additional anchoring obtainable by the leaflet guard arches 50a, 50b, 50c, the stent 10 of the second stent embodiment is secured in place on implantation via radial forces exerted by the retaining arches 16a, 16b, 16c, the auxiliary arches 18a, 18b, 18c, the radial arches 32a, 32b, 32c, and the annular collar 40, all of which project outwards in a radial direction from the circumference of the stent 10.
It can be seen from the flat roll-out view shown in
In principle, the stent 10 may have more than three radial arches 32 in order to increase the radial contact force further. It is also possible to provide barb elements on all or some of the radial arches 32a, 32b, 32c, for example, to allow a still better anchoring of the stent 10 at the implantation site.
Moreover, with respect to fixing the upper area 3 of stent 10 to the wall of the blood vessel into which the stent 10 is deployed, it would be conceivable for the stent 10 to comprise barb members arranged, for example, on the eyelets 24, the tips of the barbs pointing toward the lower end 2 of stent 10.
In addition, a liner or sheath, typically a fabric, polymeric or pericardial sheet, membrane, or the like, may be provided over at least a portion of the exterior of the stent 10 to cover all or most of the surface of the outside of the stent 10, extending from a location near the lower end section of the stent to a location near the upper end section of the stent. The liner may be attached to the stent 10 at at least one end, as well as at a plurality of locations between said ends thereby forming an exterior coverage. Such exterior coverage provides a circumferential seal against the inner wall of the blood vessel lumen in order to inhibit leakage of blood flow between the stent 10 and the luminal wall thereby and to prevent a blood flow bypassing the endoprosthesis 1.
For example, the liner may be stitched or otherwise secured to the stent 10 along a plurality of circumferentially spaced-apart axial lines. Such attachment permits the liner to fold along a plurality of axial fold lines when the stent 10 is radially compressed. The liner will further be able to open and conform to the luminal wall of the tubular frame as the frame expands. Alternatively, the liner may heat welded, or ultrasonically welded to the stent 10. The liner may be secured to the plurality of independent arches (positioning arches 15a, 15b, 15c, retaining arches 16a, 16b, 16c, auxiliary arches 18a, 18b, 18c, leaflet guard arches 50a, 50b, 50c) preferably along axial lines. In addition, the liner may be secured to the annular collar 40 provided at the lower end section 2 of the stent 10. The liner will preferably be circumferentially sealed against the stent 10 at at least one end.
By covering at least a part of the outside surface of the stent 10 with the liner or sheath, thrombogenicity of the endoprosthesis 1 resulting from exposed stent elements is greatly reduced or eliminated. Such reduction of thrombogenicity is achieved while maintaining the benefits of having a stent structure which is used for spreading up a prosthetic heart valve 100 and for anchoring the prosthetic heart valve 100 in place.
As already mentioned, the stent 10 can be compressed from a relaxed, large diameter configuration to a small diameter configuration to facilitate introduction. It is necessary, of course, that the outer liner remain attached to the stent 10 both in its radially compressed configuration and in its expanded, relaxed configuration.
The liner is composed of pericardial material or conventional biological graft materials, such as polyesters, polytetrafluoroethylenes (PTFE's), polyurethanes, and the like, usually being in the form of woven fabrics, non-woven fabrics, polymeric sheets, membranes, and the like. A presently preferred fabric liner material is a plain woven polyester, such as Dacron® yarn (Dupont, Wilmington, Del.).
A third embodiment of the stent 10 according to the present invention is described in the following with reference to
The third embodiment of the stent 10 is similar in structure and function with respect to the second embodiment. To avoid repetition, reference is therefore made to the above description of the second embodiment. In particular, the lower end section of the stent 10 is constituted by an annular collar 40 which is likewise provided with notches 12e acting as additional fastening means.
In addition, the stent 10 according to the third stent embodiment is provided with retaining arches 16a, 16b, 16c whose arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ are segmented by a plurality of bending edges 33 which are not only used for defining a bending point of two neighboring arm segments, but also as fastening notches which can be used for fixing a heart valve prosthesis 100 to the stent 10. In turn, the retaining arches 16a, 16b, 16c of the third stent embodiment are adapted to extend along the bendable transition area 104 of the prosthetic heart valve, when the endoprosthesis is assembled.
The third embodiment of the stent 10 also includes radial arches 32a, 32b, 32c extending from the positioning arches 15a, 15b, 15c towards the upper end 3 of the stent 10. As is shown in the
Contrary to the stent design of the second stent embodiment, however, the stent design of the third embodiment is not provided with leaflet guard arches 50a, 50b, 50c. Furthermore, each arm of a radial arch 32a, 32b, 32c merges at about the mid-point of the length of the stent 10 into an arm 15a′, 15a″, 15b′, 15b″, 15c′, 15c″ of an opposing positioning arch 15a, 15b, 15c.
A fourth embodiment of the stent 10 according to the present invention is described in the following with reference to
From a comparison of
The fourth embodiment of the stent 10 only differs from the second stent embodiment in that the respective lower end sections of the leaflet guard arches 50a, 50b, 50c are removed. In particular, the lower end sections of the leaflet guard arches 50a, 50b, 50c between the points where each arm of a radial arch 32a, 32b, 32c merges is removed.
Another embodiment of an endoprosthesis 1 according to the present disclosure is shown by
In particular,
As indicated hereinbefore, this U-shape of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c is achieved by segmenting the arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″. In detail, the arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ are segmented by providing a plurality of bending edges 33. In the depicted expanded state of the stent 10, two neighboring arm segments are angled relative to each other, wherein the bending point of these two neighboring arm segments is defined by the bending edge 33 which is provided in between the both neighboring arm segments. Hence, the greater the number of bending edges 33 provided in an arm 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of a retaining arch 16a, 16b, 16c, the greater the number of arm segments which may extend in different directions in the expanded state of the stent 10. In this respect, the shape of the respective arms 16a′, 16a″, 16b′, 16b″, 16c′, 16c″ of the retaining arches 16a, 16b, 16c can be adapted to the shape of transition area 104 of a prosthetic heart valve 100 to be affixed to the stent 10 adapted so as to fit the retaining arches 16a, 16b, 16c to the progression of the bendable transition area 104 of the prosthetic heart valve 100.
Further to this,
Another feature which has already been described with reference to the second embodiment of the endoprosthesis 1 depicted by
As can further be derived from
It should be noted that this third endoprosthesis embodiment is not meant to be restrictive. Of course, it is also conceivable to attach a one piece prosthetic heart valve, in accordance with the first valve embodiment (
In the figures of this specification, the prosthetic heart valve 100 is generally mounted to the inner surface of the stent 10. Of course, it is also conceivable to mount the prosthetic heart valve 100 to the outer surface of a support stent 10. That is, the skirt portion 102 could be in direct contact with the diseased native heart valve and could be attached to the stent 10 by means of sutures. Mounting the prosthetic heart valve 100 to the outer surface of the stent 10 supports the load transfer from the leaflet 102 to the stent 10 and reduces the stress concentration near the attachment regions 11b, 11c. This greatly reduces stresses on the leaflets 102 during closing and consequently improves the durability thereof. Also, it is possible to design the valve to obtain improved hemodynamics in the case of mounting the skirt portion to the outer surface of the stent. Additionally, the heart valve material which is in direct contact with the diseased native heart valve provides a good interface for sealing against leakage (i.e., paravalvular leakage), tissue in-growth and attachment.
An alternative second embodiment of a prosthetic heart valve 100 is shown in
In particular,
The steps for the connection of two of the three separate pieces 120 on their contiguous edges 112 are depicted in
In a first step, the contiguous edges 112 are brought together and sleeves 111 of the separate pieces 120 are turned to the outside, as shown in
A reinforcement element 107.8 may then be attached to the front surface of the sleeves 111 by means of sutures 101.1, preferably applying a blanket stitch. At the same time, the continuous edges 112 are sewn together by means of the same sutures 101.1, again preferably applying a blanket stitch.
In a third step, the reinforced sleeves 111 are turned even further to the outside, so that they end up being folded rearwards onto the surface of the leaflets 102. This rearward folded position is then secured by means of lateral sutures 101.2 stitched on the outer surface of the reinforcement element 107.8.
A top view of the three separate pieces 120 sewn together and attached to the commissure attachment regions 11b of a stent 10 is illustrated in
A detailed perspective view of the attachment of the prosthetic heart valve 100 to the commissure attachment regions 11b of the present embodiment is shown in FIG. 20. The reinforcement element 107.8 is wrapped around the rearward folded sleeves 111. This rearward folded position is held by the lateral suture 101.2 connecting the opposite ends of the reinforcement element 107.8. The material of the reinforcement element 107.8 preferably has much higher suturing retention strength than the heart valve material of the three separate pieces 120.
For this reason, the reinforcement element 107.8 is used to attach the prosthetic heart valve 100 to the commissure attachment regions 11b of the stent 10, by means of suturing 101.1. Thus, stresses due to the suturing 101.1 between the stent 10 and the prosthetic heart valve 100 are mainly introduced into the material of the reinforcement element 107.8, avoiding high stress concentrations in the prosthetic heart valve 100. Additionally, the intent of this design is to limit the leaflet travel during the opening phase by pinching the commissure area to prevent the leaflets 102 from hitting the stent 10. Also, this assembly method displaces the valve commissures inward radially from the stent post to further limit the leaflets from hitting the stent.
The above disclosure is intended to be illustrative and not exhaustive. This description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the claims where the term “comprising” means “including, but not limited to”. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims.
Further, the particular features presented in the dependent claims can be combined with each other in other manners within the scope of the disclosure such that the disclosure should be recognized as also specifically directed to other embodiments having any other possible combination of the features of the dependent claims. For instance, for purposes of claim publication, any dependent claim which follows should be taken as alternatively written in a multiple dependent form from all prior claims which possess all antecedents referenced in such dependent claim if such multiple dependent format is an accepted format within the jurisdiction (e.g. each claim depending directly from claim 1 should be alternatively taken as depending from all previous claims). In jurisdictions where multiple dependent claim formats are restricted, the following dependent claims should each be also taken as alternatively written in each singly dependent claim format which creates a dependency from a prior antecedent-possessing claim other than the specific claim listed in such dependent claim below.
Number | Date | Country | Kind |
---|---|---|---|
10163831 | May 2010 | EP | regional |
This application is a continuation of U.S. application Ser. No. 15/658,955, filed on Jul. 25, 2017, now U.S. Pat. No. 10,603,164, which is a continuation of U.S. application Ser. No. 13/114,582, filed on May 24, 2011, now U.S. Pat. No. 9,744,031, which claims priority to U.S. Provisional Application No. 61/348,036 filed on May 25, 2010, and to EP Application No. 10163831.0, filed on May 25, 2010, the entire disclosures of each of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
15192 | Peale | Jun 1856 | A |
388776 | Hall | Aug 1888 | A |
944214 | Rydquist | Dec 1909 | A |
2121182 | Benjamin | Jun 1938 | A |
2669896 | Clough | Feb 1954 | A |
2682057 | Lord | Jun 1954 | A |
2701559 | Cooper | Feb 1955 | A |
2832078 | Williams | Apr 1958 | A |
3029819 | Edward et al. | Apr 1962 | A |
3099016 | Lowell et al. | Jul 1963 | A |
3113586 | Edmark, Jr. et al. | Dec 1963 | A |
3130418 | Head et al. | Apr 1964 | A |
3143742 | Cromie | Aug 1964 | A |
3210836 | Johanson et al. | Oct 1965 | A |
3221006 | Moore et al. | Nov 1965 | A |
3334629 | Cohn | Aug 1967 | A |
3365728 | Lowell et al. | Jan 1968 | A |
3367364 | Cruz, Jr. et al. | Feb 1968 | A |
3409013 | Henry et al. | Nov 1968 | A |
3445916 | Schulte et al. | May 1969 | A |
3540431 | Mobin-Uddin et al. | Nov 1970 | A |
3548417 | Kischer et al. | Dec 1970 | A |
3570014 | Hancock et al. | Mar 1971 | A |
3574865 | Hamaker | Apr 1971 | A |
3587115 | Shiley et al. | Jun 1971 | A |
3592184 | Watkins et al. | Jul 1971 | A |
3628535 | Ostrowsky et al. | Dec 1971 | A |
3642004 | Osthagen et al. | Feb 1972 | A |
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3714671 | Edwards et al. | Feb 1973 | A |
3725961 | Magovern et al. | Apr 1973 | A |
3755823 | Hancock | Sep 1973 | A |
3795246 | Sturgeon | Mar 1974 | A |
3839741 | Haller | Oct 1974 | A |
3868956 | Alfidi et al. | Mar 1975 | A |
3874388 | King et al. | Apr 1975 | A |
3983581 | Angell et al. | Oct 1976 | A |
3997923 | Possis | Dec 1976 | A |
4035849 | Angell et al. | Jul 1977 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4078268 | Possis | Mar 1978 | A |
4084268 | Ionescu et al. | Apr 1978 | A |
4106126 | Traenkle | Aug 1978 | A |
4106129 | Carpentier et al. | Aug 1978 | A |
4118806 | Porier et al. | Oct 1978 | A |
4164046 | Cooley | Aug 1979 | A |
4182446 | Penny | Jan 1980 | A |
4191218 | Clark et al. | Mar 1980 | A |
4214587 | Sakura, Jr. | Jul 1980 | A |
4215871 | Hirsch et al. | Aug 1980 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4233690 | Akins | Nov 1980 | A |
4261342 | Aranguren Duo | Apr 1981 | A |
4263680 | Reul et al. | Apr 1981 | A |
4265694 | Boretos et al. | May 1981 | A |
4291420 | Reul | Sep 1981 | A |
4297749 | Davis et al. | Nov 1981 | A |
4319831 | Matsui et al. | Mar 1982 | A |
RE30912 | Hancock | Apr 1982 | E |
4323358 | Lentz et al. | Apr 1982 | A |
4326306 | Poler | Apr 1982 | A |
4339831 | Johnson | Jul 1982 | A |
4343048 | Ross et al. | Aug 1982 | A |
4345340 | Rosen | Aug 1982 | A |
4350492 | Wright et al. | Sep 1982 | A |
4373216 | Klawitter | Feb 1983 | A |
4388735 | Ionescu et al. | Jun 1983 | A |
4406022 | Roy | Sep 1983 | A |
4423809 | Mazzocco | Jan 1984 | A |
4425908 | Simon | Jan 1984 | A |
4441215 | Kaster | Apr 1984 | A |
4441216 | Ionescu et al. | Apr 1984 | A |
4470157 | Love | Sep 1984 | A |
4484579 | Meno et al. | Nov 1984 | A |
4485816 | Krumme | Dec 1984 | A |
4491986 | Gabbay | Jan 1985 | A |
4501030 | Lane | Feb 1985 | A |
4502488 | Degironimo et al. | Mar 1985 | A |
4531943 | Van Tassel et al. | Jul 1985 | A |
4535483 | Klawitter et al. | Aug 1985 | A |
4546499 | Possis et al. | Oct 1985 | A |
4562597 | Possis et al. | Jan 1986 | A |
4574803 | Storz | Mar 1986 | A |
4580568 | Gianturco | Apr 1986 | A |
4592340 | Boyles | Jun 1986 | A |
4602911 | Ahmadi et al. | Jul 1986 | A |
4605407 | Black et al. | Aug 1986 | A |
4610688 | Silvestrini et al. | Sep 1986 | A |
4612011 | Kautzky | Sep 1986 | A |
4617932 | Kornberg | Oct 1986 | A |
4619246 | Molgaard-Nielsen et al. | Oct 1986 | A |
4643732 | Pietsch et al. | Feb 1987 | A |
4647283 | Carpentier et al. | Mar 1987 | A |
4648881 | Carpentier et al. | Mar 1987 | A |
4655218 | Kulik et al. | Apr 1987 | A |
4655771 | Wallsten | Apr 1987 | A |
4662885 | DiPisa, Jr. | May 1987 | A |
4665906 | Jervis | May 1987 | A |
4665918 | Garza et al. | May 1987 | A |
4680031 | Alonso | Jul 1987 | A |
4681908 | Broderick et al. | Jul 1987 | A |
4687483 | Fisher et al. | Aug 1987 | A |
4692164 | Dzemeshkevich et al. | Sep 1987 | A |
4705516 | Barone et al. | Nov 1987 | A |
4710192 | Liotta et al. | Dec 1987 | A |
4733665 | Palmaz | Mar 1988 | A |
4755181 | Igoe | Jul 1988 | A |
4759758 | Gabbay | Jul 1988 | A |
4769029 | Patel | Sep 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4787899 | Lazarus | Nov 1988 | A |
4787901 | Baykut | Nov 1988 | A |
4796629 | Grayzel | Jan 1989 | A |
4797901 | Goerne et al. | Jan 1989 | A |
4806595 | Noishiki et al. | Feb 1989 | A |
4819751 | Shimada et al. | Apr 1989 | A |
4829990 | Thuroff et al. | May 1989 | A |
4834755 | Silvestrini et al. | May 1989 | A |
4846830 | Knoch et al. | Jul 1989 | A |
4851001 | Taheri | Jul 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4865600 | Carpentier et al. | Sep 1989 | A |
4872874 | Taheri | Oct 1989 | A |
4873978 | Ginsburg | Oct 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4878906 | Lindemann et al. | Nov 1989 | A |
4883458 | Shiber | Nov 1989 | A |
4885005 | Nashef et al. | Dec 1989 | A |
4909252 | Goldberger | Mar 1990 | A |
4917102 | Miller et al. | Apr 1990 | A |
4922905 | Strecker | May 1990 | A |
4927426 | Dretler | May 1990 | A |
4950227 | Savin et al. | Aug 1990 | A |
4953553 | Tremulis | Sep 1990 | A |
4954126 | Wallsten | Sep 1990 | A |
4966604 | Reiss | Oct 1990 | A |
4969890 | Sugita et al. | Nov 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4986830 | Owens et al. | Jan 1991 | A |
4994077 | Dobben | Feb 1991 | A |
5002556 | Ishida et al. | Mar 1991 | A |
5002559 | Tower | Mar 1991 | A |
5002566 | Carpentier et al. | Mar 1991 | A |
5007896 | Shiber | Apr 1991 | A |
5026366 | Leckrone | Jun 1991 | A |
5026377 | Burton et al. | Jun 1991 | A |
5032128 | Alonso | Jul 1991 | A |
5035706 | Giantureo et al. | Jul 1991 | A |
5037434 | Lane | Aug 1991 | A |
5047041 | Samuels | Sep 1991 | A |
5053008 | Bajaj | Oct 1991 | A |
5059177 | Towne et al. | Oct 1991 | A |
5061273 | Yock | Oct 1991 | A |
5061277 | Carpentier et al. | Oct 1991 | A |
5064435 | Porter | Nov 1991 | A |
5078720 | Burton et al. | Jan 1992 | A |
5080668 | Bolz et al. | Jan 1992 | A |
5085635 | Cragg | Feb 1992 | A |
5089015 | Ross | Feb 1992 | A |
5094661 | Levy et al. | Mar 1992 | A |
5104399 | Lazarus | Apr 1992 | A |
5104407 | Lam et al. | Apr 1992 | A |
5108425 | Hwang | Apr 1992 | A |
5122154 | Rhodes | Jun 1992 | A |
5132473 | Furutaka et al. | Jul 1992 | A |
5141494 | Danforth et al. | Aug 1992 | A |
5143987 | Hansel et al. | Sep 1992 | A |
5147388 | Yamazaki | Sep 1992 | A |
5152771 | Sabbaghian et al. | Oct 1992 | A |
5159937 | Tremulis | Nov 1992 | A |
5161547 | Tower | Nov 1992 | A |
5163953 | Vince | Nov 1992 | A |
5163955 | Love et al. | Nov 1992 | A |
5167628 | Boyles | Dec 1992 | A |
5178632 | Hanson | Jan 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5193546 | Shaknovich | Mar 1993 | A |
5197979 | Quintero et al. | Mar 1993 | A |
5201757 | Heyn et al. | Apr 1993 | A |
5207695 | Trout, III | May 1993 | A |
5209741 | Spaeth | May 1993 | A |
5211183 | Wilson | May 1993 | A |
5215541 | Nashef et al. | Jun 1993 | A |
5217481 | Barbara | Jun 1993 | A |
5217483 | Tower | Jun 1993 | A |
5232445 | Bonzel | Aug 1993 | A |
5234447 | Kaster et al. | Aug 1993 | A |
5234456 | Silvestrini | Aug 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5258008 | Wilk | Nov 1993 | A |
5258023 | Reger | Nov 1993 | A |
5258042 | Mehta | Nov 1993 | A |
5272909 | Nguyen et al. | Dec 1993 | A |
5275580 | Yamazaki | Jan 1994 | A |
5279612 | Eberhardt | Jan 1994 | A |
5282847 | Trescony et al. | Feb 1994 | A |
5287861 | Wilk | Feb 1994 | A |
5295958 | Shturman | Mar 1994 | A |
5327774 | Nguyen et al. | Jul 1994 | A |
5330486 | Wilk | Jul 1994 | A |
5330500 | Song | Jul 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5336258 | Quintero et al. | Aug 1994 | A |
5342348 | Kaplan | Aug 1994 | A |
5344426 | Lau et al. | Sep 1994 | A |
5344427 | Cottenceau et al. | Sep 1994 | A |
5344442 | Deac | Sep 1994 | A |
5350398 | Pavcnik et al. | Sep 1994 | A |
5350399 | Erlebacher et al. | Sep 1994 | A |
5352240 | Ross | Oct 1994 | A |
5354330 | Hanson et al. | Oct 1994 | A |
5360444 | Kusuhara | Nov 1994 | A |
5368608 | Levy et al. | Nov 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5380054 | Galvis | Jan 1995 | A |
5387235 | Chuter | Feb 1995 | A |
5389096 | Aita et al. | Feb 1995 | A |
5389106 | Tower | Feb 1995 | A |
5397351 | Pavcnik et al. | Mar 1995 | A |
5397355 | Marin et al. | Mar 1995 | A |
5409019 | Wilk | Apr 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5415633 | Lazarus et al. | May 1995 | A |
5425739 | Jessen | Jun 1995 | A |
5425762 | Muller | Jun 1995 | A |
5429144 | Wilk | Jul 1995 | A |
5431676 | Dubrul et al. | Jul 1995 | A |
5433723 | Lindenberg et al. | Jul 1995 | A |
5443446 | Shturman | Aug 1995 | A |
5443449 | Buelna | Aug 1995 | A |
5443477 | Marin et al. | Aug 1995 | A |
5443495 | Buscemi et al. | Aug 1995 | A |
5443499 | Schmitt | Aug 1995 | A |
5449384 | Johnson | Sep 1995 | A |
5456712 | Maginot | Oct 1995 | A |
5456713 | Chuter | Oct 1995 | A |
5464449 | Ryan et al. | Nov 1995 | A |
5469868 | Reger | Nov 1995 | A |
5470320 | Tiefenbrun et al. | Nov 1995 | A |
5476506 | Lunn | Dec 1995 | A |
5476508 | Amstrup | Dec 1995 | A |
5476510 | Eberhardt et al. | Dec 1995 | A |
5480423 | Ravenscroft et al. | Jan 1996 | A |
5480424 | Cox | Jan 1996 | A |
5486193 | Bourne et al. | Jan 1996 | A |
5487760 | Villafana | Jan 1996 | A |
5489294 | McVenes et al. | Feb 1996 | A |
5489297 | Duran | Feb 1996 | A |
5489298 | Love et al. | Feb 1996 | A |
5496346 | Horzewski et al. | Mar 1996 | A |
5499995 | Teirstein | Mar 1996 | A |
5500014 | Quijano et al. | Mar 1996 | A |
5500015 | Deac | Mar 1996 | A |
5507767 | Maeda et al. | Apr 1996 | A |
5509930 | Love | Apr 1996 | A |
5522881 | Lentz | Jun 1996 | A |
5527337 | Stack et al. | Jun 1996 | A |
5530949 | Koda et al. | Jun 1996 | A |
5534007 | St. Germain et al. | Jul 1996 | A |
5540712 | Kleshinski et al. | Jul 1996 | A |
5545133 | Burns et al. | Aug 1996 | A |
5545209 | Roberts et al. | Aug 1996 | A |
5545211 | An et al. | Aug 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5549665 | Vesely et al. | Aug 1996 | A |
5549666 | Hata et al. | Aug 1996 | A |
5554119 | Harrison et al. | Sep 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5569274 | Rapacki et al. | Oct 1996 | A |
5571167 | Maginot | Nov 1996 | A |
5571174 | Love et al. | Nov 1996 | A |
5571175 | Vanney et al. | Nov 1996 | A |
5571215 | Sterman et al. | Nov 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5580922 | Park et al. | Dec 1996 | A |
5591185 | Kilmer et al. | Jan 1997 | A |
5591195 | Taheri et al. | Jan 1997 | A |
5593434 | Williams | Jan 1997 | A |
5595571 | Jaffe et al. | Jan 1997 | A |
5596471 | Hanlin | Jan 1997 | A |
5607464 | Trescony et al. | Mar 1997 | A |
5607465 | Camilli | Mar 1997 | A |
5609626 | Quijano et al. | Mar 1997 | A |
5613982 | Goldstein | Mar 1997 | A |
5618299 | Khosravi et al. | Apr 1997 | A |
5626553 | Frassica et al. | May 1997 | A |
5628784 | Strecker | May 1997 | A |
5632778 | Goldstein | May 1997 | A |
5634942 | Chevillon et al. | Jun 1997 | A |
5643278 | Wijay | Jul 1997 | A |
5645559 | Hachtman et al. | Jul 1997 | A |
5653684 | Laptewicz et al. | Aug 1997 | A |
5653745 | Trescony et al. | Aug 1997 | A |
5653749 | Love et al. | Aug 1997 | A |
5655548 | Nelson et al. | Aug 1997 | A |
5662124 | Wilk | Sep 1997 | A |
5662671 | Barbut et al. | Sep 1997 | A |
5662703 | Yurek et al. | Sep 1997 | A |
5665115 | Cragg | Sep 1997 | A |
5667523 | Bynon et al. | Sep 1997 | A |
5674277 | Freitag | Oct 1997 | A |
5674298 | Levy et al. | Oct 1997 | A |
5679112 | Levy et al. | Oct 1997 | A |
5681345 | Euteneuer | Oct 1997 | A |
5682906 | Sterman et al. | Nov 1997 | A |
5683451 | Lenker et al. | Nov 1997 | A |
5690644 | Yurek et al. | Nov 1997 | A |
5693083 | Baker et al. | Dec 1997 | A |
5693088 | Lazarus | Dec 1997 | A |
5693310 | Gries et al. | Dec 1997 | A |
5695498 | Tower | Dec 1997 | A |
5697972 | Kim et al. | Dec 1997 | A |
5700269 | Pinchuk et al. | Dec 1997 | A |
5702368 | Stevens et al. | Dec 1997 | A |
5709713 | Evans et al. | Jan 1998 | A |
5713917 | Leonhardt et al. | Feb 1998 | A |
5713950 | Cox | Feb 1998 | A |
5713951 | Garrison et al. | Feb 1998 | A |
5713953 | Vallana et al. | Feb 1998 | A |
5716370 | Williamson, IV et al. | Feb 1998 | A |
5716417 | Girard et al. | Feb 1998 | A |
5718725 | Sterman et al. | Feb 1998 | A |
5720391 | Dohm et al. | Feb 1998 | A |
5720776 | Chuter et al. | Feb 1998 | A |
5725549 | Lam | Mar 1998 | A |
5725550 | Nadal | Mar 1998 | A |
5728068 | Leone et al. | Mar 1998 | A |
5728151 | Garrison et al. | Mar 1998 | A |
5733267 | Del Toro | Mar 1998 | A |
5733325 | Robinson et al. | Mar 1998 | A |
5735842 | Krueger et al. | Apr 1998 | A |
5746476 | Novak et al. | May 1998 | A |
5746709 | Rom et al. | May 1998 | A |
5746765 | Kleshinski et al. | May 1998 | A |
5746775 | Levy et al. | May 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5749921 | Lenker et al. | May 1998 | A |
5755682 | Knudson et al. | May 1998 | A |
5755777 | Chuter | May 1998 | A |
5755783 | Stobie et al. | May 1998 | A |
5756476 | Epstein et al. | May 1998 | A |
5758663 | Wilk et al. | Jun 1998 | A |
5766151 | Valley et al. | Jun 1998 | A |
5769780 | Hata et al. | Jun 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5769882 | Fogarty et al. | Jun 1998 | A |
5769887 | Brown et al. | Jun 1998 | A |
5772609 | Nguyen et al. | Jun 1998 | A |
5776188 | Shepherd et al. | Jul 1998 | A |
5782809 | Umeno et al. | Jul 1998 | A |
5782904 | White et al. | Jul 1998 | A |
5795331 | Cragg et al. | Aug 1998 | A |
5797946 | Chin | Aug 1998 | A |
5797960 | Stevens et al. | Aug 1998 | A |
5799661 | Boyd et al. | Sep 1998 | A |
5800456 | Maeda et al. | Sep 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5800531 | Cosgrove et al. | Sep 1998 | A |
5807327 | Green et al. | Sep 1998 | A |
5807384 | Mueller | Sep 1998 | A |
5807405 | Vanney et al. | Sep 1998 | A |
5810836 | Hussein et al. | Sep 1998 | A |
5814016 | Valley et al. | Sep 1998 | A |
5817113 | Gifford, III et al. | Oct 1998 | A |
5817126 | Imran | Oct 1998 | A |
5823956 | Roth et al. | Oct 1998 | A |
5824037 | Fogarty et al. | Oct 1998 | A |
5824038 | Wall | Oct 1998 | A |
5824041 | Lenker et al. | Oct 1998 | A |
5824043 | Cottone, Jr. | Oct 1998 | A |
5824053 | Khosravi et al. | Oct 1998 | A |
5824055 | Spiridigliozzi et al. | Oct 1998 | A |
5824056 | Rosenberg | Oct 1998 | A |
5824061 | Quijano et al. | Oct 1998 | A |
5824063 | Cox | Oct 1998 | A |
5824064 | Taheri | Oct 1998 | A |
5824071 | Nelson et al. | Oct 1998 | A |
5824080 | Lamuraglia | Oct 1998 | A |
5829447 | Stevens et al. | Nov 1998 | A |
5830222 | Makower | Nov 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5841382 | Walden et al. | Nov 1998 | A |
5843158 | Lenker et al. | Dec 1998 | A |
5843161 | Solovay | Dec 1998 | A |
5843181 | Jaffe et al. | Dec 1998 | A |
5851232 | Lois | Dec 1998 | A |
5853419 | Imran | Dec 1998 | A |
5853420 | Chevillon et al. | Dec 1998 | A |
5855210 | Sterman et al. | Jan 1999 | A |
5855597 | Jayaraman | Jan 1999 | A |
5855600 | Alt | Jan 1999 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5855602 | Angell | Jan 1999 | A |
5860966 | Tower | Jan 1999 | A |
5860996 | Urban et al. | Jan 1999 | A |
5861024 | Rashidi | Jan 1999 | A |
5861028 | Angell | Jan 1999 | A |
5865723 | Love | Feb 1999 | A |
5868783 | Tower | Feb 1999 | A |
5873812 | Ciana et al. | Feb 1999 | A |
5873906 | Lau et al. | Feb 1999 | A |
5876373 | Giba et al. | Mar 1999 | A |
5876419 | Carpenter et al. | Mar 1999 | A |
5876434 | Flomenblit et al. | Mar 1999 | A |
5876448 | Thompson et al. | Mar 1999 | A |
5878751 | Hussein et al. | Mar 1999 | A |
5880242 | Hu et al. | Mar 1999 | A |
5885228 | Rosenman et al. | Mar 1999 | A |
5885238 | Stevens et al. | Mar 1999 | A |
5885259 | Berg | Mar 1999 | A |
5888201 | Stinson et al. | Mar 1999 | A |
5891160 | Williamson, IV et al. | Apr 1999 | A |
5891191 | Stinson | Apr 1999 | A |
5895399 | Barbut et al. | Apr 1999 | A |
5895420 | Mirsch, II et al. | Apr 1999 | A |
5899936 | Goldstein | May 1999 | A |
5906619 | Olson et al. | May 1999 | A |
5907893 | Zadno-Azizi et al. | Jun 1999 | A |
5908028 | Wilk | Jun 1999 | A |
5908029 | Knudson et al. | Jun 1999 | A |
5908451 | Yeo | Jun 1999 | A |
5908452 | Bokros et al. | Jun 1999 | A |
5910144 | Hayashi | Jun 1999 | A |
5910154 | Tsugita et al. | Jun 1999 | A |
5911734 | Tsugita et al. | Jun 1999 | A |
5911752 | Dustrude et al. | Jun 1999 | A |
5913842 | Boyd et al. | Jun 1999 | A |
5916193 | Stevens et al. | Jun 1999 | A |
5922022 | Nash et al. | Jul 1999 | A |
5924424 | Stevens et al. | Jul 1999 | A |
5925012 | Murphy-Chutorian et al. | Jul 1999 | A |
5925063 | Khosravi | Jul 1999 | A |
5928281 | Huynh et al. | Jul 1999 | A |
5931848 | Saadat | Aug 1999 | A |
5935119 | Guy et al. | Aug 1999 | A |
5935161 | Robinson et al. | Aug 1999 | A |
5935163 | Gabbay | Aug 1999 | A |
5938632 | Ellis | Aug 1999 | A |
5938697 | Killion et al. | Aug 1999 | A |
5941908 | Goldsteen et al. | Aug 1999 | A |
5944019 | Knudson et al. | Aug 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5104407 | Lam et al. | Sep 1999 | B1 |
5948017 | Taheri | Sep 1999 | A |
5954764 | Parodi | Sep 1999 | A |
5954766 | Zadno-Azizi et al. | Sep 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5961549 | Nguyen et al. | Oct 1999 | A |
5964405 | Benary et al. | Oct 1999 | A |
5964798 | Imran | Oct 1999 | A |
5968064 | Selmon et al. | Oct 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
5968070 | Bley et al. | Oct 1999 | A |
5971993 | Hussein et al. | Oct 1999 | A |
5975949 | Holliday et al. | Nov 1999 | A |
5976153 | Fischell et al. | Nov 1999 | A |
5976155 | Foreman et al. | Nov 1999 | A |
5976174 | Ruiz | Nov 1999 | A |
5976178 | Goldsteen et al. | Nov 1999 | A |
5976192 | McIntyre et al. | Nov 1999 | A |
5976650 | Campbell et al. | Nov 1999 | A |
5979455 | Maginot | Nov 1999 | A |
5980455 | Daniel et al. | Nov 1999 | A |
5980533 | Holman | Nov 1999 | A |
5980548 | Evans et al. | Nov 1999 | A |
5984956 | Tweden et al. | Nov 1999 | A |
5984957 | Laptewicz, Jr. et al. | Nov 1999 | A |
5984959 | Robertson et al. | Nov 1999 | A |
5984964 | Roberts et al. | Nov 1999 | A |
5987344 | West | Nov 1999 | A |
5989276 | Houser et al. | Nov 1999 | A |
5989287 | Yang et al. | Nov 1999 | A |
5993469 | McKenzie et al. | Nov 1999 | A |
5993481 | Marcade et al. | Nov 1999 | A |
5997525 | March et al. | Dec 1999 | A |
5997557 | Barbut et al. | Dec 1999 | A |
5997563 | Kretzers | Dec 1999 | A |
5997573 | Quijano et al. | Dec 1999 | A |
5999678 | Murphy-Chutorian et al. | Dec 1999 | A |
6001123 | Lau | Dec 1999 | A |
6001126 | Nguyen-Thien-Nhon | Dec 1999 | A |
6004261 | Sinofsky et al. | Dec 1999 | A |
6004347 | McNamara et al. | Dec 1999 | A |
6004348 | Banas et al. | Dec 1999 | A |
6007543 | Ellis et al. | Dec 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6010522 | Barbut et al. | Jan 2000 | A |
6010530 | Goicoechea | Jan 2000 | A |
6010531 | Donlon et al. | Jan 2000 | A |
6012457 | Lesh | Jan 2000 | A |
6013854 | Moriuchi | Jan 2000 | A |
6015431 | Thornton et al. | Jan 2000 | A |
5061277 | Carpentier et al. | Feb 2000 | B1 |
6019777 | Mackenzie | Feb 2000 | A |
6019778 | Wilson et al. | Feb 2000 | A |
6022370 | Tower | Feb 2000 | A |
6026814 | LaFontaine et al. | Feb 2000 | A |
6027476 | Sterman et al. | Feb 2000 | A |
6027520 | Tsugita et al. | Feb 2000 | A |
6027525 | Suh et al. | Feb 2000 | A |
6029671 | Stevens et al. | Feb 2000 | A |
6029672 | Vanney et al. | Feb 2000 | A |
6033582 | Lee et al. | Mar 2000 | A |
6035856 | LaFontaine et al. | Mar 2000 | A |
6036677 | Javier, Jr. et al. | Mar 2000 | A |
6036697 | DiCaprio | Mar 2000 | A |
6042554 | Rosenman et al. | Mar 2000 | A |
6042581 | Ryan et al. | Mar 2000 | A |
6042589 | Marianne | Mar 2000 | A |
6042598 | Tsugita et al. | Mar 2000 | A |
6042607 | Williamson, IV et al. | Mar 2000 | A |
6045565 | Ellis et al. | Apr 2000 | A |
6051014 | Jang | Apr 2000 | A |
6051104 | Oriaran et al. | Apr 2000 | A |
6053924 | Hussein | Apr 2000 | A |
6053942 | Eno et al. | Apr 2000 | A |
6056743 | Ellis et al. | May 2000 | A |
6059809 | Amor et al. | May 2000 | A |
6059827 | Fenton, Jr. | May 2000 | A |
6066160 | Colvin et al. | May 2000 | A |
6067988 | Mueller | May 2000 | A |
6068638 | Makower | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6074416 | Berg et al. | Jun 2000 | A |
6074417 | Peredo | Jun 2000 | A |
6074418 | Buchanan et al. | Jun 2000 | A |
6076529 | Vanney et al. | Jun 2000 | A |
6076742 | Benary | Jun 2000 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6079414 | Roth | Jun 2000 | A |
6080163 | Hussein et al. | Jun 2000 | A |
6080170 | Nash et al. | Jun 2000 | A |
6083257 | Taylor et al. | Jul 2000 | A |
6091042 | Benary | Jul 2000 | A |
6092526 | LaFontaine et al. | Jul 2000 | A |
6092529 | Cox | Jul 2000 | A |
6093166 | Knudson et al. | Jul 2000 | A |
6093177 | Javier, Jr. et al. | Jul 2000 | A |
6093185 | Ellis et al. | Jul 2000 | A |
6093203 | Uflacker | Jul 2000 | A |
6093530 | McLlroy et al. | Jul 2000 | A |
6096074 | Pedros | Aug 2000 | A |
6102941 | Tweden et al. | Aug 2000 | A |
6102944 | Huynh et al. | Aug 2000 | A |
6106550 | Magovern et al. | Aug 2000 | A |
6110191 | Dehdashtian et al. | Aug 2000 | A |
6110198 | Fogarty et al. | Aug 2000 | A |
6110201 | Quijano et al. | Aug 2000 | A |
6113612 | Swanson et al. | Sep 2000 | A |
6113630 | Vanney et al. | Sep 2000 | A |
6113823 | Eno | Sep 2000 | A |
6117169 | Moe | Sep 2000 | A |
6120520 | Saadat et al. | Sep 2000 | A |
6120534 | Ruiz | Sep 2000 | A |
6123682 | Knudson et al. | Sep 2000 | A |
6123723 | Konya et al. | Sep 2000 | A |
6125852 | Stevens et al. | Oct 2000 | A |
6126649 | Vantassel et al. | Oct 2000 | A |
6126654 | Giba et al. | Oct 2000 | A |
6126685 | Lenker et al. | Oct 2000 | A |
6126686 | Badylak et al. | Oct 2000 | A |
6132451 | Payne et al. | Oct 2000 | A |
6132473 | Williams et al. | Oct 2000 | A |
6132986 | Pathak et al. | Oct 2000 | A |
6139510 | Palermo | Oct 2000 | A |
6139541 | Vanney et al. | Oct 2000 | A |
6142987 | Tsugita | Nov 2000 | A |
6143021 | Staehle | Nov 2000 | A |
6143987 | Makita | Nov 2000 | A |
6146366 | Schachar | Nov 2000 | A |
6146415 | Fitz | Nov 2000 | A |
6146417 | Ischinger | Nov 2000 | A |
6152937 | Peterson et al. | Nov 2000 | A |
6152956 | Pierce | Nov 2000 | A |
6155264 | Ressemann et al. | Dec 2000 | A |
6156031 | Aita et al. | Dec 2000 | A |
6156055 | Ravenscroft | Dec 2000 | A |
6156531 | Pathak et al. | Dec 2000 | A |
6157852 | Selmon et al. | Dec 2000 | A |
6159225 | Makower | Dec 2000 | A |
6159239 | Greenhalgh | Dec 2000 | A |
6162208 | Hipps | Dec 2000 | A |
6162245 | Jayaraman | Dec 2000 | A |
6165185 | Shennib et al. | Dec 2000 | A |
6165188 | Saadat et al. | Dec 2000 | A |
6165200 | Tsugita et al. | Dec 2000 | A |
6165209 | Patterson et al. | Dec 2000 | A |
6167605 | Morales | Jan 2001 | B1 |
6168579 | Tsugita | Jan 2001 | B1 |
6168614 | Andersen et al. | Jan 2001 | B1 |
6168616 | Brown, III | Jan 2001 | B1 |
6171251 | Mueller et al. | Jan 2001 | B1 |
6171327 | Daniel et al. | Jan 2001 | B1 |
6171335 | Wheatley et al. | Jan 2001 | B1 |
6177514 | Pathak et al. | Jan 2001 | B1 |
6179859 | Bates et al. | Jan 2001 | B1 |
6182664 | Cosgrove | Feb 2001 | B1 |
6182668 | Tweden et al. | Feb 2001 | B1 |
6183481 | Lee et al. | Feb 2001 | B1 |
6186972 | Nelson et al. | Feb 2001 | B1 |
6187016 | Hedges et al. | Feb 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6190393 | Bevier et al. | Feb 2001 | B1 |
6190405 | Culombo et al. | Feb 2001 | B1 |
6193726 | Vanney | Feb 2001 | B1 |
6193734 | Bolduc et al. | Feb 2001 | B1 |
6196230 | Hall et al. | Mar 2001 | B1 |
6197050 | Eno et al. | Mar 2001 | B1 |
6197053 | Cosgrove et al. | Mar 2001 | B1 |
6197296 | Davies et al. | Mar 2001 | B1 |
6197324 | Crittenden | Mar 2001 | B1 |
6200311 | Danek et al. | Mar 2001 | B1 |
6200336 | Pavcnik et al. | Mar 2001 | B1 |
6203550 | Olson | Mar 2001 | B1 |
6203556 | Evans et al. | Mar 2001 | B1 |
6206888 | Bicek et al. | Mar 2001 | B1 |
6206911 | Milo | Mar 2001 | B1 |
6210408 | Chandrasekaran et al. | Apr 2001 | B1 |
6210957 | Carpentier et al. | Apr 2001 | B1 |
6213126 | LaFontaine et al. | Apr 2001 | B1 |
6214036 | Letendre et al. | Apr 2001 | B1 |
6214041 | Tweden et al. | Apr 2001 | B1 |
6214054 | Cunanan et al. | Apr 2001 | B1 |
6214055 | Simionescu et al. | Apr 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6217549 | Selmon et al. | Apr 2001 | B1 |
6217575 | DeVore et al. | Apr 2001 | B1 |
6217609 | Haverkost | Apr 2001 | B1 |
6218662 | Tchakarov et al. | Apr 2001 | B1 |
6221006 | Dubrul et al. | Apr 2001 | B1 |
6221049 | Selmon et al. | Apr 2001 | B1 |
6221091 | Khosravi | Apr 2001 | B1 |
6221096 | Aiba et al. | Apr 2001 | B1 |
6221100 | Strecker | Apr 2001 | B1 |
6223752 | Vanney et al. | May 2001 | B1 |
6224584 | March et al. | May 2001 | B1 |
6231544 | Tsugita et al. | May 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6231551 | Barbut | May 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6231602 | Carpentier et al. | May 2001 | B1 |
6235000 | Milo et al. | May 2001 | B1 |
6237607 | Vanney et al. | May 2001 | B1 |
6238406 | Ellis et al. | May 2001 | B1 |
6241667 | Vetter et al. | Jun 2001 | B1 |
6241738 | Dereume | Jun 2001 | B1 |
6241741 | Duhaylongsod et al. | Jun 2001 | B1 |
6241757 | An et al. | Jun 2001 | B1 |
6245102 | Jayaraman | Jun 2001 | B1 |
6245103 | Stinson | Jun 2001 | B1 |
6245105 | Nguyen et al. | Jun 2001 | B1 |
6248112 | Gambale et al. | Jun 2001 | B1 |
6248116 | Chevillon et al. | Jun 2001 | B1 |
6250305 | Tweden | Jun 2001 | B1 |
6251079 | Gambale et al. | Jun 2001 | B1 |
6251104 | Kesten et al. | Jun 2001 | B1 |
6251116 | Shennib et al. | Jun 2001 | B1 |
6251135 | Stinson et al. | Jun 2001 | B1 |
6251418 | Ahern et al. | Jun 2001 | B1 |
6253768 | Wilk | Jul 2001 | B1 |
6253769 | LaFontaine et al. | Jul 2001 | B1 |
6254564 | Wilk et al. | Jul 2001 | B1 |
6254635 | Schroeder et al. | Jul 2001 | B1 |
6254636 | Peredo | Jul 2001 | B1 |
6257634 | Wei | Jul 2001 | B1 |
6258052 | Milo | Jul 2001 | B1 |
6258087 | Edwards et al. | Jul 2001 | B1 |
6258114 | Konya et al. | Jul 2001 | B1 |
6258115 | Dubrul | Jul 2001 | B1 |
6258119 | Hussein et al. | Jul 2001 | B1 |
6258120 | McKenzie et al. | Jul 2001 | B1 |
6258129 | Dybdal et al. | Jul 2001 | B1 |
6258150 | Mackellar | Jul 2001 | B1 |
6261304 | Hall et al. | Jul 2001 | B1 |
6267783 | Letendre et al. | Jul 2001 | B1 |
6269819 | Oz et al. | Aug 2001 | B1 |
6270513 | Tsugita et al. | Aug 2001 | B1 |
6270521 | Fischell et al. | Aug 2001 | B1 |
6270526 | Cox | Aug 2001 | B1 |
6273876 | Klima et al. | Aug 2001 | B1 |
6273895 | Pinchuk et al. | Aug 2001 | B1 |
6276661 | Laird | Aug 2001 | B1 |
6277555 | Duran et al. | Aug 2001 | B1 |
6283127 | Sterman et al. | Sep 2001 | B1 |
6283951 | Flaherty et al. | Sep 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6283995 | Moe et al. | Sep 2001 | B1 |
6285903 | Rosenthal et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6287334 | Moll et al. | Sep 2001 | B1 |
6287338 | Sarnowski et al. | Sep 2001 | B1 |
6287339 | Vazquez et al. | Sep 2001 | B1 |
6290709 | Ellis et al. | Sep 2001 | B1 |
6290728 | Phelps et al. | Sep 2001 | B1 |
6296662 | Caffey | Oct 2001 | B1 |
6299637 | Shaolian et al. | Oct 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6302892 | Wilk | Oct 2001 | B1 |
6302906 | Goicoechea et al. | Oct 2001 | B1 |
6306164 | Kujawski | Oct 2001 | B1 |
6309382 | Garrison et al. | Oct 2001 | B1 |
6309417 | Spence et al. | Oct 2001 | B1 |
6311693 | Sterman et al. | Nov 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6319281 | Patel | Nov 2001 | B1 |
6322548 | Payne et al. | Nov 2001 | B1 |
6322593 | Pathak et al. | Nov 2001 | B1 |
6325067 | Sterman et al. | Dec 2001 | B1 |
6327772 | Zadno-Azizi et al. | Dec 2001 | B1 |
6330884 | Kim | Dec 2001 | B1 |
6331189 | Wolinsky et al. | Dec 2001 | B1 |
6334873 | Lane et al. | Jan 2002 | B1 |
6336934 | Gilson et al. | Jan 2002 | B1 |
6336937 | Vonesh et al. | Jan 2002 | B1 |
6338735 | Stevens | Jan 2002 | B1 |
6338740 | Carpentier | Jan 2002 | B1 |
6342070 | Nguyen-Thien-Nhon | Jan 2002 | B1 |
6344044 | Fulkerson et al. | Feb 2002 | B1 |
6346074 | Roth | Feb 2002 | B1 |
6346116 | Brooks et al. | Feb 2002 | B1 |
6348063 | Yassour et al. | Feb 2002 | B1 |
6350248 | Knudson et al. | Feb 2002 | B1 |
6350277 | Kocur | Feb 2002 | B1 |
6350278 | Lenker et al. | Feb 2002 | B1 |
6352547 | Brown et al. | Mar 2002 | B1 |
6352554 | De Paulis | Mar 2002 | B2 |
6352708 | Duran et al. | Mar 2002 | B1 |
6357104 | Myers | Mar 2002 | B1 |
6358277 | Duran | Mar 2002 | B1 |
6361519 | Knudson et al. | Mar 2002 | B1 |
6361545 | Macoviak et al. | Mar 2002 | B1 |
6363938 | Saadat et al. | Apr 2002 | B2 |
6363939 | Wilk | Apr 2002 | B1 |
6364895 | Greenhalgh | Apr 2002 | B1 |
6368338 | Konya et al. | Apr 2002 | B1 |
6371970 | Khosravi et al. | Apr 2002 | B1 |
6371983 | Lane | Apr 2002 | B1 |
6375615 | Flaherty et al. | Apr 2002 | B1 |
6378221 | Ekholm, Jr. et al. | Apr 2002 | B1 |
6379319 | Garibotto et al. | Apr 2002 | B1 |
6379365 | Diaz | Apr 2002 | B1 |
6379372 | Dehdashtian et al. | Apr 2002 | B1 |
6379383 | Palmaz et al. | Apr 2002 | B1 |
6379740 | Rinaldi et al. | Apr 2002 | B1 |
6380457 | Yurek et al. | Apr 2002 | B1 |
6383193 | Cathcart et al. | May 2002 | B1 |
6387119 | Wolf et al. | May 2002 | B2 |
6387122 | Cragg | May 2002 | B1 |
6390098 | LaFontaine et al. | May 2002 | B1 |
6391051 | Sullivan, III et al. | May 2002 | B2 |
6391538 | Vyavahare et al. | May 2002 | B1 |
6395208 | Herweck et al. | May 2002 | B1 |
6398807 | Chouinard et al. | Jun 2002 | B1 |
6401720 | Stevens et al. | Jun 2002 | B1 |
6402736 | Brown et al. | Jun 2002 | B1 |
6402740 | Ellis et al. | Jun 2002 | B1 |
6406488 | Tweden et al. | Jun 2002 | B1 |
6406491 | Vanney | Jun 2002 | B1 |
6406493 | Tu et al. | Jun 2002 | B1 |
6409697 | Eno et al. | Jun 2002 | B2 |
6409750 | Hyodoh et al. | Jun 2002 | B1 |
6409751 | Hall et al. | Jun 2002 | B1 |
6409755 | Vrba | Jun 2002 | B1 |
6409759 | Peredo | Jun 2002 | B1 |
6413275 | Nguyen et al. | Jul 2002 | B1 |
6416490 | Ellis et al. | Jul 2002 | B1 |
6416510 | Altman et al. | Jul 2002 | B1 |
6423089 | Gingras et al. | Jul 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6432119 | Saadat | Aug 2002 | B1 |
6432126 | Gambale et al. | Aug 2002 | B1 |
6432127 | Kim et al. | Aug 2002 | B1 |
6432132 | Cottone et al. | Aug 2002 | B1 |
6440164 | DiMatteo et al. | Aug 2002 | B1 |
6443158 | LaFontaine et al. | Sep 2002 | B1 |
6447522 | Gambale et al. | Sep 2002 | B2 |
6447539 | Nelson et al. | Sep 2002 | B1 |
6451025 | Jervis | Sep 2002 | B1 |
6451054 | Stevens | Sep 2002 | B1 |
6454760 | Vanney | Sep 2002 | B2 |
6454794 | Knudson et al. | Sep 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458092 | Gambale et al. | Oct 2002 | B1 |
6458140 | Akin et al. | Oct 2002 | B2 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6458323 | Boekstegers | Oct 2002 | B1 |
6461382 | Cao | Oct 2002 | B1 |
6464709 | Shennib et al. | Oct 2002 | B2 |
6468303 | Amplatz et al. | Oct 2002 | B1 |
6468660 | Ogle et al. | Oct 2002 | B2 |
6471723 | Ashworth et al. | Oct 2002 | B1 |
6475169 | Ferrera | Nov 2002 | B2 |
6475226 | Belef et al. | Nov 2002 | B1 |
6475239 | Campbell et al. | Nov 2002 | B1 |
6475244 | Herweck et al. | Nov 2002 | B2 |
6478819 | Moe | Nov 2002 | B2 |
6479079 | Pathak et al. | Nov 2002 | B1 |
6482220 | Mueller | Nov 2002 | B1 |
6482228 | Norred | Nov 2002 | B1 |
6485501 | Green | Nov 2002 | B1 |
6485502 | Don Michael et al. | Nov 2002 | B2 |
6485513 | Fan | Nov 2002 | B1 |
6485524 | Strecker | Nov 2002 | B2 |
6487581 | Spence et al. | Nov 2002 | B1 |
6488704 | Connelly et al. | Dec 2002 | B1 |
6491689 | Ellis et al. | Dec 2002 | B1 |
6491707 | Makower et al. | Dec 2002 | B2 |
6494211 | Boyd et al. | Dec 2002 | B1 |
6494897 | Sterman et al. | Dec 2002 | B2 |
6494909 | Greenhalgh | Dec 2002 | B2 |
6503272 | Duerig et al. | Jan 2003 | B2 |
6508496 | Huang | Jan 2003 | B1 |
6508803 | Horikawa et al. | Jan 2003 | B1 |
6508825 | Selmon et al. | Jan 2003 | B1 |
6508833 | Pavcnik et al. | Jan 2003 | B2 |
6509145 | Torrianni | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6511491 | Grudem et al. | Jan 2003 | B2 |
6514217 | Selmon et al. | Feb 2003 | B1 |
6514271 | Evans et al. | Feb 2003 | B2 |
6517527 | Gambale et al. | Feb 2003 | B2 |
6517558 | Gittings et al. | Feb 2003 | B2 |
6517573 | Pollock et al. | Feb 2003 | B1 |
6521179 | Girardot et al. | Feb 2003 | B1 |
6524323 | Nash et al. | Feb 2003 | B1 |
6524335 | Hartley et al. | Feb 2003 | B1 |
6527800 | McGuckin, Jr. et al. | Mar 2003 | B1 |
6530949 | Konya et al. | Mar 2003 | B2 |
6530952 | Vesely | Mar 2003 | B2 |
6533807 | Wolinsky et al. | Mar 2003 | B2 |
6537297 | Tsugita et al. | Mar 2003 | B2 |
6537310 | Palmaz et al. | Mar 2003 | B1 |
6540768 | Diaz et al. | Apr 2003 | B1 |
6540782 | Snyders | Apr 2003 | B1 |
6544230 | Flaherty et al. | Apr 2003 | B1 |
6547827 | Carpentier et al. | Apr 2003 | B2 |
6551303 | Van Tassel et al. | Apr 2003 | B1 |
6558318 | Daniel et al. | May 2003 | B1 |
6558417 | Peredo | May 2003 | B2 |
6558418 | Carpentier et al. | May 2003 | B2 |
6558429 | Taylor | May 2003 | B2 |
6559132 | Holmer | May 2003 | B1 |
6561998 | Roth et al. | May 2003 | B1 |
6562031 | Chandrasekaran et al. | May 2003 | B2 |
6562058 | Seguin et al. | May 2003 | B2 |
6562063 | Euteneuer et al. | May 2003 | B1 |
6562069 | Cai et al. | May 2003 | B2 |
6564805 | Garrison et al. | May 2003 | B2 |
6565528 | Mueller | May 2003 | B1 |
6565594 | Herweck et al. | May 2003 | B1 |
6569145 | Shmulewitz et al. | May 2003 | B1 |
6569147 | Evans et al. | May 2003 | B1 |
6569196 | Vesely | May 2003 | B1 |
6572642 | Rinaldi et al. | Jun 2003 | B2 |
6572643 | Gharibadeh | Jun 2003 | B1 |
6572652 | Shaknovich | Jun 2003 | B2 |
6575168 | LaFontaine et al. | Jun 2003 | B2 |
6579311 | Makower | Jun 2003 | B1 |
6582444 | Wilk | Jun 2003 | B2 |
6582460 | Cryer | Jun 2003 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6585756 | Strecker | Jul 2003 | B1 |
6585758 | Chouinard et al. | Jul 2003 | B1 |
6585766 | Huynh et al. | Jul 2003 | B1 |
6589279 | Anderson et al. | Jul 2003 | B1 |
6592546 | Barbut et al. | Jul 2003 | B1 |
6592614 | Lenker et al. | Jul 2003 | B2 |
6599304 | Selmon et al. | Jul 2003 | B1 |
6600803 | Bruder et al. | Jul 2003 | B2 |
6605053 | Kamm et al. | Aug 2003 | B1 |
6605112 | Moll et al. | Aug 2003 | B1 |
6605113 | Wilk | Aug 2003 | B2 |
6608040 | Lin et al. | Aug 2003 | B1 |
6610077 | Hancock et al. | Aug 2003 | B1 |
6610085 | Lazarus | Aug 2003 | B1 |
6610100 | Phelps et al. | Aug 2003 | B2 |
6613069 | Boyd et al. | Sep 2003 | B2 |
6613077 | Gilligan et al. | Sep 2003 | B2 |
6613079 | Wolinsky et al. | Sep 2003 | B1 |
6613081 | Kim et al. | Sep 2003 | B2 |
6613086 | Moe et al. | Sep 2003 | B1 |
6616675 | Evard et al. | Sep 2003 | B1 |
6616682 | Joergensen et al. | Sep 2003 | B2 |
6622604 | Chouinard et al. | Sep 2003 | B1 |
6623491 | Thompson | Sep 2003 | B2 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6623521 | Steinke et al. | Sep 2003 | B2 |
6626938 | Butaric et al. | Sep 2003 | B1 |
6626939 | Burnside et al. | Sep 2003 | B1 |
6632241 | Hancock et al. | Oct 2003 | B1 |
6632243 | Zadno-Azizi et al. | Oct 2003 | B1 |
6632470 | Morra et al. | Oct 2003 | B2 |
6635068 | Dubrul et al. | Oct 2003 | B1 |
6635079 | Unsworth et al. | Oct 2003 | B2 |
6635080 | Lauterjung et al. | Oct 2003 | B1 |
6635085 | Caffey et al. | Oct 2003 | B1 |
6638237 | Guiles et al. | Oct 2003 | B1 |
6638247 | Selmon et al. | Oct 2003 | B1 |
6638293 | Makower et al. | Oct 2003 | B1 |
6641610 | Wolf et al. | Nov 2003 | B2 |
6651670 | Rapacki et al. | Nov 2003 | B2 |
6651672 | Roth | Nov 2003 | B2 |
6652540 | Cole et al. | Nov 2003 | B1 |
6652546 | Nash et al. | Nov 2003 | B1 |
6652555 | Vantassel et al. | Nov 2003 | B1 |
6652571 | White et al. | Nov 2003 | B1 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6655386 | Makower et al. | Dec 2003 | B1 |
6656213 | Solem | Dec 2003 | B2 |
6660003 | DeVore et al. | Dec 2003 | B1 |
6660024 | Flaherty et al. | Dec 2003 | B1 |
6663588 | DuBois et al. | Dec 2003 | B2 |
6663663 | Kim et al. | Dec 2003 | B2 |
6663667 | Dehdashtian et al. | Dec 2003 | B2 |
6666863 | Wentzel et al. | Dec 2003 | B2 |
6669709 | Cohn et al. | Dec 2003 | B1 |
6669724 | Park et al. | Dec 2003 | B2 |
6673089 | Yassour et al. | Jan 2004 | B1 |
6673101 | Fitzgerald et al. | Jan 2004 | B1 |
6673106 | Mitelberg et al. | Jan 2004 | B2 |
6673109 | Cox | Jan 2004 | B2 |
6676668 | Mercereau et al. | Jan 2004 | B2 |
6676692 | Rabkin et al. | Jan 2004 | B2 |
6676693 | Belding et al. | Jan 2004 | B1 |
6676698 | McGuckin, Jr. et al. | Jan 2004 | B2 |
6679268 | Stevens et al. | Jan 2004 | B2 |
6682543 | Barbut et al. | Jan 2004 | B2 |
6682558 | Tu et al. | Jan 2004 | B2 |
6682559 | Myers et al. | Jan 2004 | B2 |
6685648 | Flaherty et al. | Feb 2004 | B2 |
6685739 | DiMatteo et al. | Feb 2004 | B2 |
6689144 | Gerberding | Feb 2004 | B2 |
6689164 | Seguin | Feb 2004 | B1 |
6692512 | Jang | Feb 2004 | B2 |
6692513 | Streeter et al. | Feb 2004 | B2 |
6694983 | Wolf et al. | Feb 2004 | B2 |
6695864 | Macoviak et al. | Feb 2004 | B2 |
6695865 | Boyle et al. | Feb 2004 | B2 |
6695875 | Stelter et al. | Feb 2004 | B2 |
6695878 | McGuckin, Jr. et al. | Feb 2004 | B2 |
6699274 | Stinson | Mar 2004 | B2 |
6701932 | Knudson et al. | Mar 2004 | B2 |
6702851 | Chinn et al. | Mar 2004 | B1 |
6709425 | Gambale et al. | Mar 2004 | B2 |
6709444 | Makower | Mar 2004 | B1 |
6712842 | Gifford, III et al. | Mar 2004 | B1 |
6712843 | Elliott | Mar 2004 | B2 |
6714842 | Ito | Mar 2004 | B1 |
6719770 | Laufer et al. | Apr 2004 | B2 |
6719787 | Cox | Apr 2004 | B2 |
6719788 | Cox | Apr 2004 | B2 |
6719789 | Cox | Apr 2004 | B2 |
6723116 | Taheri | Apr 2004 | B2 |
6723122 | Yang et al. | Apr 2004 | B2 |
6726677 | Flaherty et al. | Apr 2004 | B1 |
6729356 | Baker et al. | May 2004 | B1 |
6730118 | Spenser et al. | May 2004 | B2 |
6730121 | Ortiz et al. | May 2004 | B2 |
6730377 | Wang | May 2004 | B2 |
6733513 | Boyle et al. | May 2004 | B2 |
6733525 | Yang et al. | May 2004 | B2 |
6736827 | McAndrew et al. | May 2004 | B1 |
6736839 | Cummings | May 2004 | B2 |
6736845 | Marquez et al. | May 2004 | B2 |
6736846 | Cox | May 2004 | B2 |
6743252 | Bates et al. | Jun 2004 | B1 |
6746464 | Makower | Jun 2004 | B1 |
6752828 | Thornton | Jun 2004 | B2 |
6755854 | Gillick et al. | Jun 2004 | B2 |
6755855 | Yurek et al. | Jun 2004 | B2 |
6758855 | Fulton, III et al. | Jul 2004 | B2 |
6764503 | Ishimaru | Jul 2004 | B1 |
6764509 | Chinn et al. | Jul 2004 | B2 |
6767345 | St. Germain et al. | Jul 2004 | B2 |
6767362 | Schreck | Jul 2004 | B2 |
6769434 | Liddicoat et al. | Aug 2004 | B2 |
6773454 | Wholey et al. | Aug 2004 | B2 |
6773455 | Allen et al. | Aug 2004 | B2 |
6773456 | Gordon et al. | Aug 2004 | B1 |
6774278 | Ragheb et al. | Aug 2004 | B1 |
6776791 | Stallings et al. | Aug 2004 | B1 |
6786925 | Schoon et al. | Sep 2004 | B1 |
6786929 | Gambale et al. | Sep 2004 | B2 |
6790229 | Berreklouw | Sep 2004 | B1 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6790237 | Stinson | Sep 2004 | B2 |
6792979 | Konya et al. | Sep 2004 | B2 |
6797000 | Simpson et al. | Sep 2004 | B2 |
6797002 | Spence et al. | Sep 2004 | B2 |
6802319 | Stevens et al. | Oct 2004 | B2 |
6802858 | Gambale et al. | Oct 2004 | B2 |
6805711 | Quijano et al. | Oct 2004 | B2 |
6808498 | Laroya et al. | Oct 2004 | B2 |
6808504 | Schorgl et al. | Oct 2004 | B2 |
6808529 | Fulkerson | Oct 2004 | B2 |
6814746 | Thompson et al. | Nov 2004 | B2 |
6814754 | Greenhalgh | Nov 2004 | B2 |
6820676 | Palmaz et al. | Nov 2004 | B2 |
6821211 | Otten et al. | Nov 2004 | B2 |
6821297 | Snyders | Nov 2004 | B2 |
6824041 | Grieder et al. | Nov 2004 | B2 |
6824970 | Vyavahare et al. | Nov 2004 | B2 |
6830568 | Kesten et al. | Dec 2004 | B1 |
6830575 | Stenzel et al. | Dec 2004 | B2 |
6830584 | Seguin | Dec 2004 | B1 |
6830585 | Artof et al. | Dec 2004 | B1 |
6830586 | Quijano et al. | Dec 2004 | B2 |
6837901 | Rabkin et al. | Jan 2005 | B2 |
6837902 | Nguyen et al. | Jan 2005 | B2 |
6840957 | DiMatteo et al. | Jan 2005 | B2 |
6843802 | Villalobos et al. | Jan 2005 | B1 |
6846325 | Liddicoat | Jan 2005 | B2 |
6849084 | Rabkin et al. | Feb 2005 | B2 |
6849085 | Marton | Feb 2005 | B2 |
6854467 | Boekstegers | Feb 2005 | B2 |
6860898 | Stack et al. | Mar 2005 | B2 |
6861211 | Levy et al. | Mar 2005 | B2 |
6863668 | Gillespie et al. | Mar 2005 | B2 |
6863684 | Kim et al. | Mar 2005 | B2 |
6863688 | Ralph et al. | Mar 2005 | B2 |
6866650 | Stevens et al. | Mar 2005 | B2 |
6866669 | Buzzard et al. | Mar 2005 | B2 |
6872223 | Roberts et al. | Mar 2005 | B2 |
6872226 | Cali et al. | Mar 2005 | B2 |
6875231 | Anduiza et al. | Apr 2005 | B2 |
6881199 | Wilk et al. | Apr 2005 | B2 |
6881220 | Edwin et al. | Apr 2005 | B2 |
6883522 | Spence et al. | Apr 2005 | B2 |
6887266 | Williams et al. | May 2005 | B2 |
6890330 | Streeter et al. | May 2005 | B2 |
6890340 | Duane | May 2005 | B2 |
6893459 | Macoviak | May 2005 | B1 |
6893460 | Spenser et al. | May 2005 | B2 |
6896690 | Lambrecht et al. | May 2005 | B1 |
6899704 | Sterman et al. | May 2005 | B2 |
6905743 | Chen et al. | Jun 2005 | B1 |
6908481 | Cribier | Jun 2005 | B2 |
6911036 | Douk et al. | Jun 2005 | B2 |
6911040 | Johnson et al. | Jun 2005 | B2 |
6911043 | Myers et al. | Jun 2005 | B2 |
6913021 | Knudson et al. | Jul 2005 | B2 |
6913600 | Valley et al. | Jul 2005 | B2 |
6916304 | Eno et al. | Jul 2005 | B2 |
6920674 | Thornton | Jul 2005 | B2 |
6920732 | Mårtensson | Jul 2005 | B2 |
6926690 | Renati | Aug 2005 | B2 |
6926732 | Derus et al. | Aug 2005 | B2 |
6929009 | Makower et al. | Aug 2005 | B2 |
6929011 | Knudson et al. | Aug 2005 | B2 |
6929653 | Strecter | Aug 2005 | B2 |
6936058 | Forde et al. | Aug 2005 | B2 |
6936066 | Palmaz et al. | Aug 2005 | B2 |
6936067 | Buchanan | Aug 2005 | B2 |
6939352 | Buzzard et al. | Sep 2005 | B2 |
6939359 | Tu et al. | Sep 2005 | B2 |
6939365 | Fogarty et al. | Sep 2005 | B1 |
6939370 | Hartley et al. | Sep 2005 | B2 |
6942682 | Vrba et al. | Sep 2005 | B2 |
6945949 | Wilk | Sep 2005 | B2 |
6945997 | Huynh et al. | Sep 2005 | B2 |
6949080 | Wolf et al. | Sep 2005 | B2 |
6949118 | Kohler et al. | Sep 2005 | B2 |
6951571 | Srivastava | Oct 2005 | B1 |
6953332 | Kurk et al. | Oct 2005 | B1 |
6953481 | Phelps et al. | Oct 2005 | B2 |
6955175 | Stevens et al. | Oct 2005 | B2 |
6955681 | Evans et al. | Oct 2005 | B2 |
6964652 | Guiles et al. | Nov 2005 | B2 |
6964673 | Tsugita et al. | Nov 2005 | B2 |
6964676 | Gerberding et al. | Nov 2005 | B1 |
6969395 | Eskuri | Nov 2005 | B2 |
6972025 | Wasdyke | Dec 2005 | B2 |
6972029 | Mayrhofer et al. | Dec 2005 | B2 |
6974464 | Quijano et al. | Dec 2005 | B2 |
6974474 | Pavcnik et al. | Dec 2005 | B2 |
6974476 | McGuckin, Jr. et al. | Dec 2005 | B2 |
6976990 | Mowry | Dec 2005 | B2 |
6979350 | Moll et al. | Dec 2005 | B2 |
6984242 | Campbell et al. | Jan 2006 | B2 |
6984244 | Perez et al. | Jan 2006 | B2 |
6986742 | Hart et al. | Jan 2006 | B2 |
6986784 | Weiser et al. | Jan 2006 | B1 |
6988949 | Wang | Jan 2006 | B2 |
6989027 | Allen et al. | Jan 2006 | B2 |
6989028 | Lashinski et al. | Jan 2006 | B2 |
6991649 | Sievers | Jan 2006 | B2 |
7001425 | McCullagh et al. | Feb 2006 | B2 |
7004176 | Lau | Feb 2006 | B2 |
7008397 | Tweden et al. | Mar 2006 | B2 |
7011095 | Wolf et al. | Mar 2006 | B2 |
7011681 | Vesely | Mar 2006 | B2 |
7014655 | Barbarash et al. | Mar 2006 | B2 |
7018401 | Hyodoh et al. | Mar 2006 | B1 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7018408 | Bailey et al. | Mar 2006 | B2 |
7022134 | Quijano et al. | Apr 2006 | B1 |
7025773 | Gittings et al. | Apr 2006 | B2 |
7025780 | Gabbay | Apr 2006 | B2 |
7025791 | Levine et al. | Apr 2006 | B2 |
7028692 | Sterman et al. | Apr 2006 | B2 |
7037331 | Mitelberg et al. | May 2006 | B2 |
7037333 | Myers et al. | May 2006 | B2 |
7041128 | McGuckin, Jr. et al. | May 2006 | B2 |
7041132 | Quijano et al. | May 2006 | B2 |
7044966 | Svanidze et al. | May 2006 | B2 |
7048014 | Hyodoh et al. | May 2006 | B2 |
7048757 | Shaknovich | May 2006 | B2 |
7050276 | Nishiyama | May 2006 | B2 |
7074236 | Rabkin et al. | Jul 2006 | B2 |
7078163 | Torrianni | Jul 2006 | B2 |
7081132 | Cook et al. | Jul 2006 | B2 |
7097658 | Oktay | Aug 2006 | B2 |
7097659 | Woolfson et al. | Aug 2006 | B2 |
7101396 | Artof et al. | Sep 2006 | B2 |
7105016 | Shiu et al. | Sep 2006 | B2 |
7108715 | Lawrence-Brown et al. | Sep 2006 | B2 |
7115141 | Menz et al. | Oct 2006 | B2 |
7118585 | Addis | Oct 2006 | B2 |
7122020 | Mogul | Oct 2006 | B2 |
7125418 | Duran et al. | Oct 2006 | B2 |
7128759 | Osborne et al. | Oct 2006 | B2 |
7137184 | Schreck et al. | Nov 2006 | B2 |
7141063 | White et al. | Nov 2006 | B2 |
7141064 | Scott et al. | Nov 2006 | B2 |
7143312 | Wang et al. | Nov 2006 | B1 |
7147662 | Pollock et al. | Dec 2006 | B1 |
7147663 | Berg et al. | Dec 2006 | B1 |
7153324 | Case et al. | Dec 2006 | B2 |
7160319 | Chouinard et al. | Jan 2007 | B2 |
7163556 | Xie et al. | Jan 2007 | B2 |
7166097 | Barbut | Jan 2007 | B2 |
7175652 | Cook et al. | Feb 2007 | B2 |
7175653 | Gaber | Feb 2007 | B2 |
7175654 | Bonsignore et al. | Feb 2007 | B2 |
7175656 | Khairkhahan | Feb 2007 | B2 |
7179290 | Cao | Feb 2007 | B2 |
7186265 | Sharkawy et al. | Mar 2007 | B2 |
7189258 | Johnson et al. | Mar 2007 | B2 |
7189259 | Simionescu et al. | Mar 2007 | B2 |
7191018 | Gielen et al. | Mar 2007 | B2 |
7191406 | Barber et al. | Mar 2007 | B1 |
7195641 | Palmaz et al. | Mar 2007 | B2 |
7198646 | Figulla et al. | Apr 2007 | B2 |
7201761 | Woolfson et al. | Apr 2007 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7214344 | Carpentier et al. | May 2007 | B2 |
7217287 | Wilson et al. | May 2007 | B2 |
7235092 | Banas et al. | Jun 2007 | B2 |
7235093 | Gregorich | Jun 2007 | B2 |
7238200 | Lee et al. | Jul 2007 | B2 |
7241257 | Ainsworth et al. | Jul 2007 | B1 |
7252682 | Seguin | Aug 2007 | B2 |
7258696 | Rabkin et al. | Aug 2007 | B2 |
7258891 | Pacetti et al. | Aug 2007 | B2 |
7261732 | Justino | Aug 2007 | B2 |
7264632 | Wright et al. | Sep 2007 | B2 |
7267686 | DiMatteo et al. | Sep 2007 | B2 |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7285130 | Austin | Oct 2007 | B2 |
7297150 | Cartledge et al. | Nov 2007 | B2 |
7300457 | Palmaz | Nov 2007 | B2 |
7300463 | Liddicoat | Nov 2007 | B2 |
7311730 | Gabbay | Dec 2007 | B2 |
7314449 | Pfeiffer et al. | Jan 2008 | B2 |
7314485 | Mathis | Jan 2008 | B2 |
7314880 | Chang et al. | Jan 2008 | B2 |
7316706 | Bloom et al. | Jan 2008 | B2 |
7316712 | Peredo | Jan 2008 | B2 |
7317005 | Hoekstra et al. | Jan 2008 | B2 |
7317942 | Brown | Jan 2008 | B2 |
7317950 | Lee | Jan 2008 | B2 |
7318278 | Zhang et al. | Jan 2008 | B2 |
7318998 | Goldstein et al. | Jan 2008 | B2 |
7319096 | Malm et al. | Jan 2008 | B2 |
7320692 | Bender et al. | Jan 2008 | B1 |
7320704 | Lashinski et al. | Jan 2008 | B2 |
7320705 | Quintessenza | Jan 2008 | B2 |
7320706 | Al-Najjar | Jan 2008 | B2 |
7322932 | Xie et al. | Jan 2008 | B2 |
7323006 | Andreas et al. | Jan 2008 | B2 |
7323066 | Budron | Jan 2008 | B1 |
7326174 | Cox et al. | Feb 2008 | B2 |
7326219 | Mowry et al. | Feb 2008 | B2 |
7326236 | Andreas et al. | Feb 2008 | B2 |
7327862 | Murphy et al. | Feb 2008 | B2 |
7329278 | Seguin et al. | Feb 2008 | B2 |
7329279 | Haug et al. | Feb 2008 | B2 |
7329280 | Bolling et al. | Feb 2008 | B2 |
7329777 | Harter et al. | Feb 2008 | B2 |
7331991 | Kheradvar et al. | Feb 2008 | B2 |
7331993 | White | Feb 2008 | B2 |
7333643 | Murphy et al. | Feb 2008 | B2 |
7335158 | Taylor | Feb 2008 | B2 |
7335213 | Hyde et al. | Feb 2008 | B1 |
7335218 | Wilson et al. | Feb 2008 | B2 |
7335490 | Van Gilst et al. | Feb 2008 | B2 |
7338484 | Schoon et al. | Mar 2008 | B2 |
7338520 | Bailey et al. | Mar 2008 | B2 |
7361189 | Case et al. | Apr 2008 | B2 |
7361190 | Shaoulian et al. | Apr 2008 | B2 |
7364588 | Mathis et al. | Apr 2008 | B2 |
7371258 | Woo et al. | May 2008 | B2 |
7374560 | Ressemann et al. | May 2008 | B2 |
7374571 | Pease et al. | May 2008 | B2 |
7377895 | Spence et al. | May 2008 | B2 |
7377938 | Sarac et al. | May 2008 | B2 |
7377940 | Ryan et al. | May 2008 | B2 |
7381210 | Zarbatany et al. | Jun 2008 | B2 |
7381216 | Buzzard et al. | Jun 2008 | B2 |
7381218 | Schreck | Jun 2008 | B2 |
7381219 | Salahieh et al. | Jun 2008 | B2 |
7381220 | Macoviak et al. | Jun 2008 | B2 |
7384411 | Condado | Jun 2008 | B1 |
7387640 | Cummings | Jun 2008 | B2 |
7389874 | Quest et al. | Jun 2008 | B2 |
7390325 | Wang et al. | Jun 2008 | B2 |
7393358 | Malewicz | Jul 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7396364 | Moaddeb et al. | Jul 2008 | B2 |
7399315 | Iobbi | Jul 2008 | B2 |
7402171 | Osborne et al. | Jul 2008 | B2 |
7404792 | Spence et al. | Jul 2008 | B2 |
7404793 | Lau et al. | Jul 2008 | B2 |
7405259 | Frye et al. | Jul 2008 | B2 |
7410499 | Bicer | Aug 2008 | B2 |
7412274 | Mejia | Aug 2008 | B2 |
7412290 | Janke et al. | Aug 2008 | B2 |
7415861 | Sokel | Aug 2008 | B2 |
7416530 | Turner et al. | Aug 2008 | B2 |
7422603 | Lane | Sep 2008 | B2 |
7422606 | Ung-Chhun et al. | Sep 2008 | B2 |
7423032 | Ozaki et al. | Sep 2008 | B2 |
7426413 | Balczewski et al. | Sep 2008 | B2 |
7427279 | Frazier et al. | Sep 2008 | B2 |
7427287 | Turovskiy et al. | Sep 2008 | B2 |
7427291 | Liddicoat et al. | Sep 2008 | B2 |
7429269 | Schwammenthal et al. | Sep 2008 | B2 |
7430448 | Zimmer et al. | Sep 2008 | B1 |
7430484 | Ohara | Sep 2008 | B2 |
7431691 | Wilk | Oct 2008 | B1 |
7431733 | Knight | Oct 2008 | B2 |
7435059 | Smith et al. | Oct 2008 | B2 |
7435257 | Lashinski et al. | Oct 2008 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
RE40570 | Carpentier et al. | Nov 2008 | E |
7445630 | Lashinski et al. | Nov 2008 | B2 |
7445631 | Salahieh et al. | Nov 2008 | B2 |
7445632 | McGuckin, Jr. et al. | Nov 2008 | B2 |
7452371 | Pavcnik et al. | Nov 2008 | B2 |
7455689 | Johnson | Nov 2008 | B2 |
7462156 | Mitrev | Dec 2008 | B2 |
7462184 | Worley et al. | Dec 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7468050 | Kantrowitz | Dec 2008 | B1 |
7470284 | Lambrecht et al. | Dec 2008 | B2 |
7470285 | Nugent et al. | Dec 2008 | B2 |
7473271 | Gunderson | Jan 2009 | B2 |
7473275 | Marquez | Jan 2009 | B2 |
7473417 | Zeltinger et al. | Jan 2009 | B2 |
7476196 | Spence et al. | Jan 2009 | B2 |
7476199 | Spence et al. | Jan 2009 | B2 |
7476200 | Tal | Jan 2009 | B2 |
7476244 | Buzzard et al. | Jan 2009 | B2 |
7481838 | Carpentier et al. | Jan 2009 | B2 |
7485088 | Murphy et al. | Feb 2009 | B2 |
7485143 | Webler et al. | Feb 2009 | B2 |
7488346 | Navia | Feb 2009 | B2 |
7491232 | Bolduc et al. | Feb 2009 | B2 |
7493869 | Foster et al. | Feb 2009 | B1 |
7497824 | Taylor | Mar 2009 | B2 |
7500949 | Gottlieb et al. | Mar 2009 | B2 |
7500989 | Solem et al. | Mar 2009 | B2 |
7503929 | Johnson et al. | Mar 2009 | B2 |
7503930 | Sharkawy et al. | Mar 2009 | B2 |
7507199 | Wang et al. | Mar 2009 | B2 |
7510572 | Gabbay | Mar 2009 | B2 |
7510574 | Lê et al. | Mar 2009 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7510577 | Moaddeb et al. | Mar 2009 | B2 |
7513863 | Bolling et al. | Apr 2009 | B2 |
7513909 | Lane et al. | Apr 2009 | B2 |
7522950 | Fuimaono et al. | Apr 2009 | B2 |
7524330 | Berreklouw | Apr 2009 | B2 |
7530253 | Spenser et al. | May 2009 | B2 |
7530995 | Quijano et al. | May 2009 | B2 |
7534261 | Friedman | May 2009 | B2 |
7544206 | Cohn | Jun 2009 | B2 |
7547322 | Sarac et al. | Jun 2009 | B2 |
7553324 | Andreas et al. | Jun 2009 | B2 |
7556386 | Smith | Jul 2009 | B2 |
7556646 | Yang et al. | Jul 2009 | B2 |
7569071 | Haverkost et al. | Aug 2009 | B2 |
7578828 | Gittings et al. | Aug 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7591848 | Allen | Sep 2009 | B2 |
7594974 | Cali et al. | Sep 2009 | B2 |
7601159 | Ewers et al. | Oct 2009 | B2 |
7601195 | Ichikawa | Oct 2009 | B2 |
7608099 | Johnson et al. | Oct 2009 | B2 |
7611534 | Kapadia et al. | Nov 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7622276 | Cunanan et al. | Nov 2009 | B2 |
7625403 | Krivoruchko | Dec 2009 | B2 |
7628802 | White et al. | Dec 2009 | B2 |
7628803 | Pavcnik et al. | Dec 2009 | B2 |
7632296 | Malewicz | Dec 2009 | B2 |
7632298 | Hijlkema et al. | Dec 2009 | B2 |
7635386 | Gammie | Dec 2009 | B1 |
7641687 | Chinn et al. | Jan 2010 | B2 |
7651519 | Dittman | Jan 2010 | B2 |
7655034 | Mitchell et al. | Feb 2010 | B2 |
7674282 | Wu et al. | Mar 2010 | B2 |
7682390 | Seguin | Mar 2010 | B2 |
7704222 | Wilk et al. | Apr 2010 | B2 |
7704277 | Zakay et al. | Apr 2010 | B2 |
7712606 | Salahieh et al. | May 2010 | B2 |
7717955 | Lane et al. | May 2010 | B2 |
7722638 | Deyette, Jr. et al. | May 2010 | B2 |
7722662 | Steinke et al. | May 2010 | B2 |
7722666 | Lafontaine | May 2010 | B2 |
7722671 | Carlyle et al. | May 2010 | B1 |
7731742 | Schlick et al. | Jun 2010 | B2 |
7735493 | Van Der Burg et al. | Jun 2010 | B2 |
7736327 | Wilk et al. | Jun 2010 | B2 |
7736388 | Goldfarb et al. | Jun 2010 | B2 |
7743481 | Lafont et al. | Jun 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7758625 | Wu et al. | Jul 2010 | B2 |
7763065 | Schmid et al. | Jul 2010 | B2 |
7771463 | Ton et al. | Aug 2010 | B2 |
7771467 | Svensson | Aug 2010 | B2 |
7776083 | Vesely | Aug 2010 | B2 |
7780725 | Haug et al. | Aug 2010 | B2 |
7780726 | Seguin | Aug 2010 | B2 |
7785360 | Freitag | Aug 2010 | B2 |
7794487 | Majercak et al. | Sep 2010 | B2 |
7799046 | White et al. | Sep 2010 | B2 |
7799065 | Pappas | Sep 2010 | B2 |
7803185 | Gabbay | Sep 2010 | B2 |
7806919 | Bloom et al. | Oct 2010 | B2 |
7823267 | Bolduc | Nov 2010 | B2 |
7824442 | Salahieh et al. | Nov 2010 | B2 |
7824443 | Salahieh et al. | Nov 2010 | B2 |
7833262 | McGuckin, Jr. et al. | Nov 2010 | B2 |
7837727 | Goetz et al. | Nov 2010 | B2 |
7846203 | Cribier | Dec 2010 | B2 |
7846204 | Letac et al. | Dec 2010 | B2 |
7854758 | Taheri | Dec 2010 | B2 |
7857845 | Stacchino et al. | Dec 2010 | B2 |
7862602 | Licata et al. | Jan 2011 | B2 |
7867274 | Hill et al. | Jan 2011 | B2 |
7887583 | Macoviak | Feb 2011 | B2 |
7892276 | Stocker et al. | Feb 2011 | B2 |
7892292 | Stack et al. | Feb 2011 | B2 |
7896913 | Damm et al. | Mar 2011 | B2 |
7896915 | Guyenot et al. | Mar 2011 | B2 |
7914569 | Nguyen et al. | Mar 2011 | B2 |
7914574 | Schmid et al. | Mar 2011 | B2 |
7914575 | Guyenot et al. | Mar 2011 | B2 |
7918880 | Austin | Apr 2011 | B2 |
7927363 | Perouse | Apr 2011 | B2 |
7938851 | Olson et al. | May 2011 | B2 |
7947071 | Schmid et al. | May 2011 | B2 |
7947075 | Goetz et al. | May 2011 | B2 |
7951189 | Haverkost et al. | May 2011 | B2 |
7959666 | Salahieh et al. | Jun 2011 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
7967853 | Eidenschink et al. | Jun 2011 | B2 |
7972359 | Kreidler | Jul 2011 | B2 |
7972376 | Dove et al. | Jul 2011 | B1 |
7972378 | Tabor et al. | Jul 2011 | B2 |
7988724 | Salahieh et al. | Aug 2011 | B2 |
7993386 | Elliott | Aug 2011 | B2 |
8002824 | Jenson et al. | Aug 2011 | B2 |
8002825 | Letac et al. | Aug 2011 | B2 |
8012198 | Hill et al. | Sep 2011 | B2 |
8021421 | Fogarty et al. | Sep 2011 | B2 |
RE42818 | Cali et al. | Oct 2011 | E |
RE42857 | Cali et al. | Oct 2011 | E |
8038704 | Sherburne | Oct 2011 | B2 |
8038709 | Palasis et al. | Oct 2011 | B2 |
8043450 | Cali et al. | Oct 2011 | B2 |
8048153 | Salahieh et al. | Nov 2011 | B2 |
8052715 | Quinn et al. | Nov 2011 | B2 |
8052749 | Salahieh et al. | Nov 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8057540 | Letac et al. | Nov 2011 | B2 |
8062355 | Figulla et al. | Nov 2011 | B2 |
8062536 | Liu et al. | Nov 2011 | B2 |
8062537 | Tuominen et al. | Nov 2011 | B2 |
8062749 | Shelestak et al. | Nov 2011 | B2 |
8070799 | Righini et al. | Dec 2011 | B2 |
8075641 | Aravanis et al. | Dec 2011 | B2 |
8083788 | Acosta et al. | Dec 2011 | B2 |
8092518 | Schreck | Jan 2012 | B2 |
8092520 | Quadri | Jan 2012 | B2 |
8092521 | Figulla et al. | Jan 2012 | B2 |
8128676 | Cummings | Mar 2012 | B2 |
8128681 | Shoemaker et al. | Mar 2012 | B2 |
8133217 | Stokes et al. | Mar 2012 | B2 |
8133270 | Khe et al. | Mar 2012 | B2 |
8136659 | Salahieh et al. | Mar 2012 | B2 |
8137394 | Stocker et al. | Mar 2012 | B2 |
8137398 | Tuval et al. | Mar 2012 | B2 |
8147534 | Berez et al. | Apr 2012 | B2 |
8157853 | Laske et al. | Apr 2012 | B2 |
8167894 | Miles et al. | May 2012 | B2 |
8172896 | McNamara et al. | May 2012 | B2 |
8182528 | Salahieh et al. | May 2012 | B2 |
8192351 | Fishler et al. | Jun 2012 | B2 |
8206437 | Bonhoeffer et al. | Jun 2012 | B2 |
8211107 | Parks et al. | Jul 2012 | B2 |
8216174 | Wilk et al. | Jul 2012 | B2 |
8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
8221493 | Boyle et al. | Jul 2012 | B2 |
8226707 | White | Jul 2012 | B2 |
8226710 | Nguyen et al. | Jul 2012 | B2 |
8231670 | Salahieh et al. | Jul 2012 | B2 |
8236049 | Rowe et al. | Aug 2012 | B2 |
8236241 | Carpentier et al. | Aug 2012 | B2 |
8246675 | Zegdi | Aug 2012 | B2 |
8246678 | Salahieh et al. | Aug 2012 | B2 |
8252051 | Chau et al. | Aug 2012 | B2 |
8252052 | Salahieh et al. | Aug 2012 | B2 |
8277500 | Schmid et al. | Oct 2012 | B2 |
8287584 | Salahieh et al. | Oct 2012 | B2 |
8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
8308798 | Pintor et al. | Nov 2012 | B2 |
8317858 | Straubinger et al. | Nov 2012 | B2 |
8323335 | Rowe et al. | Dec 2012 | B2 |
8328868 | Paul et al. | Dec 2012 | B2 |
8343136 | How et al. | Jan 2013 | B2 |
8343213 | Salahieh et al. | Jan 2013 | B2 |
8348995 | Tuval et al. | Jan 2013 | B2 |
8348996 | Tuval et al. | Jan 2013 | B2 |
8348999 | Kheradvar et al. | Jan 2013 | B2 |
8357387 | Dove et al. | Jan 2013 | B2 |
8366767 | Zhang | Feb 2013 | B2 |
8372134 | Schlick et al. | Feb 2013 | B2 |
8376865 | Forster et al. | Feb 2013 | B2 |
8377117 | Keidar et al. | Feb 2013 | B2 |
8382822 | Pavcnik et al. | Feb 2013 | B2 |
8398704 | Straubinger et al. | Mar 2013 | B2 |
8398708 | Meiri et al. | Mar 2013 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8414641 | Stocker et al. | Apr 2013 | B2 |
8414643 | Tuval et al. | Apr 2013 | B2 |
8414644 | Quadri et al. | Apr 2013 | B2 |
8414645 | Dwork et al. | Apr 2013 | B2 |
8439961 | Jagger et al. | May 2013 | B2 |
8445278 | Everaerts et al. | May 2013 | B2 |
8460365 | Haverkost et al. | Jun 2013 | B2 |
8465540 | Straubinger et al. | Jun 2013 | B2 |
8468667 | Straubinger et al. | Jun 2013 | B2 |
8470023 | Eidenschink et al. | Jun 2013 | B2 |
8491650 | Wiemeyer et al. | Jul 2013 | B2 |
8512394 | Schmid et al. | Aug 2013 | B2 |
8512399 | LaFontaine | Aug 2013 | B2 |
8512400 | Tran et al. | Aug 2013 | B2 |
8512401 | Murray, III et al. | Aug 2013 | B2 |
8523936 | Schmid et al. | Sep 2013 | B2 |
8535368 | Headley, Jr. et al. | Sep 2013 | B2 |
8540762 | Schmid et al. | Sep 2013 | B2 |
8545547 | Schmid et al. | Oct 2013 | B2 |
8551160 | Figulla et al. | Oct 2013 | B2 |
8556880 | Freyman et al. | Oct 2013 | B2 |
8556966 | Jenson | Oct 2013 | B2 |
8568475 | Nguyen | Oct 2013 | B2 |
8579962 | Salahieh et al. | Nov 2013 | B2 |
8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
8585759 | Bumbalough | Nov 2013 | B2 |
8591570 | Revuelta et al. | Nov 2013 | B2 |
8597226 | Wilk et al. | Dec 2013 | B2 |
8603159 | Seguin et al. | Dec 2013 | B2 |
8603160 | Salahieh et al. | Dec 2013 | B2 |
8617235 | Schmid et al. | Dec 2013 | B2 |
8617236 | Paul et al. | Dec 2013 | B2 |
8623074 | Ryan | Jan 2014 | B2 |
8623075 | Murray, III et al. | Jan 2014 | B2 |
8623076 | Salahieh et al. | Jan 2014 | B2 |
8623078 | Salahieh et al. | Jan 2014 | B2 |
8628562 | Cummings | Jan 2014 | B2 |
8628571 | Hacohen et al. | Jan 2014 | B1 |
8647381 | Essinger et al. | Feb 2014 | B2 |
8668733 | Haug et al. | Mar 2014 | B2 |
8672997 | Drasler et al. | Mar 2014 | B2 |
8679174 | Ottma et al. | Mar 2014 | B2 |
8685077 | Laske et al. | Apr 2014 | B2 |
8696743 | Holecek | Apr 2014 | B2 |
8721713 | Tower et al. | May 2014 | B2 |
8721717 | Shoemaker et al. | May 2014 | B2 |
8734508 | Hastings et al. | May 2014 | B2 |
8758430 | Ferrari et al. | Jun 2014 | B2 |
8764818 | Gregg | Jul 2014 | B2 |
8778020 | Gregg | Jul 2014 | B2 |
8790395 | Straubinger et al. | Jul 2014 | B2 |
8795305 | Martin et al. | Aug 2014 | B2 |
8795356 | Quadri et al. | Aug 2014 | B2 |
8808356 | Braido et al. | Aug 2014 | B2 |
8808364 | Palasis et al. | Aug 2014 | B2 |
8828078 | Salahieh et al. | Sep 2014 | B2 |
8828079 | Thielen et al. | Sep 2014 | B2 |
8840662 | Salahieh et al. | Sep 2014 | B2 |
8840663 | Salahieh et al. | Sep 2014 | B2 |
8845721 | Braido et al. | Sep 2014 | B2 |
8851286 | Chang et al. | Oct 2014 | B2 |
8852272 | Gross et al. | Oct 2014 | B2 |
8858620 | Salahieh et al. | Oct 2014 | B2 |
8894703 | Salahieh et al. | Nov 2014 | B2 |
8932349 | Jenson et al. | Jan 2015 | B2 |
8940014 | Gamarra et al. | Jan 2015 | B2 |
8951243 | Crisostomo et al. | Feb 2015 | B2 |
8951299 | Paul et al. | Feb 2015 | B2 |
8956383 | Aklog et al. | Feb 2015 | B2 |
8992608 | Haug et al. | Mar 2015 | B2 |
8998976 | Gregg et al. | Apr 2015 | B2 |
9005273 | Salahieh et al. | Apr 2015 | B2 |
9011521 | Haug et al. | Apr 2015 | B2 |
9023099 | Duffy et al. | May 2015 | B2 |
9028542 | Hill et al. | May 2015 | B2 |
9039756 | White | May 2015 | B2 |
9044318 | Straubinger et al. | Jun 2015 | B2 |
9131926 | Crisostomo et al. | Sep 2015 | B2 |
9149358 | Tabor et al. | Oct 2015 | B2 |
9168130 | Straubinger et al. | Oct 2015 | B2 |
9168131 | Yohanan et al. | Oct 2015 | B2 |
9168136 | Yang et al. | Oct 2015 | B2 |
9180005 | Lashinski et al. | Nov 2015 | B1 |
9186482 | Dorn | Nov 2015 | B2 |
9211266 | Iwazawa et al. | Dec 2015 | B2 |
9216082 | Von Segesser et al. | Dec 2015 | B2 |
9248037 | Roeder et al. | Feb 2016 | B2 |
9265608 | Miller et al. | Feb 2016 | B2 |
9277991 | Salahieh et al. | Mar 2016 | B2 |
9277993 | Gamarra et al. | Mar 2016 | B2 |
9301840 | Nguyen et al. | Apr 2016 | B2 |
9301843 | Richardson et al. | Apr 2016 | B2 |
9308085 | Salahieh et al. | Apr 2016 | B2 |
9320599 | Salahieh et al. | Apr 2016 | B2 |
9326853 | Olson et al. | May 2016 | B2 |
9358106 | Salahieh et al. | Jun 2016 | B2 |
9358110 | Paul et al. | Jun 2016 | B2 |
9370419 | Hill et al. | Jun 2016 | B2 |
9370421 | Crisostomo et al. | Jun 2016 | B2 |
9387076 | Paul et al. | Jul 2016 | B2 |
9393094 | Salahieh et al. | Jul 2016 | B2 |
9393113 | Salahieh et al. | Jul 2016 | B2 |
9393114 | Sutton et al. | Jul 2016 | B2 |
9393115 | Tabor et al. | Jul 2016 | B2 |
9415567 | Sogard et al. | Aug 2016 | B2 |
9421083 | Eidenschink et al. | Aug 2016 | B2 |
9439759 | Straubinger et al. | Sep 2016 | B2 |
9463084 | Stinson | Oct 2016 | B2 |
9474598 | Gregg et al. | Oct 2016 | B2 |
9474609 | Haverkost et al. | Oct 2016 | B2 |
9492276 | Lee et al. | Nov 2016 | B2 |
9510945 | Sutton et al. | Dec 2016 | B2 |
9526609 | Salahieh et al. | Dec 2016 | B2 |
9532872 | Salahieh et al. | Jan 2017 | B2 |
9539091 | Yang et al. | Jan 2017 | B2 |
9554924 | Schlick et al. | Jan 2017 | B2 |
9597432 | Nakamura | Mar 2017 | B2 |
9649212 | Fargahi | May 2017 | B2 |
9717593 | Alkhatib et al. | Aug 2017 | B2 |
D800908 | Hariton et al. | Oct 2017 | S |
9775709 | Miller et al. | Oct 2017 | B2 |
9788945 | Ottma et al. | Oct 2017 | B2 |
9861476 | Salahieh et al. | Jan 2018 | B2 |
9867694 | Girard et al. | Jan 2018 | B2 |
9867699 | Straubinger et al. | Jan 2018 | B2 |
9872768 | Paul et al. | Jan 2018 | B2 |
9889002 | Bonhoeffer et al. | Feb 2018 | B2 |
9901445 | Backus et al. | Feb 2018 | B2 |
9949824 | Bonhoeffer et al. | Apr 2018 | B2 |
9956075 | Salahieh et al. | May 2018 | B2 |
9987133 | Straubinger et al. | Jun 2018 | B2 |
10092324 | Gillespie et al. | Oct 2018 | B2 |
10143552 | Wallace et al. | Dec 2018 | B2 |
10154901 | Straubinger et al. | Dec 2018 | B2 |
10321987 | Wang et al. | Jun 2019 | B2 |
10363134 | Figulla | Jul 2019 | B2 |
10543084 | Guyenot et al. | Jan 2020 | B2 |
10702382 | Straubinger et al. | Jul 2020 | B2 |
10709555 | Schreck et al. | Jul 2020 | B2 |
11266497 | Cao | Mar 2022 | B2 |
20010000041 | Selmon et al. | Mar 2001 | A1 |
20010001314 | Davison et al. | May 2001 | A1 |
20010002445 | Vesely | May 2001 | A1 |
20010004683 | Gambale et al. | Jun 2001 | A1 |
20010004690 | Gambale et al. | Jun 2001 | A1 |
20010004699 | Gittings et al. | Jun 2001 | A1 |
20010007956 | Letac et al. | Jul 2001 | A1 |
20010008969 | Evans et al. | Jul 2001 | A1 |
20010010017 | Letac et al. | Jul 2001 | A1 |
20010011187 | Pavcnik et al. | Aug 2001 | A1 |
20010011189 | Drasler et al. | Aug 2001 | A1 |
20010012948 | Vanney | Aug 2001 | A1 |
20010014813 | Saadat et al. | Aug 2001 | A1 |
20010016700 | Eno et al. | Aug 2001 | A1 |
20010018596 | Selmon et al. | Aug 2001 | A1 |
20010020172 | Selmon et al. | Sep 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010025196 | Chinn et al. | Sep 2001 | A1 |
20010025643 | Foley | Oct 2001 | A1 |
20010027287 | Shmulewitz et al. | Oct 2001 | A1 |
20010027338 | Greenberg | Oct 2001 | A1 |
20010027339 | Boatman et al. | Oct 2001 | A1 |
20010029385 | Shennib et al. | Oct 2001 | A1 |
20010032013 | Marton | Oct 2001 | A1 |
20010034547 | Hall et al. | Oct 2001 | A1 |
20010037117 | Gambale et al. | Nov 2001 | A1 |
20010037141 | Yee et al. | Nov 2001 | A1 |
20010037149 | Wilk | Nov 2001 | A1 |
20010039426 | Makower et al. | Nov 2001 | A1 |
20010039445 | Hall et al. | Nov 2001 | A1 |
20010039450 | Pavcnik et al. | Nov 2001 | A1 |
20010041902 | Lepulu et al. | Nov 2001 | A1 |
20010041928 | Pavcnik et al. | Nov 2001 | A1 |
20010041930 | Globerman et al. | Nov 2001 | A1 |
20010044631 | Akin et al. | Nov 2001 | A1 |
20010044634 | Don Michael et al. | Nov 2001 | A1 |
20010044647 | Pinchuk et al. | Nov 2001 | A1 |
20010044652 | Moore | Nov 2001 | A1 |
20010044656 | Williamson, IV et al. | Nov 2001 | A1 |
20010047165 | Makower et al. | Nov 2001 | A1 |
20010049523 | DeVore et al. | Dec 2001 | A1 |
20010051822 | Stack et al. | Dec 2001 | A1 |
20010053932 | Phelps et al. | Dec 2001 | A1 |
20020002349 | Flaherty et al. | Jan 2002 | A1 |
20020002396 | Fulkerson | Jan 2002 | A1 |
20020002401 | McGuckin, Jr. et al. | Jan 2002 | A1 |
20020004662 | Wilk | Jan 2002 | A1 |
20020004663 | Gittings et al. | Jan 2002 | A1 |
20020007138 | Wilk et al. | Jan 2002 | A1 |
20020010489 | Gayzel et al. | Jan 2002 | A1 |
20020010508 | Chobotov | Jan 2002 | A1 |
20020026233 | Shaknovich | Feb 2002 | A1 |
20020029014 | Jayaraman | Mar 2002 | A1 |
20020029079 | Kim et al. | Mar 2002 | A1 |
20020029981 | Nigam | Mar 2002 | A1 |
20020032476 | Gambale et al. | Mar 2002 | A1 |
20020032478 | Boekstegers et al. | Mar 2002 | A1 |
20020032480 | Spence et al. | Mar 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020035390 | Schaldach et al. | Mar 2002 | A1 |
20020035396 | Heath | Mar 2002 | A1 |
20020042650 | Vardi et al. | Apr 2002 | A1 |
20020042651 | Liddicoat et al. | Apr 2002 | A1 |
20020045846 | Kaplon et al. | Apr 2002 | A1 |
20020045928 | Boekstegers | Apr 2002 | A1 |
20020045929 | Diaz | Apr 2002 | A1 |
20020049486 | Knudson et al. | Apr 2002 | A1 |
20020052651 | Myers | May 2002 | A1 |
20020055767 | Forde et al. | May 2002 | A1 |
20020055769 | Wang | May 2002 | A1 |
20020055772 | McGuckin, Jr. et al. | May 2002 | A1 |
20020055774 | Liddicoat | May 2002 | A1 |
20020055775 | Carpentier et al. | May 2002 | A1 |
20020058897 | Renati | May 2002 | A1 |
20020058987 | Butaric et al. | May 2002 | A1 |
20020058993 | Landau et al. | May 2002 | A1 |
20020058995 | Stevens | May 2002 | A1 |
20020062146 | Makower et al. | May 2002 | A1 |
20020065478 | Knudson et al. | May 2002 | A1 |
20020065485 | DuBois et al. | May 2002 | A1 |
20020072699 | Knudson et al. | Jun 2002 | A1 |
20020072789 | Hackett et al. | Jun 2002 | A1 |
20020077566 | Laroya et al. | Jun 2002 | A1 |
20020077654 | Javier, Jr. et al. | Jun 2002 | A1 |
20020077696 | Zadno-Azizi et al. | Jun 2002 | A1 |
20020082584 | Rosenman et al. | Jun 2002 | A1 |
20020082609 | Green | Jun 2002 | A1 |
20020092535 | Wilk | Jul 2002 | A1 |
20020092536 | LaFontaine et al. | Jul 2002 | A1 |
20020095111 | Tweden et al. | Jul 2002 | A1 |
20020095173 | Mazzocchi et al. | Jul 2002 | A1 |
20020095206 | Addonizio et al. | Jul 2002 | A1 |
20020095209 | Zadno-Azizi et al. | Jul 2002 | A1 |
20020099439 | Schwartz et al. | Jul 2002 | A1 |
20020100484 | Hall et al. | Aug 2002 | A1 |
20020103533 | Langberg et al. | Aug 2002 | A1 |
20020107565 | Greenhalgh | Aug 2002 | A1 |
20020111627 | Vincent-Prestigiacomo | Aug 2002 | A1 |
20020111665 | Lauterjung | Aug 2002 | A1 |
20020111668 | Smith | Aug 2002 | A1 |
20020111672 | Kim et al. | Aug 2002 | A1 |
20020111674 | Chouinard et al. | Aug 2002 | A1 |
20020117789 | Childers et al. | Aug 2002 | A1 |
20020120322 | Thompson et al. | Aug 2002 | A1 |
20020120323 | Thompson et al. | Aug 2002 | A1 |
20020120328 | Pathak et al. | Aug 2002 | A1 |
20020123698 | Garibotto et al. | Sep 2002 | A1 |
20020123786 | Gittings et al. | Sep 2002 | A1 |
20020123790 | White et al. | Sep 2002 | A1 |
20020123802 | Snyders | Sep 2002 | A1 |
20020133183 | Lentz et al. | Sep 2002 | A1 |
20020133226 | Marquez et al. | Sep 2002 | A1 |
20020138087 | Shennib et al. | Sep 2002 | A1 |
20020138138 | Yang | Sep 2002 | A1 |
20020143285 | Eno et al. | Oct 2002 | A1 |
20020143289 | Ellis et al. | Oct 2002 | A1 |
20020143387 | Soetikno et al. | Oct 2002 | A1 |
20020144696 | Sharkawy et al. | Oct 2002 | A1 |
20020151913 | Berg et al. | Oct 2002 | A1 |
20020151970 | Garrison et al. | Oct 2002 | A1 |
20020156522 | Ivancev et al. | Oct 2002 | A1 |
20020161377 | Rabkin | Oct 2002 | A1 |
20020161383 | Akin et al. | Oct 2002 | A1 |
20020161390 | Mouw | Oct 2002 | A1 |
20020161392 | Dubrul | Oct 2002 | A1 |
20020161394 | Macoviak et al. | Oct 2002 | A1 |
20020161424 | Rapacki et al. | Oct 2002 | A1 |
20020161426 | Iancea | Oct 2002 | A1 |
20020165479 | Wilk | Nov 2002 | A1 |
20020165576 | Boyle et al. | Nov 2002 | A1 |
20020165606 | Wolf et al. | Nov 2002 | A1 |
20020173842 | Buchanan | Nov 2002 | A1 |
20020177766 | Mogul | Nov 2002 | A1 |
20020177772 | Altman et al. | Nov 2002 | A1 |
20020177840 | Farnholtz | Nov 2002 | A1 |
20020177894 | Acosta et al. | Nov 2002 | A1 |
20020179098 | Makower et al. | Dec 2002 | A1 |
20020183716 | Herweck et al. | Dec 2002 | A1 |
20020183781 | Casey et al. | Dec 2002 | A1 |
20020186558 | Plank et al. | Dec 2002 | A1 |
20020188341 | Elliott | Dec 2002 | A1 |
20020188344 | Bolea et al. | Dec 2002 | A1 |
20020193782 | Ellis et al. | Dec 2002 | A1 |
20020193871 | Beyersdorf et al. | Dec 2002 | A1 |
20020198594 | Schreck | Dec 2002 | A1 |
20030004541 | Linder et al. | Jan 2003 | A1 |
20030004560 | Chobotov et al. | Jan 2003 | A1 |
20030009189 | Gilson et al. | Jan 2003 | A1 |
20030014104 | Cribier | Jan 2003 | A1 |
20030018377 | Berg et al. | Jan 2003 | A1 |
20030018379 | Knudson et al. | Jan 2003 | A1 |
20030023300 | Bailey et al. | Jan 2003 | A1 |
20030023303 | Palmaz et al. | Jan 2003 | A1 |
20030027332 | Lafrance et al. | Feb 2003 | A1 |
20030028213 | Thill et al. | Feb 2003 | A1 |
20030028247 | Cali | Feb 2003 | A1 |
20030033001 | Igaki | Feb 2003 | A1 |
20030036791 | Philipp et al. | Feb 2003 | A1 |
20030036795 | Andersen et al. | Feb 2003 | A1 |
20030040736 | Stevens et al. | Feb 2003 | A1 |
20030040771 | Hyodoh et al. | Feb 2003 | A1 |
20030040772 | Hyodoh et al. | Feb 2003 | A1 |
20030040791 | Oktay | Feb 2003 | A1 |
20030040792 | Gabbay | Feb 2003 | A1 |
20030042186 | Boyle | Mar 2003 | A1 |
20030044315 | Boekstegers | Mar 2003 | A1 |
20030045828 | Wilk | Mar 2003 | A1 |
20030050694 | Yang et al. | Mar 2003 | A1 |
20030055371 | Wolf et al. | Mar 2003 | A1 |
20030055495 | Pease | Mar 2003 | A1 |
20030057156 | Peterson et al. | Mar 2003 | A1 |
20030060844 | Borillo et al. | Mar 2003 | A1 |
20030065386 | Weadock | Apr 2003 | A1 |
20030069492 | Abrams et al. | Apr 2003 | A1 |
20030069646 | Stinson | Apr 2003 | A1 |
20030070944 | Nigam | Apr 2003 | A1 |
20030073973 | Evans et al. | Apr 2003 | A1 |
20030074058 | Sherry | Apr 2003 | A1 |
20030078561 | Gambale et al. | Apr 2003 | A1 |
20030078652 | Sutherland | Apr 2003 | A1 |
20030083730 | Stinson | May 2003 | A1 |
20030093145 | Lawrence-Brown et al. | May 2003 | A1 |
20030100918 | Duane | May 2003 | A1 |
20030100919 | Hopkins et al. | May 2003 | A1 |
20030100920 | Akin et al. | May 2003 | A1 |
20030105514 | Phelps et al. | Jun 2003 | A1 |
20030109924 | Cribier | Jun 2003 | A1 |
20030109930 | Bluni et al. | Jun 2003 | A1 |
20030114912 | Sequin et al. | Jun 2003 | A1 |
20030114913 | Spenser et al. | Jun 2003 | A1 |
20030120195 | Milo et al. | Jun 2003 | A1 |
20030125795 | Pavcnik et al. | Jul 2003 | A1 |
20030130726 | Thorpe et al. | Jul 2003 | A1 |
20030130727 | Drasler et al. | Jul 2003 | A1 |
20030130729 | Paniagua et al. | Jul 2003 | A1 |
20030130746 | Ashworth et al. | Jul 2003 | A1 |
20030135257 | Taheri | Jul 2003 | A1 |
20030139796 | Sequin et al. | Jul 2003 | A1 |
20030139798 | Brown et al. | Jul 2003 | A1 |
20030139803 | Sequin et al. | Jul 2003 | A1 |
20030139804 | Hankh et al. | Jul 2003 | A1 |
20030144657 | Bowe et al. | Jul 2003 | A1 |
20030144732 | Cosgrove et al. | Jul 2003 | A1 |
20030149474 | Becker | Aug 2003 | A1 |
20030149475 | Hyodoh et al. | Aug 2003 | A1 |
20030149476 | Damm et al. | Aug 2003 | A1 |
20030149477 | Gabbay | Aug 2003 | A1 |
20030149478 | Figulla et al. | Aug 2003 | A1 |
20030153971 | Chandrasekaran | Aug 2003 | A1 |
20030153974 | Spenser et al. | Aug 2003 | A1 |
20030158573 | Gittings et al. | Aug 2003 | A1 |
20030158595 | Randall et al. | Aug 2003 | A1 |
20030163193 | Widenhouse | Aug 2003 | A1 |
20030163198 | Morra et al. | Aug 2003 | A1 |
20030165352 | Ibrahim et al. | Sep 2003 | A1 |
20030171803 | Shimon | Sep 2003 | A1 |
20030171805 | Berg et al. | Sep 2003 | A1 |
20030176884 | Berrada et al. | Sep 2003 | A1 |
20030181850 | Diamond et al. | Sep 2003 | A1 |
20030181938 | Roth et al. | Sep 2003 | A1 |
20030181942 | Sutton et al. | Sep 2003 | A1 |
20030187495 | Cully et al. | Oct 2003 | A1 |
20030191449 | Nash et al. | Oct 2003 | A1 |
20030191516 | Weldon et al. | Oct 2003 | A1 |
20030191519 | Lombardi et al. | Oct 2003 | A1 |
20030191526 | Van Tassel et al. | Oct 2003 | A1 |
20030195457 | LaFontaine et al. | Oct 2003 | A1 |
20030195458 | Phelps et al. | Oct 2003 | A1 |
20030195609 | Berenstein et al. | Oct 2003 | A1 |
20030195620 | Huynh et al. | Oct 2003 | A1 |
20030198722 | Johnston, Jr. et al. | Oct 2003 | A1 |
20030199759 | Richard | Oct 2003 | A1 |
20030199913 | Dubrul et al. | Oct 2003 | A1 |
20030199963 | Tower et al. | Oct 2003 | A1 |
20030199971 | Tower et al. | Oct 2003 | A1 |
20030199972 | Zadno-Azizi et al. | Oct 2003 | A1 |
20030204160 | Kamm et al. | Oct 2003 | A1 |
20030204249 | Letort | Oct 2003 | A1 |
20030208224 | Broome | Nov 2003 | A1 |
20030212410 | Stenzel et al. | Nov 2003 | A1 |
20030212413 | Wilk | Nov 2003 | A1 |
20030212429 | Keegan et al. | Nov 2003 | A1 |
20030212452 | Zadno-Azizi et al. | Nov 2003 | A1 |
20030212454 | Scott et al. | Nov 2003 | A1 |
20030216678 | March et al. | Nov 2003 | A1 |
20030216679 | Wolf et al. | Nov 2003 | A1 |
20030216774 | Larson | Nov 2003 | A1 |
20030220661 | Mowry et al. | Nov 2003 | A1 |
20030220667 | Van Der Burg et al. | Nov 2003 | A1 |
20030225445 | Derus et al. | Dec 2003 | A1 |
20030229366 | Reggie et al. | Dec 2003 | A1 |
20030229390 | Ashton et al. | Dec 2003 | A1 |
20030233117 | Adams et al. | Dec 2003 | A1 |
20030236542 | Makower | Dec 2003 | A1 |
20030236567 | Elliot | Dec 2003 | A1 |
20030236568 | Hojeibane et al. | Dec 2003 | A1 |
20030236570 | Cook et al. | Dec 2003 | A1 |
20040004926 | Maeda | Jan 2004 | A1 |
20040006298 | Wilk | Jan 2004 | A1 |
20040006380 | Buck et al. | Jan 2004 | A1 |
20040015225 | Kim et al. | Jan 2004 | A1 |
20040015228 | Lombardi et al. | Jan 2004 | A1 |
20040018651 | Nadeau | Jan 2004 | A1 |
20040019348 | Stevens et al. | Jan 2004 | A1 |
20040019374 | Hojeibane et al. | Jan 2004 | A1 |
20040026389 | Kessler et al. | Feb 2004 | A1 |
20040033364 | Spiridigliozzi et al. | Feb 2004 | A1 |
20040034411 | Quijano et al. | Feb 2004 | A1 |
20040037946 | Morra et al. | Feb 2004 | A1 |
20040039343 | Eppstein et al. | Feb 2004 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20040044361 | Frazier et al. | Mar 2004 | A1 |
20040044392 | Von Oepen | Mar 2004 | A1 |
20040044400 | Cheng et al. | Mar 2004 | A1 |
20040044402 | Jung et al. | Mar 2004 | A1 |
20040049204 | Harari et al. | Mar 2004 | A1 |
20040049207 | Goldfarb et al. | Mar 2004 | A1 |
20040049224 | Buehlmann et al. | Mar 2004 | A1 |
20040049226 | Keegan et al. | Mar 2004 | A1 |
20040049262 | Obermiller et al. | Mar 2004 | A1 |
20040049266 | Anduiza et al. | Mar 2004 | A1 |
20040058097 | Weder | Mar 2004 | A1 |
20040059280 | Makower et al. | Mar 2004 | A1 |
20040059407 | Escamilla et al. | Mar 2004 | A1 |
20040059409 | Stenzel | Mar 2004 | A1 |
20040059429 | Amin et al. | Mar 2004 | A1 |
20040073157 | Knudson et al. | Apr 2004 | A1 |
20040073198 | Gilson et al. | Apr 2004 | A1 |
20040073238 | Makower | Apr 2004 | A1 |
20040073289 | Hartley et al. | Apr 2004 | A1 |
20040077987 | Rapacki et al. | Apr 2004 | A1 |
20040077988 | Tweden et al. | Apr 2004 | A1 |
20040077990 | Knudson et al. | Apr 2004 | A1 |
20040078950 | Schreck et al. | Apr 2004 | A1 |
20040082904 | Houde et al. | Apr 2004 | A1 |
20040082967 | Broome et al. | Apr 2004 | A1 |
20040082989 | Cook et al. | Apr 2004 | A1 |
20040087982 | Eskuri | May 2004 | A1 |
20040088042 | Kim et al. | May 2004 | A1 |
20040088045 | Cox | May 2004 | A1 |
20040092858 | Wilson et al. | May 2004 | A1 |
20040092989 | Wilson et al. | May 2004 | A1 |
20040093005 | Durcan | May 2004 | A1 |
20040093016 | Root et al. | May 2004 | A1 |
20040093060 | Seguin et al. | May 2004 | A1 |
20040093063 | Wright et al. | May 2004 | A1 |
20040093070 | Hojeibane et al. | May 2004 | A1 |
20040093075 | Kuehne | May 2004 | A1 |
20040097788 | Mourlas et al. | May 2004 | A1 |
20040098022 | Barone | May 2004 | A1 |
20040098098 | McGuckin, Jr. et al. | May 2004 | A1 |
20040098099 | McCullagh et al. | May 2004 | A1 |
20040098112 | DiMatteo et al. | May 2004 | A1 |
20040102855 | Shank | May 2004 | A1 |
20040106931 | Guiles et al. | Jun 2004 | A1 |
20040106976 | Bailey et al. | Jun 2004 | A1 |
20040106990 | Spence et al. | Jun 2004 | A1 |
20040107004 | Levine et al. | Jun 2004 | A1 |
20040111096 | Tu et al. | Jun 2004 | A1 |
20040113306 | Rapacki et al. | Jun 2004 | A1 |
20040116951 | Rosengart | Jun 2004 | A1 |
20040116999 | Ledergerber | Jun 2004 | A1 |
20040117004 | Osborne et al. | Jun 2004 | A1 |
20040117009 | Cali et al. | Jun 2004 | A1 |
20040118415 | Hall et al. | Jun 2004 | A1 |
20040122318 | Flaherty et al. | Jun 2004 | A1 |
20040122347 | Knudson et al. | Jun 2004 | A1 |
20040122468 | Yodfat et al. | Jun 2004 | A1 |
20040122514 | Fogarty et al. | Jun 2004 | A1 |
20040122516 | Fogarty et al. | Jun 2004 | A1 |
20040127847 | DuBois et al. | Jul 2004 | A1 |
20040127912 | Rabkin et al. | Jul 2004 | A1 |
20040127936 | Salahieh et al. | Jul 2004 | A1 |
20040127979 | Wilson et al. | Jul 2004 | A1 |
20040127982 | Machold et al. | Jul 2004 | A1 |
20040133154 | Flaherty et al. | Jul 2004 | A1 |
20040133225 | Makower | Jul 2004 | A1 |
20040133274 | Webler et al. | Jul 2004 | A1 |
20040138694 | Tran et al. | Jul 2004 | A1 |
20040138742 | Myers et al. | Jul 2004 | A1 |
20040138743 | Myers et al. | Jul 2004 | A1 |
20040138745 | Macoviak et al. | Jul 2004 | A1 |
20040147868 | Bardsley et al. | Jul 2004 | A1 |
20040147869 | Wolf et al. | Jul 2004 | A1 |
20040148018 | Carpentier et al. | Jul 2004 | A1 |
20040148021 | Cartledge et al. | Jul 2004 | A1 |
20040153094 | Dunfee et al. | Aug 2004 | A1 |
20040153145 | Simionescu et al. | Aug 2004 | A1 |
20040153146 | Lashinski et al. | Aug 2004 | A1 |
20040158143 | Flaherty et al. | Aug 2004 | A1 |
20040158277 | Lowe et al. | Aug 2004 | A1 |
20040163094 | Matsui et al. | Aug 2004 | A1 |
20040167444 | Laroya et al. | Aug 2004 | A1 |
20040167565 | Beulke et al. | Aug 2004 | A1 |
20040167573 | Williamson, IV et al. | Aug 2004 | A1 |
20040167620 | Ortiz et al. | Aug 2004 | A1 |
20040168691 | Sharkawy et al. | Sep 2004 | A1 |
20040176791 | Lim et al. | Sep 2004 | A1 |
20040181140 | Falwell et al. | Sep 2004 | A1 |
20040186507 | Hall et al. | Sep 2004 | A1 |
20040186557 | Gambale et al. | Sep 2004 | A1 |
20040186558 | Pavcnik et al. | Sep 2004 | A1 |
20040186563 | Lobbi | Sep 2004 | A1 |
20040186565 | Schreck | Sep 2004 | A1 |
20040186587 | Ahern | Sep 2004 | A1 |
20040193180 | Buzzard et al. | Sep 2004 | A1 |
20040193244 | Hartley et al. | Sep 2004 | A1 |
20040193252 | Perez et al. | Sep 2004 | A1 |
20040193261 | Berreklouw | Sep 2004 | A1 |
20040197695 | Aono | Oct 2004 | A1 |
20040199245 | Lauterjung | Oct 2004 | A1 |
20040204683 | McGuckin, Jr. et al. | Oct 2004 | A1 |
20040204755 | Robin | Oct 2004 | A1 |
20040206363 | McCarthy et al. | Oct 2004 | A1 |
20040210104 | Lau et al. | Oct 2004 | A1 |
20040210190 | Kohler et al. | Oct 2004 | A1 |
20040210240 | Saint | Oct 2004 | A1 |
20040210301 | Obermiller et al. | Oct 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040210306 | Quijano et al. | Oct 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040215317 | Cummings | Oct 2004 | A1 |
20040215331 | Chew et al. | Oct 2004 | A1 |
20040215333 | Duran et al. | Oct 2004 | A1 |
20040215339 | Drasler et al. | Oct 2004 | A1 |
20040219180 | Gambale et al. | Nov 2004 | A1 |
20040220598 | Bolduc et al. | Nov 2004 | A1 |
20040220655 | Swanson et al. | Nov 2004 | A1 |
20040225321 | Krolik et al. | Nov 2004 | A1 |
20040225353 | McGuckin, Jr. et al. | Nov 2004 | A1 |
20040225354 | Allen et al. | Nov 2004 | A1 |
20040225355 | Stevens | Nov 2004 | A1 |
20040236411 | Sarac et al. | Nov 2004 | A1 |
20040236418 | Stevens | Nov 2004 | A1 |
20040243143 | Corcoran et al. | Dec 2004 | A1 |
20040243221 | Fawzi et al. | Dec 2004 | A1 |
20040249343 | Cioanta | Dec 2004 | A1 |
20040254594 | Alfaro | Dec 2004 | A1 |
20040254636 | Flagle et al. | Dec 2004 | A1 |
20040260389 | Case et al. | Dec 2004 | A1 |
20040260390 | Sarac et al. | Dec 2004 | A1 |
20040260393 | Rahdert et al. | Dec 2004 | A1 |
20040260394 | Douk et al. | Dec 2004 | A1 |
20040267357 | Allen et al. | Dec 2004 | A1 |
20050000858 | Roovers | Jan 2005 | A1 |
20050004505 | Phelps et al. | Jan 2005 | A1 |
20050004558 | Gambale et al. | Jan 2005 | A1 |
20050004648 | Boekstegers | Jan 2005 | A1 |
20050008589 | Legrand et al. | Jan 2005 | A1 |
20050009000 | Wilhelm et al. | Jan 2005 | A1 |
20050010246 | Streeter et al. | Jan 2005 | A1 |
20050010285 | Lambrecht et al. | Jan 2005 | A1 |
20050010287 | Macoviak et al. | Jan 2005 | A1 |
20050015112 | Cohn et al. | Jan 2005 | A1 |
20050021136 | Xie et al. | Jan 2005 | A1 |
20050025857 | Schoenherr et al. | Feb 2005 | A1 |
20050027305 | Shiu et al. | Feb 2005 | A1 |
20050027348 | Case et al. | Feb 2005 | A1 |
20050033220 | Wilk et al. | Feb 2005 | A1 |
20050033398 | Seguin | Feb 2005 | A1 |
20050033402 | Cully et al. | Feb 2005 | A1 |
20050038495 | Greenan | Feb 2005 | A1 |
20050038509 | Ashe | Feb 2005 | A1 |
20050043585 | Datta et al. | Feb 2005 | A1 |
20050043711 | Corcoran et al. | Feb 2005 | A1 |
20050043757 | Arad et al. | Feb 2005 | A1 |
20050043759 | Chanduszko | Feb 2005 | A1 |
20050043760 | Fogarty et al. | Feb 2005 | A1 |
20050043781 | Foley | Feb 2005 | A1 |
20050043790 | Seguin | Feb 2005 | A1 |
20050049674 | Berra et al. | Mar 2005 | A1 |
20050049692 | Numamoto et al. | Mar 2005 | A1 |
20050049696 | Siess et al. | Mar 2005 | A1 |
20050055088 | Liddicoat et al. | Mar 2005 | A1 |
20050060016 | Wu et al. | Mar 2005 | A1 |
20050060018 | Dittman | Mar 2005 | A1 |
20050060029 | Le et al. | Mar 2005 | A1 |
20050060030 | Lashinski et al. | Mar 2005 | A1 |
20050065594 | DiMatteo et al. | Mar 2005 | A1 |
20050070794 | Deal et al. | Mar 2005 | A1 |
20050070957 | Das | Mar 2005 | A1 |
20050075584 | Cali | Apr 2005 | A1 |
20050075662 | Pedersen et al. | Apr 2005 | A1 |
20050075712 | Biancucci et al. | Apr 2005 | A1 |
20050075717 | Nguyen et al. | Apr 2005 | A1 |
20050075719 | Bergheim | Apr 2005 | A1 |
20050075720 | Nguyen et al. | Apr 2005 | A1 |
20050075724 | Svanidze et al. | Apr 2005 | A1 |
20050075725 | Rowe | Apr 2005 | A1 |
20050075726 | Svanidze et al. | Apr 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050075730 | Myers et al. | Apr 2005 | A1 |
20050075731 | Artof et al. | Apr 2005 | A1 |
20050075776 | Cho | Apr 2005 | A1 |
20050084595 | Shukla et al. | Apr 2005 | A1 |
20050085841 | Eversull et al. | Apr 2005 | A1 |
20050085842 | Eversull et al. | Apr 2005 | A1 |
20050085843 | Opolski et al. | Apr 2005 | A1 |
20050085890 | Rasmussen et al. | Apr 2005 | A1 |
20050085900 | Case et al. | Apr 2005 | A1 |
20050090846 | Pedersen et al. | Apr 2005 | A1 |
20050090890 | Wu et al. | Apr 2005 | A1 |
20050096568 | Kato | May 2005 | A1 |
20050096692 | Linder et al. | May 2005 | A1 |
20050096724 | Stenzel et al. | May 2005 | A1 |
20050096726 | Sequin et al. | May 2005 | A1 |
20050096734 | Majercak et al. | May 2005 | A1 |
20050096735 | Hojeibane et al. | May 2005 | A1 |
20050096736 | Osse et al. | May 2005 | A1 |
20050096738 | Cali et al. | May 2005 | A1 |
20050096768 | Huang et al. | May 2005 | A1 |
20050098547 | Cali et al. | May 2005 | A1 |
20050100580 | Osborne et al. | May 2005 | A1 |
20050101903 | Kohler et al. | May 2005 | A1 |
20050101904 | Wilk | May 2005 | A1 |
20050101968 | Dadourian | May 2005 | A1 |
20050107822 | Wasdyke | May 2005 | A1 |
20050107871 | Realyvasquez et al. | May 2005 | A1 |
20050113902 | Geiser et al. | May 2005 | A1 |
20050113904 | Shank et al. | May 2005 | A1 |
20050113910 | Paniagua et al. | May 2005 | A1 |
20050119688 | Bergheim | Jun 2005 | A1 |
20050119728 | Sarac | Jun 2005 | A1 |
20050119736 | Zilla et al. | Jun 2005 | A1 |
20050125075 | Meade et al. | Jun 2005 | A1 |
20050131438 | Cohn | Jun 2005 | A1 |
20050137499 | Sheets et al. | Jun 2005 | A1 |
20050137609 | Guiraudon | Jun 2005 | A1 |
20050137681 | Shoemaker et al. | Jun 2005 | A1 |
20050137682 | Justino | Jun 2005 | A1 |
20050137683 | Hezi-Yamit et al. | Jun 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137687 | Salahieh et al. | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137689 | Salahieh et al. | Jun 2005 | A1 |
20050137690 | Salahieh et al. | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050137692 | Haug et al. | Jun 2005 | A1 |
20050137693 | Haug et al. | Jun 2005 | A1 |
20050137694 | Haug et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137696 | Salahieh et al. | Jun 2005 | A1 |
20050137697 | Salahieh et al. | Jun 2005 | A1 |
20050137698 | Salahieh et al. | Jun 2005 | A1 |
20050137699 | Salahieh et al. | Jun 2005 | A1 |
20050137701 | Salahieh et al. | Jun 2005 | A1 |
20050137702 | Haug et al. | Jun 2005 | A1 |
20050138689 | Aukerman | Jun 2005 | A1 |
20050143804 | Haverkost | Jun 2005 | A1 |
20050143807 | Pavcnik et al. | Jun 2005 | A1 |
20050143809 | Salahieh et al. | Jun 2005 | A1 |
20050148997 | Valley et al. | Jul 2005 | A1 |
20050149159 | Andreas et al. | Jul 2005 | A1 |
20050149166 | Schaeffer et al. | Jul 2005 | A1 |
20050149181 | Eberhardt | Jul 2005 | A1 |
20050150775 | Zhang et al. | Jul 2005 | A1 |
20050159726 | Evans et al. | Jul 2005 | A1 |
20050165352 | Henry et al. | Jul 2005 | A1 |
20050165477 | Anduiza et al. | Jul 2005 | A1 |
20050165479 | Drews et al. | Jul 2005 | A1 |
20050171597 | Boatman et al. | Aug 2005 | A1 |
20050171598 | Schaeffer | Aug 2005 | A1 |
20050177227 | Heim et al. | Aug 2005 | A1 |
20050182483 | Osborne et al. | Aug 2005 | A1 |
20050182486 | Gabbay | Aug 2005 | A1 |
20050186349 | Loper et al. | Aug 2005 | A1 |
20050187616 | Realyvasquez | Aug 2005 | A1 |
20050192527 | Gharib et al. | Sep 2005 | A1 |
20050192665 | Spenser et al. | Sep 2005 | A1 |
20050197694 | Pai et al. | Sep 2005 | A1 |
20050197695 | Stacchino et al. | Sep 2005 | A1 |
20050203549 | Realyvasquez | Sep 2005 | A1 |
20050203605 | Dolan | Sep 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203615 | Forster et al. | Sep 2005 | A1 |
20050203616 | Cribier | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050203618 | Sharkawy et al. | Sep 2005 | A1 |
20050203818 | Rotman et al. | Sep 2005 | A9 |
20050209580 | Freyman | Sep 2005 | A1 |
20050214342 | Tweden et al. | Sep 2005 | A1 |
20050222664 | Parker | Oct 2005 | A1 |
20050222668 | Schaeffer et al. | Oct 2005 | A1 |
20050222674 | Paine | Oct 2005 | A1 |
20050228334 | Knudson et al. | Oct 2005 | A1 |
20050228472 | Case et al. | Oct 2005 | A1 |
20050228495 | Macoviak | Oct 2005 | A1 |
20050228496 | Mensah et al. | Oct 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20050240200 | Bergheim | Oct 2005 | A1 |
20050240262 | White | Oct 2005 | A1 |
20050240263 | Fogarty et al. | Oct 2005 | A1 |
20050251243 | Seppala et al. | Nov 2005 | A1 |
20050251250 | Verhoeven et al. | Nov 2005 | A1 |
20050251251 | Cribier | Nov 2005 | A1 |
20050251252 | Stobie | Nov 2005 | A1 |
20050256532 | Nayak et al. | Nov 2005 | A1 |
20050261759 | Lambrecht et al. | Nov 2005 | A1 |
20050267523 | Devellian et al. | Dec 2005 | A1 |
20050267560 | Bates | Dec 2005 | A1 |
20050267567 | Shalev | Dec 2005 | A1 |
20050267573 | Macoviak et al. | Dec 2005 | A9 |
20050283231 | Haug et al. | Dec 2005 | A1 |
20050283962 | Boudjemline | Dec 2005 | A1 |
20050288627 | Mogul | Dec 2005 | A1 |
20050288685 | Gulles et al. | Dec 2005 | A1 |
20050288706 | Widomski et al. | Dec 2005 | A1 |
20060004439 | Spenser et al. | Jan 2006 | A1 |
20060004442 | Spenser et al. | Jan 2006 | A1 |
20060004469 | Sokel | Jan 2006 | A1 |
20060009841 | McGuckin, Jr. et al. | Jan 2006 | A1 |
20060009842 | Huynh et al. | Jan 2006 | A1 |
20060015168 | Gunderson | Jan 2006 | A1 |
20060025855 | Lashinski et al. | Feb 2006 | A1 |
20060025857 | Bergheim | Feb 2006 | A1 |
20060028766 | Khizroev | Feb 2006 | A1 |
20060041218 | Phelps et al. | Feb 2006 | A1 |
20060047338 | Jenson et al. | Mar 2006 | A1 |
20060047343 | Oviatt et al. | Mar 2006 | A1 |
20060052736 | Tweden et al. | Mar 2006 | A1 |
20060052867 | Revuelta et al. | Mar 2006 | A1 |
20060058775 | Stevens et al. | Mar 2006 | A1 |
20060058864 | Schaeffer et al. | Mar 2006 | A1 |
20060058871 | Zakay et al. | Mar 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060064151 | Guterman et al. | Mar 2006 | A1 |
20060069424 | Acosta et al. | Mar 2006 | A1 |
20060074477 | Berthiaume et al. | Apr 2006 | A1 |
20060074484 | Huber | Apr 2006 | A1 |
20060074485 | Realyvasquez | Apr 2006 | A1 |
20060077447 | Sojian et al. | Apr 2006 | A1 |
20060085060 | Campbell | Apr 2006 | A1 |
20060089711 | Dolan | Apr 2006 | A1 |
20060100685 | Seguin et al. | May 2006 | A1 |
20060111770 | Pavcnik et al. | May 2006 | A1 |
20060116757 | Lashinski et al. | Jun 2006 | A1 |
20060122692 | Gilad et al. | Jun 2006 | A1 |
20060135961 | Rosenman et al. | Jun 2006 | A1 |
20060135964 | Vesely | Jun 2006 | A1 |
20060136034 | Modesitt et al. | Jun 2006 | A1 |
20060142846 | Pavcnik et al. | Jun 2006 | A1 |
20060142848 | Gabbay | Jun 2006 | A1 |
20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
20060155312 | Levine et al. | Jul 2006 | A1 |
20060155363 | LaDuca et al. | Jul 2006 | A1 |
20060155366 | LaDuca et al. | Jul 2006 | A1 |
20060161248 | Case et al. | Jul 2006 | A1 |
20060161249 | Realyvasquez et al. | Jul 2006 | A1 |
20060161265 | Levine et al. | Jul 2006 | A1 |
20060167474 | Bloom et al. | Jul 2006 | A1 |
20060167543 | Bailey et al. | Jul 2006 | A1 |
20060173524 | Salahieh et al. | Aug 2006 | A1 |
20060178740 | Stacchino et al. | Aug 2006 | A1 |
20060190070 | Dieck et al. | Aug 2006 | A1 |
20060193885 | Neethling et al. | Aug 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060195183 | Navia et al. | Aug 2006 | A1 |
20060195186 | Drews et al. | Aug 2006 | A1 |
20060206192 | Tower et al. | Sep 2006 | A1 |
20060206202 | Bonhoeffer et al. | Sep 2006 | A1 |
20060210597 | Hiles | Sep 2006 | A1 |
20060212110 | Osborne et al. | Sep 2006 | A1 |
20060212111 | Case et al. | Sep 2006 | A1 |
20060217802 | Ruiz et al. | Sep 2006 | A1 |
20060224183 | Freudenthal | Oct 2006 | A1 |
20060229561 | Huszar | Oct 2006 | A1 |
20060229718 | Marquez | Oct 2006 | A1 |
20060229719 | Marquez et al. | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060246584 | Covelli | Nov 2006 | A1 |
20060247570 | Pokorney | Nov 2006 | A1 |
20060247763 | Slater | Nov 2006 | A1 |
20060253191 | Salahieh et al. | Nov 2006 | A1 |
20060259134 | Schwammenthal et al. | Nov 2006 | A1 |
20060259135 | Navia et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060259137 | Artof et al. | Nov 2006 | A1 |
20060265043 | Mandrusov et al. | Nov 2006 | A1 |
20060265056 | Nguyen et al. | Nov 2006 | A1 |
20060270958 | George | Nov 2006 | A1 |
20060271149 | Berez et al. | Nov 2006 | A1 |
20060271161 | Meyer et al. | Nov 2006 | A1 |
20060271166 | Thill et al. | Nov 2006 | A1 |
20060271175 | Woolfson et al. | Nov 2006 | A1 |
20060276873 | Sato | Dec 2006 | A1 |
20060276874 | Wilson et al. | Dec 2006 | A1 |
20060276882 | Case et al. | Dec 2006 | A1 |
20060276887 | Brady et al. | Dec 2006 | A1 |
20060282161 | Huynh et al. | Dec 2006 | A1 |
20060287668 | Fawzi et al. | Dec 2006 | A1 |
20060287717 | Rowe et al. | Dec 2006 | A1 |
20060287719 | Rowe et al. | Dec 2006 | A1 |
20060290027 | O'Connor et al. | Dec 2006 | A1 |
20060293745 | Carpentier et al. | Dec 2006 | A1 |
20070005129 | Damm et al. | Jan 2007 | A1 |
20070005131 | Taylor | Jan 2007 | A1 |
20070005132 | Simionescu et al. | Jan 2007 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070010877 | Salahieh et al. | Jan 2007 | A1 |
20070010878 | Rafiee et al. | Jan 2007 | A1 |
20070010887 | Williams et al. | Jan 2007 | A1 |
20070016286 | Herrmann et al. | Jan 2007 | A1 |
20070016288 | Gurskis et al. | Jan 2007 | A1 |
20070020248 | Everaerts et al. | Jan 2007 | A1 |
20070021826 | Case et al. | Jan 2007 | A1 |
20070027518 | Case et al. | Feb 2007 | A1 |
20070027520 | Sherburne | Feb 2007 | A1 |
20070027533 | Douk | Feb 2007 | A1 |
20070027535 | Purdy, Jr. et al. | Feb 2007 | A1 |
20070032856 | Limon | Feb 2007 | A1 |
20070038291 | Case et al. | Feb 2007 | A1 |
20070038295 | Case et al. | Feb 2007 | A1 |
20070043420 | Lostetter | Feb 2007 | A1 |
20070043424 | Pryor | Feb 2007 | A1 |
20070043431 | Melsheimer | Feb 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070050014 | Johnson | Mar 2007 | A1 |
20070051377 | Douk et al. | Mar 2007 | A1 |
20070055340 | Pryor | Mar 2007 | A1 |
20070056346 | Spenser et al. | Mar 2007 | A1 |
20070060998 | Butterwick et al. | Mar 2007 | A1 |
20070061002 | Paul, Jr. et al. | Mar 2007 | A1 |
20070061008 | Salahieh et al. | Mar 2007 | A1 |
20070073389 | Bolduc et al. | Mar 2007 | A1 |
20070073392 | Heyninck-Jantz et al. | Mar 2007 | A1 |
20070078504 | Mialhe | Apr 2007 | A1 |
20070078509 | Lotfy | Apr 2007 | A1 |
20070078510 | Ryan | Apr 2007 | A1 |
20070088431 | Bourang et al. | Apr 2007 | A1 |
20070093869 | Bloom et al. | Apr 2007 | A1 |
20070093887 | Case et al. | Apr 2007 | A1 |
20070100427 | Perouse | May 2007 | A1 |
20070100435 | Case et al. | May 2007 | A1 |
20070100439 | Cangialosi et al. | May 2007 | A1 |
20070100440 | Figulla et al. | May 2007 | A1 |
20070100449 | O'Neil et al. | May 2007 | A1 |
20070112355 | Salahieh et al. | May 2007 | A1 |
20070112358 | Abbott et al. | May 2007 | A1 |
20070112415 | Bartlett | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070118214 | Salahieh et al. | May 2007 | A1 |
20070123700 | Ueda et al. | May 2007 | A1 |
20070123979 | Perier et al. | May 2007 | A1 |
20070135889 | Moore et al. | Jun 2007 | A1 |
20070142906 | Figulla et al. | Jun 2007 | A1 |
20070142907 | Moaddeb et al. | Jun 2007 | A1 |
20070155010 | Farnsworth et al. | Jul 2007 | A1 |
20070156233 | Kapadia et al. | Jul 2007 | A1 |
20070162102 | Ryan et al. | Jul 2007 | A1 |
20070162103 | Case et al. | Jul 2007 | A1 |
20070162107 | Haug et al. | Jul 2007 | A1 |
20070162113 | Sharkawy et al. | Jul 2007 | A1 |
20070173918 | Dreher et al. | Jul 2007 | A1 |
20070173932 | Cali et al. | Jul 2007 | A1 |
20070179592 | Schaeffer | Aug 2007 | A1 |
20070179600 | Vardi | Aug 2007 | A1 |
20070185513 | Woolfson et al. | Aug 2007 | A1 |
20070185565 | Schwammenthal et al. | Aug 2007 | A1 |
20070185571 | Kapadia et al. | Aug 2007 | A1 |
20070198078 | Berra et al. | Aug 2007 | A1 |
20070198097 | Zegdi | Aug 2007 | A1 |
20070203391 | Bloom et al. | Aug 2007 | A1 |
20070203503 | Salahieh et al. | Aug 2007 | A1 |
20070203560 | Forster et al. | Aug 2007 | A1 |
20070203576 | Lee et al. | Aug 2007 | A1 |
20070208550 | Cali et al. | Sep 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070225681 | House | Sep 2007 | A1 |
20070225802 | Forsell | Sep 2007 | A1 |
20070232898 | Huynh et al. | Oct 2007 | A1 |
20070233222 | Roeder et al. | Oct 2007 | A1 |
20070233228 | Eberhardt et al. | Oct 2007 | A1 |
20070233237 | Krivoruchko | Oct 2007 | A1 |
20070233238 | Huynh et al. | Oct 2007 | A1 |
20070238979 | Huynh et al. | Oct 2007 | A1 |
20070239254 | Chia et al. | Oct 2007 | A1 |
20070239265 | Birdsall | Oct 2007 | A1 |
20070239266 | Birdsall | Oct 2007 | A1 |
20070239269 | Dolan et al. | Oct 2007 | A1 |
20070239271 | Nguyen | Oct 2007 | A1 |
20070239273 | Allen | Oct 2007 | A1 |
20070244543 | Mitchell | Oct 2007 | A1 |
20070244544 | Birdsall et al. | Oct 2007 | A1 |
20070244545 | Birdsall et al. | Oct 2007 | A1 |
20070244546 | Francis | Oct 2007 | A1 |
20070244551 | Stobie | Oct 2007 | A1 |
20070244552 | Salahieh et al. | Oct 2007 | A1 |
20070244553 | Rafiee et al. | Oct 2007 | A1 |
20070244554 | Rafiee et al. | Oct 2007 | A1 |
20070244555 | Rafiee et al. | Oct 2007 | A1 |
20070244556 | Rafiee et al. | Oct 2007 | A1 |
20070244557 | Rafiee et al. | Oct 2007 | A1 |
20070250151 | Pereira | Oct 2007 | A1 |
20070250160 | Rafiee | Oct 2007 | A1 |
20070255386 | Tenne | Nov 2007 | A1 |
20070255390 | Ducke et al. | Nov 2007 | A1 |
20070255394 | Ryan | Nov 2007 | A1 |
20070255396 | Douk et al. | Nov 2007 | A1 |
20070260301 | Chuter et al. | Nov 2007 | A1 |
20070260327 | Case et al. | Nov 2007 | A1 |
20070265701 | Gurskis et al. | Nov 2007 | A1 |
20070270751 | Stangenes et al. | Nov 2007 | A1 |
20070270943 | Solem et al. | Nov 2007 | A1 |
20070273813 | Yoshida et al. | Nov 2007 | A1 |
20070282436 | Pinchuk | Dec 2007 | A1 |
20070287717 | Fanning et al. | Dec 2007 | A1 |
20070288000 | Bonan | Dec 2007 | A1 |
20070288087 | Fearnot et al. | Dec 2007 | A1 |
20070288089 | Gurskis et al. | Dec 2007 | A1 |
20080004688 | Spenser et al. | Jan 2008 | A1 |
20080004696 | Vesely | Jan 2008 | A1 |
20080009934 | Schneider et al. | Jan 2008 | A1 |
20080009940 | Cribier | Jan 2008 | A1 |
20080015671 | Bonhoeffer | Jan 2008 | A1 |
20080021546 | Patz et al. | Jan 2008 | A1 |
20080021552 | Gabbay | Jan 2008 | A1 |
20080022504 | Melsheimer | Jan 2008 | A1 |
20080033534 | Cook et al. | Feb 2008 | A1 |
20080033541 | Gelbart et al. | Feb 2008 | A1 |
20080039925 | Ishimaru et al. | Feb 2008 | A1 |
20080039934 | Styrc | Feb 2008 | A1 |
20080045921 | Anderson et al. | Feb 2008 | A1 |
20080048656 | Tan et al. | Feb 2008 | A1 |
20080065001 | DiNucci et al. | Mar 2008 | A1 |
20080065011 | Marchand et al. | Mar 2008 | A1 |
20080065206 | Liddicoat | Mar 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071362 | Tuval et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080071368 | Tuval | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080077227 | Ouellette et al. | Mar 2008 | A1 |
20080077234 | Styrc | Mar 2008 | A1 |
20080077236 | Letac et al. | Mar 2008 | A1 |
20080082165 | Wilson et al. | Apr 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080086205 | Gordy et al. | Apr 2008 | A1 |
20080097586 | Pavcnik et al. | Apr 2008 | A1 |
20080102439 | Tian et al. | May 2008 | A1 |
20080109070 | Wagner et al. | May 2008 | A1 |
20080125859 | Salahieh et al. | May 2008 | A1 |
20080127707 | Kokish et al. | Jun 2008 | A1 |
20080133002 | Gelbart et al. | Jun 2008 | A1 |
20080133003 | Seguin et al. | Jun 2008 | A1 |
20080140188 | Rahdert et al. | Jun 2008 | A1 |
20080140189 | Nguyen et al. | Jun 2008 | A1 |
20080147105 | Wilson et al. | Jun 2008 | A1 |
20080147180 | Ghione et al. | Jun 2008 | A1 |
20080147181 | Ghione et al. | Jun 2008 | A1 |
20080147182 | Righini et al. | Jun 2008 | A1 |
20080154355 | Benichou et al. | Jun 2008 | A1 |
20080154356 | Obermiller et al. | Jun 2008 | A1 |
20080161909 | Kheradvar et al. | Jul 2008 | A1 |
20080161910 | Revuelta et al. | Jul 2008 | A1 |
20080161911 | Revuelta et al. | Jul 2008 | A1 |
20080172119 | Yamasaki et al. | Jul 2008 | A1 |
20080177381 | Navia et al. | Jul 2008 | A1 |
20080183273 | Mesana et al. | Jul 2008 | A1 |
20080188928 | Salahieh et al. | Aug 2008 | A1 |
20080195193 | Purdy et al. | Aug 2008 | A1 |
20080195199 | Kheradvar et al. | Aug 2008 | A1 |
20080200977 | Paul et al. | Aug 2008 | A1 |
20080208209 | Fischer et al. | Aug 2008 | A1 |
20080208327 | Rowe | Aug 2008 | A1 |
20080208328 | Antocci et al. | Aug 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080215143 | Seguin | Sep 2008 | A1 |
20080215144 | Ryan et al. | Sep 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080221703 | Que et al. | Sep 2008 | A1 |
20080228254 | Ryan | Sep 2008 | A1 |
20080228263 | Ryan | Sep 2008 | A1 |
20080234443 | Kiss et al. | Sep 2008 | A1 |
20080234797 | Styrc | Sep 2008 | A1 |
20080234814 | Salahieh et al. | Sep 2008 | A1 |
20080243246 | Ryan et al. | Oct 2008 | A1 |
20080255651 | Dwork | Oct 2008 | A1 |
20080255660 | Guyenot et al. | Oct 2008 | A1 |
20080255661 | Straubinger et al. | Oct 2008 | A1 |
20080262590 | Murray | Oct 2008 | A1 |
20080262592 | Jordan et al. | Oct 2008 | A1 |
20080262593 | Ryan et al. | Oct 2008 | A1 |
20080262602 | Wilk et al. | Oct 2008 | A1 |
20080264102 | Berra | Oct 2008 | A1 |
20080269878 | Lobbi | Oct 2008 | A1 |
20080275549 | Rowe | Nov 2008 | A1 |
20080275550 | Kheradvar et al. | Nov 2008 | A1 |
20080288054 | Pulnev et al. | Nov 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090012356 | Dann et al. | Jan 2009 | A1 |
20090012600 | Styrc et al. | Jan 2009 | A1 |
20090030512 | Thielen et al. | Jan 2009 | A1 |
20090048656 | Wen | Feb 2009 | A1 |
20090054968 | Bonhoeffer et al. | Feb 2009 | A1 |
20090054969 | Salahieh et al. | Feb 2009 | A1 |
20090054976 | Tuval et al. | Feb 2009 | A1 |
20090062908 | Bonhoeffer et al. | Mar 2009 | A1 |
20090069886 | Suri et al. | Mar 2009 | A1 |
20090069887 | Righini et al. | Mar 2009 | A1 |
20090069889 | Suri | Mar 2009 | A1 |
20090069890 | Suri | Mar 2009 | A1 |
20090076598 | Salahieh et al. | Mar 2009 | A1 |
20090082844 | Zacharias et al. | Mar 2009 | A1 |
20090082858 | Nugent et al. | Mar 2009 | A1 |
20090085900 | Weiner | Apr 2009 | A1 |
20090093876 | Nitzan et al. | Apr 2009 | A1 |
20090093877 | Keidar et al. | Apr 2009 | A1 |
20090099640 | Weng | Apr 2009 | A1 |
20090099641 | Wu et al. | Apr 2009 | A1 |
20090099643 | Hyodoh et al. | Apr 2009 | A1 |
20090099653 | Suri et al. | Apr 2009 | A1 |
20090112309 | Jaramillo et al. | Apr 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090163951 | Simmons et al. | Jun 2009 | A1 |
20090164004 | Cohn | Jun 2009 | A1 |
20090164006 | Seguin et al. | Jun 2009 | A1 |
20090171432 | Von Segesser et al. | Jul 2009 | A1 |
20090171447 | Von Segesser et al. | Jul 2009 | A1 |
20090171456 | Kveen et al. | Jul 2009 | A1 |
20090182405 | Arnault De La Menardiere et al. | Jul 2009 | A1 |
20090192585 | Bloom et al. | Jul 2009 | A1 |
20090192586 | Tabor et al. | Jul 2009 | A1 |
20090192591 | Ryan et al. | Jul 2009 | A1 |
20090192601 | Rafiee et al. | Jul 2009 | A1 |
20090198316 | Laske et al. | Aug 2009 | A1 |
20090198323 | Johnson et al. | Aug 2009 | A1 |
20090210052 | Forster et al. | Aug 2009 | A1 |
20090216310 | Straubinger et al. | Aug 2009 | A1 |
20090216312 | Straubinger et al. | Aug 2009 | A1 |
20090216313 | Straubinger | Aug 2009 | A1 |
20090222076 | Figulla et al. | Sep 2009 | A1 |
20090222082 | Lock et al. | Sep 2009 | A1 |
20090234407 | Hastings et al. | Sep 2009 | A1 |
20090234443 | Ottma et al. | Sep 2009 | A1 |
20090240264 | Tuval et al. | Sep 2009 | A1 |
20090240320 | Tuval et al. | Sep 2009 | A1 |
20090248143 | Laham | Oct 2009 | A1 |
20090259306 | Rowe | Oct 2009 | A1 |
20090264759 | Byrd | Oct 2009 | A1 |
20090264997 | Salahieh et al. | Oct 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287290 | Macaulay et al. | Nov 2009 | A1 |
20090287296 | Manasse | Nov 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090299462 | Fawzi et al. | Dec 2009 | A1 |
20090319037 | Rowe et al. | Dec 2009 | A1 |
20100004739 | Vesely | Jan 2010 | A1 |
20100004740 | Seguin et al. | Jan 2010 | A1 |
20100011564 | Millwee et al. | Jan 2010 | A1 |
20100030328 | Seguin et al. | Feb 2010 | A1 |
20100036479 | Hill et al. | Feb 2010 | A1 |
20100036485 | Seguin | Feb 2010 | A1 |
20100049313 | Alon et al. | Feb 2010 | A1 |
20100057051 | How et al. | Mar 2010 | A1 |
20100057185 | Melsheimer et al. | Mar 2010 | A1 |
20100069852 | Kelley | Mar 2010 | A1 |
20100069916 | Cully et al. | Mar 2010 | A1 |
20100070027 | Bonhoeffer et al. | Mar 2010 | A1 |
20100082089 | Quadri et al. | Apr 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100087913 | Rabkin et al. | Apr 2010 | A1 |
20100094399 | Dorn et al. | Apr 2010 | A1 |
20100094411 | Tuval et al. | Apr 2010 | A1 |
20100100167 | Bortlein et al. | Apr 2010 | A1 |
20100121434 | Paul et al. | May 2010 | A1 |
20100131054 | Tuval et al. | May 2010 | A1 |
20100131057 | Subramanian et al. | May 2010 | A1 |
20100137979 | Tuval et al. | Jun 2010 | A1 |
20100145439 | Seguin et al. | Jun 2010 | A1 |
20100152840 | Seguin et al. | Jun 2010 | A1 |
20100160725 | Kiser et al. | Jun 2010 | A1 |
20100161045 | Righini | Jun 2010 | A1 |
20100168839 | Braido et al. | Jul 2010 | A1 |
20100174362 | Straubinger et al. | Jul 2010 | A1 |
20100185275 | Richter et al. | Jul 2010 | A1 |
20100185277 | Braido et al. | Jul 2010 | A1 |
20100191320 | Straubinger et al. | Jul 2010 | A1 |
20100191326 | Alkhatib | Jul 2010 | A1 |
20100198346 | Keogh et al. | Aug 2010 | A1 |
20100210991 | Wilk et al. | Aug 2010 | A1 |
20100219092 | Salahieh et al. | Sep 2010 | A1 |
20100234932 | Arbefeuille et al. | Sep 2010 | A1 |
20100234940 | Dolan | Sep 2010 | A1 |
20100239917 | Lee et al. | Sep 2010 | A1 |
20100249908 | Chau et al. | Sep 2010 | A1 |
20100249915 | Zhang | Sep 2010 | A1 |
20100249916 | Zhang | Sep 2010 | A1 |
20100249917 | Zhang | Sep 2010 | A1 |
20100249918 | Zhang | Sep 2010 | A1 |
20100256723 | Murray | Oct 2010 | A1 |
20100262231 | Tuval et al. | Oct 2010 | A1 |
20100268332 | Tuval et al. | Oct 2010 | A1 |
20100280459 | Werner | Nov 2010 | A1 |
20100280495 | Paul et al. | Nov 2010 | A1 |
20100286768 | Alkhatib | Nov 2010 | A1 |
20100292779 | Straubinger et al. | Nov 2010 | A1 |
20100292780 | Straubinger et al. | Nov 2010 | A1 |
20100292785 | Seguin et al. | Nov 2010 | A1 |
20100298931 | Quadri et al. | Nov 2010 | A1 |
20110004297 | Sogard et al. | Jan 2011 | A1 |
20110015616 | Straubinger et al. | Jan 2011 | A1 |
20110022157 | Essinger et al. | Jan 2011 | A1 |
20110029066 | Gilad et al. | Feb 2011 | A1 |
20110034852 | Hausler et al. | Feb 2011 | A1 |
20110040366 | Goetz et al. | Feb 2011 | A1 |
20110040374 | Goetz et al. | Feb 2011 | A1 |
20110071613 | Wood et al. | Mar 2011 | A1 |
20110093007 | Abbott et al. | Apr 2011 | A1 |
20110098805 | Dwork et al. | Apr 2011 | A1 |
20110106244 | Ferrari et al. | May 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110166637 | Irwin et al. | Jul 2011 | A1 |
20110190862 | Bashiri et al. | Aug 2011 | A1 |
20110190874 | Celermajer et al. | Aug 2011 | A1 |
20110208290 | Straubinger et al. | Aug 2011 | A1 |
20110208297 | Tuval et al. | Aug 2011 | A1 |
20110224780 | Tabor et al. | Sep 2011 | A1 |
20110238159 | Guyenot et al. | Sep 2011 | A1 |
20110238167 | Dove et al. | Sep 2011 | A1 |
20110257729 | Spenser et al. | Oct 2011 | A1 |
20110257733 | Dwork | Oct 2011 | A1 |
20110257735 | Salahieh et al. | Oct 2011 | A1 |
20110264191 | Rothstein | Oct 2011 | A1 |
20110264196 | Savage et al. | Oct 2011 | A1 |
20110264203 | Dwork et al. | Oct 2011 | A1 |
20110276121 | Levine | Nov 2011 | A1 |
20110276129 | Salahieh et al. | Nov 2011 | A1 |
20110288626 | Straubinger et al. | Nov 2011 | A1 |
20110288634 | Tuval et al. | Nov 2011 | A1 |
20110295363 | Girard et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20120016469 | Salahieh et al. | Jan 2012 | A1 |
20120016471 | Salahieh et al. | Jan 2012 | A1 |
20120022633 | Olson et al. | Jan 2012 | A1 |
20120022642 | Haug et al. | Jan 2012 | A1 |
20120029627 | Salahieh et al. | Feb 2012 | A1 |
20120035719 | Forster et al. | Feb 2012 | A1 |
20120035720 | Cali et al. | Feb 2012 | A1 |
20120041547 | Duffy et al. | Feb 2012 | A1 |
20120041549 | Salahieh et al. | Feb 2012 | A1 |
20120041550 | Salahieh et al. | Feb 2012 | A1 |
20120046740 | Paul et al. | Feb 2012 | A1 |
20120053683 | Salahieh et al. | Mar 2012 | A1 |
20120059447 | Zilla et al. | Mar 2012 | A1 |
20120065464 | Ellis et al. | Mar 2012 | A1 |
20120078347 | Braido et al. | Mar 2012 | A1 |
20120078357 | Conklin | Mar 2012 | A1 |
20120078360 | Rafiee | Mar 2012 | A1 |
20120089224 | Haug et al. | Apr 2012 | A1 |
20120100182 | Mooney et al. | Apr 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120101572 | Kovalsky et al. | Apr 2012 | A1 |
20120116496 | Chuter et al. | May 2012 | A1 |
20120123515 | Hosford et al. | May 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120130468 | Khosravi et al. | May 2012 | A1 |
20120132547 | Salahieh et al. | May 2012 | A1 |
20120136430 | Sochman et al. | May 2012 | A1 |
20120165957 | Everland et al. | Jun 2012 | A1 |
20120172982 | Stacchino et al. | Jul 2012 | A1 |
20120179244 | Schankereli et al. | Jul 2012 | A1 |
20120185030 | Igaki et al. | Jul 2012 | A1 |
20120197379 | Laske et al. | Aug 2012 | A1 |
20120209374 | Bonhoeffer et al. | Aug 2012 | A1 |
20120209376 | Hauser et al. | Aug 2012 | A1 |
20120221100 | Huber | Aug 2012 | A1 |
20120226341 | Schreck et al. | Sep 2012 | A1 |
20120283715 | Mihalik et al. | Nov 2012 | A1 |
20120283823 | Bonhoeffer et al. | Nov 2012 | A1 |
20120303113 | Benichou et al. | Nov 2012 | A1 |
20120303116 | Gorman, III et al. | Nov 2012 | A1 |
20120305441 | Murray et al. | Dec 2012 | A1 |
20120310332 | Murray et al. | Dec 2012 | A1 |
20120316637 | Holm et al. | Dec 2012 | A1 |
20120330408 | Hillukka et al. | Dec 2012 | A1 |
20120330409 | Haug et al. | Dec 2012 | A1 |
20130013057 | Salahieh et al. | Jan 2013 | A1 |
20130018457 | Gregg et al. | Jan 2013 | A1 |
20130030519 | Tran et al. | Jan 2013 | A1 |
20130030520 | Lee et al. | Jan 2013 | A1 |
20130046373 | Cartledge et al. | Feb 2013 | A1 |
20130053949 | Pintor et al. | Feb 2013 | A1 |
20130066342 | Dell et al. | Mar 2013 | A1 |
20130066419 | Gregg | Mar 2013 | A1 |
20130071441 | Iwazawa et al. | Mar 2013 | A1 |
20130073037 | Gregg et al. | Mar 2013 | A1 |
20130079867 | Hoffman et al. | Mar 2013 | A1 |
20130079869 | Straubinger et al. | Mar 2013 | A1 |
20130089655 | Gregg | Apr 2013 | A1 |
20130090728 | Solem | Apr 2013 | A1 |
20130090729 | Gregg et al. | Apr 2013 | A1 |
20130096664 | Goetz et al. | Apr 2013 | A1 |
20130116778 | Gregg et al. | May 2013 | A1 |
20130118949 | Chang et al. | May 2013 | A1 |
20130123757 | Crisostomo et al. | May 2013 | A1 |
20130123795 | Gamarra et al. | May 2013 | A1 |
20130123796 | Sutton et al. | May 2013 | A1 |
20130123898 | Tung et al. | May 2013 | A1 |
20130138207 | Quadri et al. | May 2013 | A1 |
20130144203 | Wilk et al. | Jun 2013 | A1 |
20130144276 | Crisostomo et al. | Jun 2013 | A1 |
20130158653 | Gamarra et al. | Jun 2013 | A1 |
20130158655 | Sutton et al. | Jun 2013 | A1 |
20130158656 | Sutton et al. | Jun 2013 | A1 |
20130166017 | Cartledge et al. | Jun 2013 | A1 |
20130178930 | Straubinger et al. | Jul 2013 | A1 |
20130184813 | Quadri et al. | Jul 2013 | A1 |
20130190865 | Anderson | Jul 2013 | A1 |
20130204359 | Thubrikar et al. | Aug 2013 | A1 |
20130231735 | Deem et al. | Sep 2013 | A1 |
20130245752 | Goetz et al. | Sep 2013 | A1 |
20130253342 | Griswold et al. | Sep 2013 | A1 |
20130253635 | Straubinger et al. | Sep 2013 | A1 |
20130253640 | Meiri et al. | Sep 2013 | A1 |
20130268067 | Forster et al. | Oct 2013 | A1 |
20130274865 | Haverkost et al. | Oct 2013 | A1 |
20130274870 | Lombardi et al. | Oct 2013 | A1 |
20130289698 | Wang et al. | Oct 2013 | A1 |
20130296999 | Burriesci et al. | Nov 2013 | A1 |
20130304199 | Sutton et al. | Nov 2013 | A1 |
20130310917 | Richter et al. | Nov 2013 | A1 |
20130310923 | Kheradvar et al. | Nov 2013 | A1 |
20130310928 | Morriss et al. | Nov 2013 | A1 |
20130325101 | Goetz et al. | Dec 2013 | A1 |
20130338755 | Goetz et al. | Dec 2013 | A1 |
20130345799 | Lafontaine | Dec 2013 | A1 |
20140012368 | Sugimoto et al. | Jan 2014 | A1 |
20140012370 | Bonhoeffer et al. | Jan 2014 | A1 |
20140018911 | Zhou et al. | Jan 2014 | A1 |
20140052239 | Kong et al. | Feb 2014 | A1 |
20140058501 | Bonhoeffer et al. | Feb 2014 | A1 |
20140083190 | Kaack et al. | Mar 2014 | A1 |
20140088680 | Costello et al. | Mar 2014 | A1 |
20140094904 | Salahieh et al. | Apr 2014 | A1 |
20140114390 | Tobis et al. | Apr 2014 | A1 |
20140114405 | Paul et al. | Apr 2014 | A1 |
20140114406 | Salahieh et al. | Apr 2014 | A1 |
20140114407 | Rajamannan | Apr 2014 | A1 |
20140121763 | Duffy et al. | May 2014 | A1 |
20140121766 | Salahieh et al. | May 2014 | A1 |
20140128969 | Hill et al. | May 2014 | A1 |
20140135912 | Salahieh et al. | May 2014 | A1 |
20140207229 | Shoemaker et al. | Jul 2014 | A1 |
20140222142 | Kovalsky et al. | Aug 2014 | A1 |
20140236287 | Clague et al. | Aug 2014 | A1 |
20140243962 | Wilson et al. | Aug 2014 | A1 |
20140243963 | Sheps et al. | Aug 2014 | A1 |
20140243967 | Salahieh et al. | Aug 2014 | A1 |
20140249621 | Eidenschink | Sep 2014 | A1 |
20140257473 | Rajamannan | Sep 2014 | A1 |
20140277414 | Kheradvar | Sep 2014 | A1 |
20140296962 | Cartledge et al. | Oct 2014 | A1 |
20140309732 | Solem | Oct 2014 | A1 |
20140316518 | Kheradvar et al. | Oct 2014 | A1 |
20140330371 | Gloss et al. | Nov 2014 | A1 |
20140343669 | Lane et al. | Nov 2014 | A1 |
20140379068 | Thielen et al. | Dec 2014 | A1 |
20150012085 | Salahieh et al. | Jan 2015 | A1 |
20150032056 | Okamura et al. | Jan 2015 | A1 |
20150073540 | Salahieh et al. | Mar 2015 | A1 |
20150073541 | Salahieh et al. | Mar 2015 | A1 |
20150088252 | Jenson et al. | Mar 2015 | A1 |
20150094804 | Bonhoeffer et al. | Apr 2015 | A1 |
20150105857 | Bonhoeffer et al. | Apr 2015 | A1 |
20150127092 | Straubinger et al. | May 2015 | A1 |
20150127094 | Salahieh et al. | May 2015 | A1 |
20150142102 | Lafontaine et al. | May 2015 | A1 |
20150209142 | Paul et al. | Jul 2015 | A1 |
20150209146 | Hill et al. | Jul 2015 | A1 |
20150223933 | Haug et al. | Aug 2015 | A1 |
20150238315 | Rabito et al. | Aug 2015 | A1 |
20150245909 | Salahieh et al. | Sep 2015 | A1 |
20150272731 | Racchini et al. | Oct 2015 | A1 |
20150320557 | Sutton et al. | Nov 2015 | A1 |
20150335423 | Gregg et al. | Nov 2015 | A1 |
20150352252 | Nakamura et al. | Dec 2015 | A1 |
20150359997 | Crisostomo et al. | Dec 2015 | A1 |
20160022418 | Salahieh et al. | Jan 2016 | A1 |
20160045306 | Agrawal et al. | Feb 2016 | A1 |
20160045307 | Yohanan et al. | Feb 2016 | A1 |
20160051362 | Cooper et al. | Feb 2016 | A1 |
20160067040 | Agrawal et al. | Mar 2016 | A1 |
20160120645 | Alon | May 2016 | A1 |
20160135951 | Salahieh et al. | May 2016 | A1 |
20160143731 | Backus et al. | May 2016 | A1 |
20160158003 | Wallace et al. | Jun 2016 | A1 |
20160166384 | Olson et al. | Jun 2016 | A1 |
20160199184 | Ma et al. | Jul 2016 | A1 |
20160206423 | O'Connor et al. | Jul 2016 | A1 |
20160213467 | Backus et al. | Jul 2016 | A1 |
20160220359 | Backus et al. | Aug 2016 | A1 |
20160220360 | Lin et al. | Aug 2016 | A1 |
20160220365 | Backus et al. | Aug 2016 | A1 |
20160250024 | Hill et al. | Sep 2016 | A1 |
20160256271 | Backus et al. | Sep 2016 | A1 |
20160262878 | Backus et al. | Sep 2016 | A1 |
20160346107 | Matthison-Hansen et al. | Dec 2016 | A1 |
20160354203 | Tuval et al. | Dec 2016 | A1 |
20160374793 | Lafontaine et al. | Dec 2016 | A1 |
20160376063 | Salahieh et al. | Dec 2016 | A1 |
20170000609 | Gross et al. | Jan 2017 | A1 |
20170007400 | Sogard et al. | Jan 2017 | A1 |
20170027693 | Paul et al. | Feb 2017 | A1 |
20170049563 | Straubinger et al. | Feb 2017 | A1 |
20170049568 | Straubinger et al. | Feb 2017 | A1 |
20170056172 | Salahieh et al. | Mar 2017 | A1 |
20170065410 | Straubinger et al. | Mar 2017 | A1 |
20170095595 | Nakamura | Apr 2017 | A1 |
20170333230 | Folan et al. | Nov 2017 | A1 |
20170348013 | Mottola et al. | Dec 2017 | A1 |
20180368976 | Bonhoeffer et al. | Dec 2018 | A1 |
20190328522 | Straubinger et al. | Oct 2019 | A1 |
20200054449 | Min et al. | Feb 2020 | A1 |
20210322153 | Tuval | Oct 2021 | A1 |
20220304803 | Guyenot | Sep 2022 | A1 |
Number | Date | Country |
---|---|---|
757647 | Feb 2003 | AU |
776895 | Sep 2004 | AU |
777443 | Oct 2004 | AU |
778831 | Dec 2004 | AU |
2004231189 | Dec 2004 | AU |
2004242527 | Jan 2005 | AU |
2001281277 | Sep 2005 | AU |
2006328896 | Jun 2007 | AU |
2002329324 | Jul 2007 | AU |
2007294199 | Mar 2008 | AU |
2009200985 | Apr 2009 | AU |
2006328896 | Aug 2013 | AU |
2378589 | Feb 2001 | CA |
2381192 | Feb 2001 | CA |
2385662 | Mar 2001 | CA |
2407987 | Nov 2001 | CA |
2418958 | Feb 2002 | CA |
2435962 | Aug 2002 | CA |
2457755 | Feb 2003 | CA |
2436258 | Jan 2005 | CA |
2848485 | Jan 2005 | CA |
2848490 | Jan 2005 | CA |
2595233 | Jul 2006 | CA |
2627409 | May 2007 | CA |
2627555 | May 2007 | CA |
2634358 | Jun 2007 | CA |
2657839 | Mar 2008 | CA |
2659690 | Mar 2008 | CA |
1338951 | Mar 2002 | CN |
1342443 | Apr 2002 | CN |
1745727 | Mar 2006 | CN |
2762776 | Mar 2006 | CN |
1897892 | Jan 2007 | CN |
2933337 | Aug 2007 | CN |
101011298 | Aug 2007 | CN |
101431963 | May 2009 | CN |
101605509 | Dec 2009 | CN |
101623217 | Jan 2010 | CN |
101700199 | May 2010 | CN |
101720211 | Jun 2010 | CN |
102271626 | Dec 2011 | CN |
102413793 | Apr 2012 | CN |
103118630 | May 2013 | CN |
2815756 | Oct 1979 | DE |
3640745 | Jun 1987 | DE |
3920657 | Jan 1991 | DE |
3640745 | Mar 1992 | DE |
4316971 | Nov 1994 | DE |
19532846 | Mar 1997 | DE |
19 546 692 | Jun 1997 | DE |
19633901 | Feb 1998 | DE |
19 857 887 | Jul 2000 | DE |
19907646 | Aug 2000 | DE |
10034105 | Apr 2002 | DE |
10049812 | Apr 2002 | DE |
10049813 | Apr 2002 | DE |
10049814 | Apr 2002 | DE |
10049815 | Apr 2002 | DE |
10048814 | May 2002 | DE |
10049812 | Jun 2004 | DE |
10335948 | Jul 2004 | DE |
10049815 | Oct 2005 | DE |
102005003632 | Aug 2006 | DE |
20221871 | Sep 2008 | DE |
69937568 | Sep 2008 | DE |
1112042 | Feb 2008 | DK |
200800058 | Jun 2008 | DK |
200800058 | Jul 2008 | DK |
1259195 | Feb 2009 | DK |
1281375 | May 2012 | DK |
0 084 395 | Jul 1983 | EP |
0103546 | Mar 1984 | EP |
0103546 | May 1988 | EP |
0144167 | Nov 1989 | EP |
0 402 036 | Dec 1990 | EP |
0 402 176 | Dec 1990 | EP |
0411118 | Feb 1991 | EP |
0 458 877 | Apr 1991 | EP |
0 515 324 | Nov 1992 | EP |
0 547 135 | Jun 1993 | EP |
0579523 | Jan 1994 | EP |
0402176 | Apr 1994 | EP |
0592410 | Apr 1994 | EP |
0597967 | May 1994 | EP |
0597967 | Dec 1994 | EP |
0458877 | May 1995 | EP |
0657147 | Jun 1995 | EP |
0 592 410 | Nov 1995 | EP |
0696447 | Feb 1996 | EP |
0402036 | Apr 1996 | EP |
0 729 364 | Sep 1996 | EP |
0732088 | Sep 1996 | EP |
0409929 | Apr 1997 | EP |
0 756 498 | May 1997 | EP |
0 778 775 | Jun 1997 | EP |
0786970 | Aug 1997 | EP |
0792624 | Sep 1997 | EP |
0797957 | Oct 1997 | EP |
0797958 | Oct 1997 | EP |
0799604 | Oct 1997 | EP |
0801928 | Oct 1997 | EP |
0815798 | Jan 1998 | EP |
0826346 | Mar 1998 | EP |
0829239 | Mar 1998 | EP |
0836834 | Apr 1998 | EP |
0850607 | Jul 1998 | EP |
0853921 | Jul 1998 | EP |
0858779 | Aug 1998 | EP |
0871414 | Oct 1998 | EP |
0876796 | Nov 1998 | EP |
0876803 | Nov 1998 | EP |
0778775 | Jan 1999 | EP |
0888142 | Jan 1999 | EP |
0888750 | Jan 1999 | EP |
0895752 | Feb 1999 | EP |
0896813 | Feb 1999 | EP |
0903122 | Mar 1999 | EP |
0876796 | May 1999 | EP |
0 928 615 | Jul 1999 | EP |
0657147 | Aug 1999 | EP |
0934728 | Aug 1999 | EP |
0938877 | Sep 1999 | EP |
0943302 | Sep 1999 | EP |
0597967 | Dec 1999 | EP |
0696447 | Jan 2000 | EP |
0971649 | Jan 2000 | EP |
0 986 348 | Mar 2000 | EP |
1000590 | May 2000 | EP |
1011523 | Jun 2000 | EP |
1020166 | Jul 2000 | EP |
1027870 | Aug 2000 | EP |
1 041 942 | Oct 2000 | EP |
1 041 943 | Oct 2000 | EP |
1051204 | Nov 2000 | EP |
1057459 | Dec 2000 | EP |
1057460 | Dec 2000 | EP |
1078610 | Feb 2001 | EP |
1088529 | Apr 2001 | EP |
1089676 | Apr 2001 | EP |
1093771 | Apr 2001 | EP |
1097676 | May 2001 | EP |
1 117 446 | Jul 2001 | EP |
1112042 | Jul 2001 | EP |
1112097 | Jul 2001 | EP |
1158937 | Dec 2001 | EP |
0547135 | Jan 2002 | EP |
0729364 | Jan 2002 | EP |
1164976 | Jan 2002 | EP |
1166721 | Jan 2002 | EP |
1171061 | Jan 2002 | EP |
1 206 179 | May 2002 | EP |
0756498 | Jul 2002 | EP |
1233731 | Aug 2002 | EP |
0986348 | Sep 2002 | EP |
1235537 | Sep 2002 | EP |
1 251 804 | Oct 2002 | EP |
1248655 | Oct 2002 | EP |
1251805 | Oct 2002 | EP |
1255510 | Nov 2002 | EP |
1257305 | Nov 2002 | EP |
1259193 | Nov 2002 | EP |
1259195 | Nov 2002 | EP |
0 971 649 | Dec 2002 | EP |
0959815 | Dec 2002 | EP |
1262201 | Dec 2002 | EP |
1264582 | Dec 2002 | EP |
1 281 375 | Feb 2003 | EP |
1281357 | Feb 2003 | EP |
0888142 | May 2003 | EP |
1112097 | Jun 2003 | EP |
1330213 | Jul 2003 | EP |
1 017 868 | Sep 2003 | EP |
0937439 | Sep 2003 | EP |
1340473 | Sep 2003 | EP |
1347785 | Oct 2003 | EP |
1354569 | Oct 2003 | EP |
1356793 | Oct 2003 | EP |
1281375 | Dec 2003 | EP |
1340473 | Feb 2004 | EP |
1041943 | Mar 2004 | EP |
1356793 | Mar 2004 | EP |
1395208 | Mar 2004 | EP |
1401359 | Mar 2004 | EP |
0871414 | Apr 2004 | EP |
1406561 | Apr 2004 | EP |
1408882 | Apr 2004 | EP |
1042045 | May 2004 | EP |
1414295 | May 2004 | EP |
0819013 | Jun 2004 | EP |
1430853 | Jun 2004 | EP |
1347785 | Jul 2004 | EP |
1435878 | Jul 2004 | EP |
1435879 | Jul 2004 | EP |
1439800 | Jul 2004 | EP |
1441672 | Aug 2004 | EP |
1 452 153 | Sep 2004 | EP |
0954248 | Sep 2004 | EP |
0 987 998 | Oct 2004 | EP |
1206179 | Oct 2004 | EP |
1469797 | Oct 2004 | EP |
1 087 727 | Nov 2004 | EP |
1115452 | Nov 2004 | EP |
1117446 | Nov 2004 | EP |
1472996 | Nov 2004 | EP |
1477202 | Nov 2004 | EP |
1 233 731 | Dec 2004 | EP |
1107710 | Dec 2004 | EP |
1484081 | Dec 2004 | EP |
1 499 366 | Jan 2005 | EP |
1494616 | Jan 2005 | EP |
1143879 | Mar 2005 | EP |
1516599 | Mar 2005 | EP |
1518518 | Mar 2005 | EP |
1 253 875 | Apr 2005 | EP |
1229864 | Apr 2005 | EP |
1519697 | Apr 2005 | EP |
1521414 | Apr 2005 | EP |
1522278 | Apr 2005 | EP |
1 251 803 | Jun 2005 | EP |
1088529 | Jun 2005 | EP |
1093771 | Jun 2005 | EP |
1430853 | Jun 2005 | EP |
1539047 | Jun 2005 | EP |
1547533 | Jun 2005 | EP |
1059894 | Jul 2005 | EP |
1551274 | Jul 2005 | EP |
1551336 | Jul 2005 | EP |
1000590 | Aug 2005 | EP |
1027013 | Aug 2005 | EP |
1078610 | Aug 2005 | EP |
1560542 | Aug 2005 | EP |
1562515 | Aug 2005 | EP |
1570809 | Sep 2005 | EP |
1576937 | Sep 2005 | EP |
0943302 | Oct 2005 | EP |
1267753 | Oct 2005 | EP |
1582178 | Oct 2005 | EP |
1582179 | Oct 2005 | EP |
1011523 | Nov 2005 | EP |
1067869 | Nov 2005 | EP |
1589902 | Nov 2005 | EP |
1598031 | Nov 2005 | EP |
1600110 | Nov 2005 | EP |
1600121 | Nov 2005 | EP |
0786970 | Dec 2005 | EP |
1156757 | Dec 2005 | EP |
1603493 | Dec 2005 | EP |
1605871 | Dec 2005 | EP |
1021141 | Jan 2006 | EP |
1614400 | Jan 2006 | EP |
1616531 | Jan 2006 | EP |
1616536 | Jan 2006 | EP |
1041942 | Jun 2006 | EP |
1441672 | Jun 2006 | EP |
1663070 | Jun 2006 | EP |
1667614 | Jun 2006 | EP |
1494616 | Jul 2006 | EP |
1 690 515 | Aug 2006 | EP |
1702247 | Sep 2006 | EP |
1051204 | Dec 2006 | EP |
1734902 | Dec 2006 | EP |
1395208 | Jan 2007 | EP |
1 251 805 | Mar 2007 | EP |
1 255 510 | Mar 2007 | EP |
1499366 | Jul 2007 | EP |
1600121 | Jul 2007 | EP |
1835948 | Sep 2007 | EP |
1 112 042 | Nov 2007 | EP |
1251797 | Nov 2007 | EP |
1616531 | Dec 2007 | EP |
1863545 | Dec 2007 | EP |
1 878 407 | Jan 2008 | EP |
1 886 649 | Feb 2008 | EP |
1 900 343 | Mar 2008 | EP |
1406561 | Mar 2008 | EP |
1893132 | Mar 2008 | EP |
1901681 | Mar 2008 | EP |
1435878 | Apr 2008 | EP |
1886649 | Apr 2008 | EP |
1251804 | Jul 2008 | EP |
EP-1605871 | Jul 2008 | EP |
1968491 | Sep 2008 | EP |
1 259 195 | Oct 2008 | EP |
1 980 220 | Oct 2008 | EP |
2 000 115 | Dec 2008 | EP |
1994913 | Dec 2008 | EP |
1560542 | Jan 2009 | EP |
1408882 | Feb 2009 | EP |
1255510 | Mar 2009 | EP |
1330213 | Mar 2009 | EP |
2033593 | Mar 2009 | EP |
2047824 | Apr 2009 | EP |
2059192 | May 2009 | EP |
2074964 | Jul 2009 | EP |
1401359 | Aug 2009 | EP |
1968491 | Jul 2010 | EP |
1259193 | Nov 2010 | EP |
2257242 | Dec 2010 | EP |
2266503 | Dec 2010 | EP |
2266504 | Dec 2010 | EP |
1893132 | Mar 2011 | EP |
2266503 | Apr 2011 | EP |
2266504 | Apr 2011 | EP |
2059192 | Jul 2011 | EP |
1441672 | Sep 2011 | EP |
2364669 | Sep 2011 | EP |
2387977 | Nov 2011 | EP |
1603493 | Dec 2011 | EP |
1281375 | Feb 2012 | EP |
2364669 | Mar 2012 | EP |
2047824 | May 2012 | EP |
2474287 | Jul 2012 | EP |
2387977 | Nov 2013 | EP |
1551274 | Dec 2014 | EP |
2874812 | May 2015 | EP |
2749254 | Jun 2015 | EP |
1702247 | Aug 2015 | EP |
2926766 | Oct 2015 | EP |
1519697 | Nov 2015 | EP |
1863545 | Nov 2015 | EP |
1835948 | Feb 2016 | EP |
1734902 | Jun 2016 | EP |
3028668 | Jun 2016 | EP |
1539047 | Nov 2016 | EP |
1667614 | Dec 2016 | EP |
3181096 | Jun 2017 | EP |
2659861 | Mar 2019 | EP |
1667614 | Apr 2020 | EP |
2293734 | Mar 2008 | ES |
2313954 | Mar 2009 | ES |
2353733 | Mar 2011 | ES |
2381337 | May 2012 | ES |
2421438 | Sep 2013 | ES |
2432305 | Feb 1980 | FR |
2788217 | Jul 2000 | FR |
2815844 | May 2002 | FR |
2826863 | Jan 2003 | FR |
2874812 | Mar 2006 | FR |
2828263 | May 2007 | FR |
2018950 | Oct 1979 | GB |
2056023 | Mar 1981 | GB |
2316322 | Feb 1998 | GB |
2316322 | Oct 1998 | GB |
2398214 | Aug 2004 | GB |
2398245 | Aug 2004 | GB |
2398245 | Mar 2007 | GB |
2433700 | Jul 2007 | GB |
2433700 | Dec 2007 | GB |
2440809 | Feb 2008 | GB |
2440809 | Aug 2011 | GB |
1053600 | Jul 2012 | HK |
S5286296 | Jul 1977 | JP |
S54137896 | Sep 1979 | JP |
S62227352 | Oct 1987 | JP |
S6449571 | Feb 1989 | JP |
H0447576 | Aug 1992 | JP |
H04505866 | Oct 1992 | JP |
H06505187 | Jun 1994 | JP |
H06343703 | Dec 1994 | JP |
H07504091 | May 1995 | JP |
H07505803 | Jun 1995 | JP |
H07265339 | Oct 1995 | JP |
H0833715 | Feb 1996 | JP |
H1049571 | Feb 1998 | JP |
H10507673 | Jul 1998 | JP |
2001000460 | Jan 2001 | JP |
2001504016 | Mar 2001 | JP |
2001526574 | Dec 2001 | JP |
2002525168 | Aug 2002 | JP |
2002525169 | Aug 2002 | JP |
2002536115 | Oct 2002 | JP |
2003515386 | May 2003 | JP |
2003518984 | Jun 2003 | JP |
2003-524504 | Aug 2003 | JP |
2004504111 | Feb 2004 | JP |
2004130068 | Apr 2004 | JP |
2004514467 | May 2004 | JP |
2004255186 | Sep 2004 | JP |
2004267750 | Sep 2004 | JP |
2004283461 | Oct 2004 | JP |
2005505343 | Feb 2005 | JP |
2007521125 | Aug 2007 | JP |
2007298375 | Nov 2007 | JP |
2007534381 | Nov 2007 | JP |
2007536003 | Dec 2007 | JP |
2008506497 | Mar 2008 | JP |
2008514345 | May 2008 | JP |
2008535572 | Sep 2008 | JP |
2008539985 | Nov 2008 | JP |
2008541865 | Nov 2008 | JP |
2009034529 | Feb 2009 | JP |
2009061293 | Mar 2009 | JP |
2009509635 | Mar 2009 | JP |
4246433 | Apr 2009 | JP |
2009520535 | May 2009 | JP |
2009131397 | Jun 2009 | JP |
4295460 | Jul 2009 | JP |
2009528905 | Aug 2009 | JP |
2009534157 | Sep 2009 | JP |
2010525896 | Jul 2010 | JP |
2010526609 | Aug 2010 | JP |
4636794 | Feb 2011 | JP |
2011509805 | Mar 2011 | JP |
4739223 | Aug 2011 | JP |
2012500665 | Jan 2012 | JP |
4904362 | Mar 2012 | JP |
4912395 | Apr 2012 | JP |
2012518446 | Aug 2012 | JP |
2013520260 | Jun 2013 | JP |
2013521884 | Jun 2013 | JP |
2013526388 | Jun 2013 | JP |
5341455 | Nov 2013 | JP |
2013540495 | Nov 2013 | JP |
6144009 | Jun 2017 | JP |
6449571 | Jan 2019 | JP |
1112042 | Jan 2008 | PT |
1259195 | Dec 2008 | PT |
1259193 | Jan 2011 | PT |
1281375 | Mar 2012 | PT |
1994913 | Aug 2013 | PT |
2149037 | May 2000 | RU |
7901667 | Oct 1979 | SE |
WO-8402266 | Jun 1984 | WO |
WO 9009102 | Aug 1990 | WO |
WO-9014804 | Dec 1990 | WO |
WO-9117720 | Nov 1991 | WO |
WO-9203990 | Mar 1992 | WO |
WO-9212690 | Aug 1992 | WO |
WO-9214419 | Sep 1992 | WO |
WO-9217118 | Oct 1992 | WO |
WO-9301768 | Feb 1993 | WO |
WO-9315693 | Aug 1993 | WO |
WO-9320757 | Oct 1993 | WO |
WO-9504556 | Feb 1995 | WO |
WO 9511055 | Apr 1995 | WO |
WO-9504556 | Apr 1995 | WO |
WO 9524873 | Sep 1995 | WO |
WO 9528183 | Oct 1995 | WO |
WO-9528899 | Nov 1995 | WO |
WO-9529640 | Nov 1995 | WO |
WO-9529713 | Nov 1995 | WO |
WO 9613227 | May 1996 | WO |
WO-9614032 | May 1996 | WO |
WO-9624306 | Aug 1996 | WO |
WO-9630072 | Oct 1996 | WO |
WO-9632972 | Oct 1996 | WO |
WO-9635469 | Nov 1996 | WO |
WO-9639962 | Dec 1996 | WO |
WO-9639964 | Dec 1996 | WO |
WO-9639965 | Dec 1996 | WO |
WO-9640012 | Dec 1996 | WO |
WO-9713463 | Apr 1997 | WO |
WO-9713471 | Apr 1997 | WO |
WO-9724082 | Jul 1997 | WO |
WO-9727893 | Aug 1997 | WO |
WO-9727897 | Aug 1997 | WO |
WO-9727898 | Aug 1997 | WO |
WO-9728839 | Aug 1997 | WO |
WO 9732615 | Sep 1997 | WO |
WO-9732551 | Sep 1997 | WO |
WO-9743961 | Nov 1997 | WO |
WO-9748350 | Dec 1997 | WO |
WO-9803118 | Jan 1998 | WO |
WO-9806356 | Feb 1998 | WO |
WO-9808456 | Mar 1998 | WO |
WO-9810714 | Mar 1998 | WO |
WO-9811846 | Mar 1998 | WO |
WO-9814137 | Apr 1998 | WO |
WO-9816161 | Apr 1998 | WO |
WO-9819633 | May 1998 | WO |
WO-9824373 | Jun 1998 | WO |
WO-9825533 | Jun 1998 | WO |
WO-9825549 | Jun 1998 | WO |
WO-9829057 | Jul 1998 | WO |
WO-9836790 | Aug 1998 | WO |
WO-9838916 | Sep 1998 | WO |
WO-9838925 | Sep 1998 | WO |
WO-9838939 | Sep 1998 | WO |
WO-9838941 | Sep 1998 | WO |
WO-9839038 | Sep 1998 | WO |
WO 9843556 | Oct 1998 | WO |
WO 9846165 | Oct 1998 | WO |
WO-9844869 | Oct 1998 | WO |
WO-9846115 | Oct 1998 | WO |
WO-9846119 | Oct 1998 | WO |
WO-9849964 | Nov 1998 | WO |
WO-9850103 | Nov 1998 | WO |
WO-9853759 | Dec 1998 | WO |
WO-9853761 | Dec 1998 | WO |
WO-9855027 | Dec 1998 | WO |
WO-9855047 | Dec 1998 | WO |
WO-9857590 | Dec 1998 | WO |
WO-9857591 | Dec 1998 | WO |
WO-9857592 | Dec 1998 | WO |
WO-9857599 | Dec 1998 | WO |
WO-9907296 | Feb 1999 | WO |
WO-9908624 | Feb 1999 | WO |
WO-9915112 | Apr 1999 | WO |
WO-9915220 | Apr 1999 | WO |
WO-9917671 | Apr 1999 | WO |
WO-9917683 | Apr 1999 | WO |
WO-9921490 | May 1999 | WO |
WO-9921510 | May 1999 | WO |
WO-9922655 | May 1999 | WO |
WO-9922656 | May 1999 | WO |
WO-9922658 | May 1999 | WO |
WO-9925273 | May 1999 | WO |
WO-9927985 | Jun 1999 | WO |
WO 9937337 | Jul 1999 | WO |
WO-9933414 | Jul 1999 | WO |
WO-9935977 | Jul 1999 | WO |
WO-9935979 | Jul 1999 | WO |
WO-9935980 | Jul 1999 | WO |
WO-9936000 | Jul 1999 | WO |
WO-9936001 | Jul 1999 | WO |
WO-9938459 | Aug 1999 | WO |
WO-9940853 | Aug 1999 | WO |
WO-9940868 | Aug 1999 | WO |
WO-9940963 | Aug 1999 | WO |
WO-9940964 | Aug 1999 | WO |
WO-9942058 | Aug 1999 | WO |
WO-9944524 | Sep 1999 | WO |
WO-9944540 | Sep 1999 | WO |
WO-9944542 | Sep 1999 | WO |
WO-9947071 | Sep 1999 | WO |
WO-9947075 | Sep 1999 | WO |
WO-9948545 | Sep 1999 | WO |
WO-9948549 | Sep 1999 | WO |
WO-9949793 | Oct 1999 | WO |
WO-9949910 | Oct 1999 | WO |
WO-9951162 | Oct 1999 | WO |
WO-9951165 | Oct 1999 | WO |
WO-9953863 | Oct 1999 | WO |
WO-9953987 | Oct 1999 | WO |
WO-9955406 | Nov 1999 | WO |
WO 9966863 | Dec 1999 | WO |
WO-9960941 | Dec 1999 | WO |
WO-9962430 | Dec 1999 | WO |
WO-0002503 | Jan 2000 | WO |
WO-0009059 | Feb 2000 | WO |
WO-0009195 | Feb 2000 | WO |
WO 0015148 | Mar 2000 | WO |
WO-0010623 | Mar 2000 | WO |
WO-0012029 | Mar 2000 | WO |
WO-0013722 | Mar 2000 | WO |
WO-0015146 | Mar 2000 | WO |
WO-0015147 | Mar 2000 | WO |
WO-0015149 | Mar 2000 | WO |
WO-0015275 | Mar 2000 | WO |
WO-0016848 | Mar 2000 | WO |
WO 0018445 | Apr 2000 | WO |
WO-0018302 | Apr 2000 | WO |
WO-0018323 | Apr 2000 | WO |
WO-0018325 | Apr 2000 | WO |
WO-0018326 | Apr 2000 | WO |
WO-0018330 | Apr 2000 | WO |
WO-0018331 | Apr 2000 | WO |
WO-0018333 | Apr 2000 | WO |
WO-0018462 | Apr 2000 | WO |
WO-0021436 | Apr 2000 | WO |
WO-0021461 | Apr 2000 | WO |
WO-0021463 | Apr 2000 | WO |
WO-0021464 | Apr 2000 | WO |
WO 200025702 | May 2000 | WO |
WO-0024449 | May 2000 | WO |
WO-0028922 | May 2000 | WO |
WO-0028924 | May 2000 | WO |
WO-0033725 | Jun 2000 | WO |
WO-0035376 | Jun 2000 | WO |
WO-0036997 | Jun 2000 | WO |
WO-0041632 | Jul 2000 | WO |
WO-0041633 | Jul 2000 | WO |
WO-0041652 | Jul 2000 | WO |
WO-0043051 | Jul 2000 | WO |
WO-0044211 | Jul 2000 | WO |
WO 0047139 | Aug 2000 | WO |
WO-0044308 | Aug 2000 | WO |
WO-0044311 | Aug 2000 | WO |
WO-0044313 | Aug 2000 | WO |
WO-0044331 | Aug 2000 | WO |
WO-0045711 | Aug 2000 | WO |
WO-0045874 | Aug 2000 | WO |
WO-0045886 | Aug 2000 | WO |
WO-0047136 | Aug 2000 | WO |
WO-0048531 | Aug 2000 | WO |
WO-0049952 | Aug 2000 | WO |
WO-0049954 | Aug 2000 | WO |
WO-0049956 | Aug 2000 | WO |
WO-0049970 | Aug 2000 | WO |
WO 0053125 | Sep 2000 | WO |
WO-0053122 | Sep 2000 | WO |
WO-0054660 | Sep 2000 | WO |
WO-0054661 | Sep 2000 | WO |
WO-0056224 | Sep 2000 | WO |
WO-0056225 | Sep 2000 | WO |
WO-0056387 | Sep 2000 | WO |
WO 0062714 | Oct 2000 | WO |
WO-0060995 | Oct 2000 | WO |
WO-0066007 | Nov 2000 | WO |
WO-0066009 | Nov 2000 | WO |
WO-0066035 | Nov 2000 | WO |
WO-0067661 | Nov 2000 | WO |
WO-0069345 | Nov 2000 | WO |
WO-0069367 | Nov 2000 | WO |
WO-0069504 | Nov 2000 | WO |
WO-0071195 | Nov 2000 | WO |
WO-0078226 | Dec 2000 | WO |
WO-0105331 | Jan 2001 | WO |
WO 0110209 | Feb 2001 | WO |
WO-0106959 | Feb 2001 | WO |
WO-0108566 | Feb 2001 | WO |
WO-0108596 | Feb 2001 | WO |
WO-0108602 | Feb 2001 | WO |
WO-0110320 | Feb 2001 | WO |
WO-0110340 | Feb 2001 | WO |
WO-0110341 | Feb 2001 | WO |
WO-0110343 | Feb 2001 | WO |
WO-0110347 | Feb 2001 | WO |
WO-0110348 | Feb 2001 | WO |
WO-0110349 | Feb 2001 | WO |
WO-0110350 | Feb 2001 | WO |
WO-0117440 | Mar 2001 | WO |
WO-0117456 | Mar 2001 | WO |
WO 200135870 | May 2001 | WO |
WO-0135864 | May 2001 | WO |
WO-0136870 | May 2001 | WO |
WO 0141679 | Jun 2001 | WO |
WO-0139700 | Jun 2001 | WO |
WO 0151104 | Jul 2001 | WO |
WO-0149185 | Jul 2001 | WO |
WO-0149187 | Jul 2001 | WO |
WO-0149213 | Jul 2001 | WO |
WO 0154625 | Aug 2001 | WO |
WO 0158503 | Aug 2001 | WO |
WO 0162189 | Aug 2001 | WO |
WO 0164137 | Sep 2001 | WO |
WO-0047139 | Sep 2001 | WO |
WO-0176510 | Oct 2001 | WO |
WO-0182837 | Nov 2001 | WO |
WO-0197715 | Dec 2001 | WO |
WO-0211647 | Feb 2002 | WO |
WO-0219926 | Mar 2002 | WO |
WO-0222054 | Mar 2002 | WO |
WO-0224118 | Mar 2002 | WO |
WO 200236048 | May 2002 | WO |
WO-0241789 | May 2002 | WO |
WO-0243620 | Jun 2002 | WO |
WO-0247575 | Jun 2002 | WO |
WO-0249540 | Jun 2002 | WO |
WO-02051489 | Jul 2002 | WO |
WO-02056798 | Jul 2002 | WO |
WO-02056955 | Jul 2002 | WO |
WO 02058745 | Aug 2002 | WO |
WO-02060509 | Aug 2002 | WO |
WO-02067782 | Sep 2002 | WO |
WO-02069842 | Sep 2002 | WO |
WO-02076349 | Oct 2002 | WO |
WO 02100301 | Dec 2002 | WO |
WO 02102286 | Dec 2002 | WO |
WO-02100297 | Dec 2002 | WO |
WO 03007795 | Jan 2003 | WO |
WO 2003003949 | Jan 2003 | WO |
WO-03003943 | Jan 2003 | WO |
WO 03009785 | Feb 2003 | WO |
WO 03013239 | Feb 2003 | WO |
WO 2003011195 | Feb 2003 | WO |
WO-03015851 | Feb 2003 | WO |
WO 03028592 | Apr 2003 | WO |
WO-03030776 | Apr 2003 | WO |
WO-03032869 | Apr 2003 | WO |
WO-03032870 | Apr 2003 | WO |
WO-03037222 | May 2003 | WO |
WO-03037227 | May 2003 | WO |
WO 03047468 | Jun 2003 | WO |
WO-03047460 | Jun 2003 | WO |
WO-03047648 | Jun 2003 | WO |
WO-03051231 | Jun 2003 | WO |
WO-03063729 | Aug 2003 | WO |
WO 03079928 | Oct 2003 | WO |
WO-03079932 | Oct 2003 | WO |
WO-03079933 | Oct 2003 | WO |
WO-03088873 | Oct 2003 | WO |
WO 2003096935 | Nov 2003 | WO |
WO-03015851 | Nov 2003 | WO |
WO-03063729 | Nov 2003 | WO |
WO-03092554 | Nov 2003 | WO |
WO-03094793 | Nov 2003 | WO |
WO-03094797 | Nov 2003 | WO |
WO-03096932 | Nov 2003 | WO |
WO-03101195 | Dec 2003 | WO |
WO-03103949 | Dec 2003 | WO |
WO 2004004597 | Jan 2004 | WO |
WO-03003949 | Jan 2004 | WO |
WO-2004006803 | Jan 2004 | WO |
WO-2004006804 | Jan 2004 | WO |
WO 2004016200 | Feb 2004 | WO |
WO 2004016201 | Feb 2004 | WO |
WO-2004014256 | Feb 2004 | WO |
WO 2004019825 | Mar 2004 | WO |
WO-2004019811 | Mar 2004 | WO |
WO-2004019817 | Mar 2004 | WO |
WO-2004021922 | Mar 2004 | WO |
WO-2004023980 | Mar 2004 | WO |
WO 2004026117 | Apr 2004 | WO |
WO 2004026173 | Apr 2004 | WO |
WO 2004028399 | Apr 2004 | WO |
WO-2004019811 | Apr 2004 | WO |
WO-2004030515 | Apr 2004 | WO |
WO 2004043301 | May 2004 | WO |
WO-2004041126 | May 2004 | WO |
WO-2004043293 | May 2004 | WO |
WO-2004047681 | Jun 2004 | WO |
WO-2004058106 | Jul 2004 | WO |
WO-2004062980 | Jul 2004 | WO |
WO-2004058106 | Aug 2004 | WO |
WO-2004064671 | Aug 2004 | WO |
WO-2004066876 | Aug 2004 | WO |
WO-2004071352 | Aug 2004 | WO |
WO 2004082527 | Sep 2004 | WO |
WO 2004082528 | Sep 2004 | WO |
WO-2004082536 | Sep 2004 | WO |
WO-2004089250 | Oct 2004 | WO |
WO-2004089253 | Oct 2004 | WO |
WO 2004096100 | Nov 2004 | WO |
WO-2004093728 | Nov 2004 | WO |
WO-2004103162 | Dec 2004 | WO |
WO-2004105651 | Dec 2004 | WO |
WO-2005002466 | Jan 2005 | WO |
WO-2005004753 | Jan 2005 | WO |
WO-2005007343 | Jan 2005 | WO |
WO-2005009285 | Feb 2005 | WO |
WO-2005011534 | Feb 2005 | WO |
WO-2005011535 | Feb 2005 | WO |
WO 2005021063 | Mar 2005 | WO |
WO-2005023155 | Mar 2005 | WO |
WO-2005027790 | Mar 2005 | WO |
WO-2005027797 | Mar 2005 | WO |
WO 2005034812 | Apr 2005 | WO |
WO-2005032622 | Apr 2005 | WO |
WO-2005010215 | May 2005 | WO |
WO-2005046528 | May 2005 | WO |
WO-2005046529 | May 2005 | WO |
WO-2005048883 | Jun 2005 | WO |
WO 2005062980 | Jul 2005 | WO |
WO-2005063980 | Jul 2005 | WO |
WO-2005065585 | Jul 2005 | WO |
WO-2005065594 | Jul 2005 | WO |
WO 2005072654 | Aug 2005 | WO |
WO-2005070343 | Aug 2005 | WO |
WO-2005076890 | Aug 2005 | WO |
WO-2005084595 | Sep 2005 | WO |
WO-2005087140 | Sep 2005 | WO |
WO-2005096993 | Oct 2005 | WO |
WO-2005102015 | Nov 2005 | WO |
WO-2005110240 | Nov 2005 | WO |
WO-2005112779 | Dec 2005 | WO |
WO-2006005015 | Jan 2006 | WO |
WO-2006009690 | Jan 2006 | WO |
WO-2006026371 | Mar 2006 | WO |
WO-2006027499 | Mar 2006 | WO |
WO-2005062980 | May 2006 | WO |
WO 2006066327 | Jun 2006 | WO |
WO-2006058163 | Jun 2006 | WO |
WO-2006065949 | Jun 2006 | WO |
WO-2006068944 | Jun 2006 | WO |
WO 2006076890 | Jul 2006 | WO |
WO-2006070372 | Jul 2006 | WO |
WO-2006083763 | Aug 2006 | WO |
WO-2006086135 | Aug 2006 | WO |
WO-2006086736 | Aug 2006 | WO |
WO-2006089517 | Aug 2006 | WO |
WO 2006102063 | Sep 2006 | WO |
WO-2006093795 | Sep 2006 | WO |
WO 2006108090 | Oct 2006 | WO |
WO 2006124649 | Nov 2006 | WO |
WO 2006127756 | Nov 2006 | WO |
WO 2006127765 | Nov 2006 | WO |
WO-2006118766 | Nov 2006 | WO |
WO 2006132948 | Dec 2006 | WO |
WO-2006129441 | Dec 2006 | WO |
WO-2006133959 | Dec 2006 | WO |
WO-2006138173 | Dec 2006 | WO |
WO-2006138391 | Dec 2006 | WO |
WO-2007009117 | Jan 2007 | WO |
WO-2007009609 | Jan 2007 | WO |
WO-2007013999 | Feb 2007 | WO |
WO-2007033093 | Mar 2007 | WO |
WO-2007035471 | Mar 2007 | WO |
WO 2007047488 | Apr 2007 | WO |
WO 2007047945 | Apr 2007 | WO |
WO-2005102015 | Apr 2007 | WO |
WO-2006138391 | Apr 2007 | WO |
WO-2007044285 | Apr 2007 | WO |
WO 2007048529 | May 2007 | WO |
WO 2007051620 | May 2007 | WO |
WO 2007059252 | May 2007 | WO |
WO-2007053243 | May 2007 | WO |
WO-2007058847 | May 2007 | WO |
WO 2007071436 | Jun 2007 | WO |
WO-2006086736 | Jun 2007 | WO |
WO 2007098232 | Aug 2007 | WO |
WO-2007092354 | Aug 2007 | WO |
WO-2007097983 | Aug 2007 | WO |
WO-2007053243 | Sep 2007 | WO |
WO 2007120543 | Oct 2007 | WO |
WO-2007071436 | Nov 2007 | WO |
WO-2007123658 | Nov 2007 | WO |
WO-2007123956 | Nov 2007 | WO |
WO-2007033093 | Jan 2008 | WO |
WO-2007071436 | Jan 2008 | WO |
WO 2008028569 | Mar 2008 | WO |
WO 2008035337 | Mar 2008 | WO |
WO-2008031103 | Mar 2008 | WO |
WO 2008045949 | Apr 2008 | WO |
WO-2008040555 | Apr 2008 | WO |
WO-2008047354 | Apr 2008 | WO |
WO-2008051554 | May 2008 | WO |
WO 2008070797 | Jun 2008 | WO |
WO-2008070442 | Jun 2008 | WO |
WO 2008079962 | Jul 2008 | WO |
WO 2008101083 | Aug 2008 | WO |
WO-2008098191 | Aug 2008 | WO |
WO-2008100599 | Aug 2008 | WO |
WO 2008125153 | Oct 2008 | WO |
WO 2008138584 | Nov 2008 | WO |
WO-2008137603 | Nov 2008 | WO |
WO 2008150529 | Dec 2008 | WO |
WO-2009002548 | Dec 2008 | WO |
WO-2009024859 | Feb 2009 | WO |
WO-2009029199 | Mar 2009 | WO |
WO-2009042196 | Apr 2009 | WO |
WO-2009045334 | Apr 2009 | WO |
WO-2009045338 | Apr 2009 | WO |
WO-2009053497 | Apr 2009 | WO |
WO-2009054397 | Apr 2009 | WO |
WO-2007044285 | May 2009 | WO |
WO-2009061389 | May 2009 | WO |
WO-2009085206 | Jul 2009 | WO |
WO-2009091509 | Jul 2009 | WO |
WO-2009094188 | Jul 2009 | WO |
WO-2009094501 | Jul 2009 | WO |
WO-2009100198 | Aug 2009 | WO |
WO-2009106545 | Sep 2009 | WO |
WO-2009108615 | Sep 2009 | WO |
WO-2009111241 | Sep 2009 | WO |
WO-2009149462 | Dec 2009 | WO |
WO-2009155561 | Dec 2009 | WO |
WO-2010022138 | Feb 2010 | WO |
WO-2010042950 | Apr 2010 | WO |
WO-2010043950 | Apr 2010 | WO |
WO-2010044851 | Apr 2010 | WO |
WO-2010045238 | Apr 2010 | WO |
WO-2010045297 | Apr 2010 | WO |
WO-2010049160 | May 2010 | WO |
WO-2010083558 | Jul 2010 | WO |
WO-2010086460 | Aug 2010 | WO |
WO-2010098857 | Sep 2010 | WO |
WO-2010104638 | Sep 2010 | WO |
WO-2010045238 | Oct 2010 | WO |
WO-2010141626 | Dec 2010 | WO |
WO-2011008812 | Jan 2011 | WO |
WO-2011008853 | Jan 2011 | WO |
WO-2011051043 | May 2011 | WO |
WO-2011057087 | May 2011 | WO |
WO-2011060386 | May 2011 | WO |
WO-2011102968 | Aug 2011 | WO |
WO-2011104269 | Sep 2011 | WO |
WO-2011120050 | Sep 2011 | WO |
WO-2011133368 | Oct 2011 | WO |
WO-2011144351 | Nov 2011 | WO |
WO 2011147849 | Dec 2011 | WO |
WO-2012002228 | Jan 2012 | WO |
WO-2012023980 | Feb 2012 | WO |
WO-2012036742 | Mar 2012 | WO |
WO-2012038550 | Mar 2012 | WO |
WO-2012039748 | Mar 2012 | WO |
WO-2012082952 | Jun 2012 | WO |
WO-2012106491 | Aug 2012 | WO |
WO-2012116368 | Aug 2012 | WO |
WO-2012142189 | Oct 2012 | WO |
WO-2012145546 | Oct 2012 | WO |
WO-2012162228 | Nov 2012 | WO |
WO-2013009975 | Jan 2013 | WO |
WO-2013028387 | Feb 2013 | WO |
WO-2013033791 | Mar 2013 | WO |
WO-2013074671 | May 2013 | WO |
WO-2013096545 | Jun 2013 | WO |
WO-2013134214 | Sep 2013 | WO |
WO-2014056644 | Apr 2014 | WO |
WO-2014072439 | May 2014 | WO |
WO-2014072439 | Jul 2014 | WO |
WO-2015028209 | Mar 2015 | WO |
WO-2016093877 | Jun 2016 | WO |
WO-2016126511 | Aug 2016 | WO |
Entry |
---|
US 6,331,185 B1, 12/2001, Gambale et al. (withdrawn) |
US 8,062,356 B2, 11/2011, Salahieh et al. (withdrawn) |
US 8,062,357 B2, 11/2011, Salahieh et al. (withdrawn) |
US 8,075,614 B2, 12/2011, Salahieh et al. (withdrawn) |
US 8,133,271 B2, 03/2012, Salahieh et al. (withdrawn) |
US 8,211,170 B2, 07/2012, Paul et al. (withdrawn) |
Akins C.W., et al., “Risk of Reoperative Valve Replacement for Failed Mitral and Aortic Bioprostheses,” The Annals of Thoracic Surgery, 65:545-1552 (Jan. 1998). Retrieved from the Internet: URL: http://ats.ctsnetjournals.org/cgi/contenUfull/65/6/1545 (Jan. 1998). |
Allen et al., “What are the characteristics of the ideal endovascular graft for abdominal aortic aneurysm exclusion?”, J. Endovasc. Surg., vol. 4(2), May 1997, pp. 195-202. |
Anabtawi I.N., et al., “Experimental evaluation of myocardial tunnelization as a method of myocardial revascularization,” Journal of Thoracic and Cardiovascular Surgery, 58(5):638-646 (Nov. 1969). |
Andersen et al., “Transluminal implantation of artificial heart valves, Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs,” Euro. Heart J., vol. 13, May 1992, pp. 704-708. |
Archie J.P., et al., “Intramyocardial Pressure: Effect of Preload on Transmural Distribution of Systolic Coronary Blood Flow,” The American Journal of Cardiology, 35(6):904-911 (Jun. 1975). |
Baba H., et al., “Hemodynamic effects of venous valves in aorta-coronary bypass grafts,” The Journal of Thoracic and Cardiovascular Surgery, 71(5):774-778 (May 1976). |
Block et al., “Percutaneous Approaches to Valvular Heart Disease,” Current Cardiology Reports, 7(2):108-113 ( Mar. 2005). |
Blum et al., “Endoluminal Stent-Grafts for Intrarenal Abdominal Aortic Aneurysms.” New Engl. J. Med., 336:13-20 (Jan. 1997). |
Bonhoeffer et al., “Percutaneous Insertion of the Pulmonary Valve,” J. Am. Coll. Cardiol., vol. 39, May 15, 2002, pp. 1664-1669. |
Bonhoeffer et al., “Percutaneous Mitral Valve Dilatation with the Multi-Track System,” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiograhy & Interventions, United States (Oct. 1999), pp. 178-183. |
Bonhoeffer et al., “Percutaneous replacement of pulmonary valve in a right ventricle to pulmonary-artery prosthetic conduit with valve dysfunction”, The Lancet, Oct. 21, 2000, vol. 356, pp. 1403-1405. |
Bonhoeffer et al., “Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study,” Circulation, vol. 102, Aug. 15, 2000, pp. 813-816. |
Bonhoeffer P., et al., “Technique and Results of Percutaneous Mitral Valvuloplasty With the Multi-Track System,” Journal of Interventional Cadiology, 13(4):263-268 (Aug. 2000). |
Boudjemline et al., “Percutaneous Implantation of a Biological Valve in Aortic Position: Preliminary Results in a Sheep Study,” European Heart Journal, vol. 22, p. 630, Abstract Only (Sep. 2001). |
Boudjemline et al., “Percutaneous Implantation of a Biological Valve in the Aorta to Treat Aortic Valve Insufficiency—A Sheep Study.” Med Sci. Monit., 8:4:BR113-116 (Apr. 2002). |
Boudjemline et al., “Percutaneous Implantation of a Valve in the Descending Aorta in Lambs.” Euro. Heart J., Jul. 2002, 23, pp. 1045-1049. |
Boudjemline et al., “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract: An Experimental Study.” Journal of the American College of Cardiology, 43(6):1082-1087 (Mar. 2004). |
Boudjemline et al., “Percutaneous Valve Insertion: A New Approach?”, J. of Thoracic and Cardio. Surg, 125(3):741-743, Mar. 2003. |
Boudjemline et al., “Stent Implantation Combined with a Valve Replacement to Treat Degenerated Right Ventricle to Pulmonary Artery Prosthetic Conduits,” European Heart Journal, vol. 22, p. 355, Abstract Only (Sep. 2001). |
Boudjemline et al., “Steps Toward Percutaneous Aortic Valve Replacement.” Circulation, Feb. 12, 2002, vol. 105, pp. 775-778. |
Boudjemline et al., “The Percutaneous Implantable Heart Valve,” Progress in Pediatric Cardiology, vol. 14, pp. 89-93, (Nov. 2001). |
Boudjemline Y., et al., “Images in Cardiovascular Medicine, Percutaneous Aortic Valve Replacement in Animals,” Circulation, vol. 109:e161, United States, Mar. 16, 2004, 1 page. |
Boudjemline Y., et al., “Is Percutaneous Implantation of a Bovine Venous Valve in the Inferior Vena Cava a Reliable Technique to Treat Chronic Venous Insufficiency Syndrome?” Medical Science Monitor-International Medical Journal of Experimental and Clinical Research, Poland, Mar. 2004, pp. BR61-66. |
Boudjemline Y., et al., “Off-pump Replacement of the Pulmonary Valve in Large Right Ventricular Outflow Tracts: A Hybrid Approach,” Journal of Thoracic and Cardiovascular Surgery, United States, vol. 129, No. 4, Apr. 2005, pp. 831-837. |
Boudjemline Y., et al., “Percutaneous Aortic Valve Replacement: Will We Get There?” Heart, British Cardiac Society, England, Dec. 2001, pp. 705-706. |
Boudjemline Y., et al., “Transcatheter Reconstruction of the Right Heart,” Cardiology in the Young, England, Jun. 2003, pp. 308-311. |
Bruce C.J., et al., “Right-sided Valve Disease Deserves Little More Respect,” Circulation, 119(2):2726-2734 (May 2009). |
Coats L., et al., “The Potential Impact of Percutaneous Pulmonary Valve Stent Implantation on Right Ventricular Outflow Tract Re-Intervention,” European Journal of Cardio-Thoracic Surgery, vol. 27, England, Apr. 2005, pp. 536-543. |
Commeau P et al., “Percutaneous Balloon Dilatation of calcific aortic Valve Stenosis: Anatomical and Haemodynamic Evaluation,” British Heart Journal, 59:227-238 (Feb. 1988). |
Cribier et al., “Early Experience with Percutaneous Transcatheter Implantation of Heart Valve Prosthesis for the Treatment of End-Stage Inoperable Patients with Calcific Aortic Stenosis”, J. of Am. Coll. of Cardio, Feb. 18, 2004, 43(4), pp. 698-703. |
Cribier et al., “Percutaneous Transluminal Valvuloplasty of Acquired Aortic Stenosis in Elderly Patients: An Alternative to Valve Replacement?”, The Lancet, Jan. 11, 1986, pp. 63-67. |
Cunanan et al., “Tissue Characterization and Calcification Potential of Commercial Bioprosthetic Heart Valves.” Ann. Thorac. Surg., May 15, 2001, pp. S417-S421. |
Cunliffe et al., “Glutaraldehyde Inactivation of Exotic Animal Viruses in Swine Heart Tissue,” Applied and Environmental Microbiology, Greenport, New York, vol. 37, No. 5, May 1979, pp. 1044-1046. |
Dake et al., “Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms.” New Engl. J. of Med., 331(26):1729-34 (Dec. 1994). |
Dalby et al., “Non-Surgical Aortic Valve Replacement” Br. J. Cardiol., 10(6):450-452 (Nov. 2003). |
Davidson et al., “Percutaneous therapies for valvular heart disease,” Cardiovascular Pathology 15:123-129 (Jan. 2006). |
Dewey et al., “Transapical aortic valve implantation: An Animal Feasibility Study”, The annals of thoracic surgery, 82:110-116 (Feb. 2006). |
Dhasmana et al., “Factors Associated With Periprosthetic Leakage Following Primary Mitral Valve Replacement: With Special Consideration of Suture Technique.” Annals of Thorac. Surg., (Feb. 1983), 35(2), pp. 170-178. |
Dotter, “Transluminally-Placed Coilspring Endarterial Tube Grafts,” Investigative Radiology, pp. 329-332 (Oct. 1969). |
Emery et al., “Replacement of the Aortic Valve in Patients Under 50 Years of Age: Long-Term Follow-Up of the St. Jude Medical Prosthesis.” Ann. Thorac. Surg., 75:1815-1819 (Jun. 2003). |
European Search Report dated Aug. 10, 2011 for EP Application No. 06824992.9. |
European Search Report for EP Patent Appl. Serial No. 12179049.7 (1257), dated Oct. 30, 2012, 4 pages. |
European Search Report for EP Patent Appl. Serial No. 12179075.2 (1257), dated Oct. 29, 2012, 3 pages. |
European Search Report for EP Patent Appl. Serial No. 12179141.2 (1257), dated Nov. 2, 2012, 3 pages. |
European Search Report for EP Patent Appl. Serial No. 12179146.1 (1257), dated Nov. 7, 2012, 8 pages. |
European Search Report for EP Patent Appl. Serial No. 12179330.1 (1257), dated Nov. 22, 2012, 3 pages. |
European Search Report for EP Patent Appl. Serial No. 12179338.4 (1257), dated Nov. 2, 2012, 3 pages. |
European Search Report for EP Patent Appl. Serial No. 12179339.2 (1257), dated Oct. 29, 2012, 4 pages. |
European Search Report for EP Patent Appl. Serial No. 12179914.2 (1257), dated Nov. 7, 2012, 6 pages. |
European Search Report for EP Patent Appl. Serial No. 13150337.7 (1257), dated Jul. 9, 2013, 3 pages. |
European Search Report for EP Patent Appl. Serial No. 13183134.9 (1651), dated Nov. 19, 2013, 3 pages. |
European Search Report for EP Patent Appl. Serial No. 14159630.4 (1651), dated May 22, 2014, 3 pages. |
European Search Report for EP Patent Appl. Serial No. 14161991.6 (1651), dated Jun. 3, 2014, 3 pages. |
European Search Report for EP Patent Appl. Serial No. 15167832.3 (1651), dated Jul. 23, 2015, 3 pages. |
European Search Report for EP Patent Appl. Serial No. 15167847.1 (1651), dated Jul. 23, 2015, 3 pages. |
European Search Report for EP Patent Appl. Serial No. 17196833.2, dated Mar. 6, 2018, 4 pages. |
European Search Report for EP Patent Appl. Serial No. 18164490.7, dated Sep. 17, 2018 5 pages. |
European Search Report from EP Patent Office for EP Application No. 15177718.2, dated Jan. 18, 2016, 4 pages. |
European Search Report from EP Patent Office for EP Application No. 15177731.5, dated Apr. 14, 2016, 4 pages. |
European Search Report from EP Patent Office for EP Application No. 16151726.3, dated Feb. 25, 2016, 4 pages. |
Extended European Search Report dated Apr. 11, 2008 in EP Patent Appl. Serial No. 081630410, 5 pages. |
Extended EP Search Report dated Sep. 24, 2020 in EP Patent Appl. Serial No. 20165841.6 (JVT-0280). |
Extended European Search Report for Application No. 10183946.2.4-2320 dated Feb. 14, 2012, 7 pages. |
Extended European Search Report dated Aug. 9, 2018 in EP Patent Appl. Serial No. 18158901.1 (1113). |
Extended European Search Report dated Jun. 12, 2018 in EP Patent Appl. Serial No. 17209326.2 (1113). |
Extended European Search Report dated May 16, 2012 in EP Patent Appl. Serial No. 11178135.7 (1257). |
Extended European Search Report for Application No. 11178076.3-1257 dated Feb. 29, 2012, 5 pages. |
Extended European Search Report from EP Patent Office for EP Application No. 17162616.1, dated Jul. 27, 2017, 7 pages. |
Extended European Search Report dated Apr. 9, 2014 in EP Patent Appl. Serial No. 14164683.6. |
Extended European Search Report dated May 9, 2013 in EP Patent Appl. Serial No. 130178309.4,4 pages. |
Extended European Search Report dated Aug. 19, 2011 in EP Patent Appl. Serial No. 07827132.7. |
Extended European Search Report dated Feb. 27, 2017 in EP Patent Appl. Serial No. 16186773,6 pages. |
Extended European Search Report dated Sep. 29, 2014 in EP Patent Appl. Serial No. 14166480, 5 pages. |
Extended European Search Report for Application No. 07116242.4-2310 dated Mar. 31, 2008, 10 pages. |
Extended European Search Report for Application No. 09154935.2, dated May 29, 2009, 7 pages. |
Extended European Search Report for Application No. 10012198.7 dated Mar. 23, 2011, 7 pages. |
Extended European Search Report for Application No. 10168525.3-1257 dated Feb. 3, 2011, 13 pages. |
Extended European Search Report for Application No. 11153142.2-1257 dated Aug. 3, 2011, 10 pages. |
Extended European Search Report for Application No. 11165093.3-1257 dated Aug. 30, 2011, 6 pages. |
Extended European Search Report for Application No. 11178073.0-1257 dated Oct. 14, 2011, 5 pages. |
Extended European Search Report for Application No. 11178145.6-1257 dated Feb. 29, 2012, 5 pages. |
Extended European Search Report for Application No. 13188858.8-1651 dated Jan. 13, 2014, 6 pages. |
Extended European Search Report for Application No. 19195062 dated Jan. 2, 2020, 7 pages. |
ExtendedEuropean Search Report for EP Patent Appl. Serial No. 06827630.2 dated Jun. 7, 2010, 5 pages. |
Extended European Search Report for EP Patent Appl. Serial No. 07110318.8, dated May 29, 2008, 10 pages. |
Extended European Search Report for EP Patent Appl. Serial No. 10163478.0, dated Mar. 22, 2011, 9 pages. |
Extended European Search Report for EP Patent Appl. Serial No. 10184842.2, dated Mar. 23, 2011, 7 pages. |
Extended European Search Report for EP Patent Appl. Serial No. 11162971.3, dated Jun. 30, 2011, 5 pages. |
Extended European Search Report for EP Patent Appl. Serial No. 13163918.9, dated Jul. 24, 2013, 8 pages. |
Extended European Search Report for EP Patent Appl. Serial No. 14179639.1, dated Mar. 9, 2015, 7 pages. |
Extended European Search Report for EP Patent Appl. Serial No. 16201320.5, dated May 19, 2017, 6 pages. |
Extended European Search Report for EP Patent Appl. Serial No. 18200191.7, dated May 6, 2019, 8 pages. |
Ferrari, “Entwicklung eines Verfahrens zum transvaskularen Aortenklappenersatz,” Habilitationsschrift, Medizinische Fakultat der Friedrich-Schiller-Universitat Jena, Sep. 2003, pp. 1-159. (With English Translation). |
Ferrari, “Entwicklung eines Verfahrens zum transvaskularen Aortenklappenersatz,” Habilitationsschrift, Medizinische Fakultät der Friedrich-Schiller-Universität Jena, Sep. 2003, pp. 49-52. (With English Translation). |
Ferrari M.W., “Transarterial Aortic Valve Replacement with a Self Expanding Stent in Pigs,” Heart, vol. 90, No. 11, doi:10.1136/hrt.2003.028951, ISSN 1355-6037, XP055137208, Nov. 2004, pp. 1326-1331. |
Filsoufi F., et al., “Long-term Outcomes of Tricuspid Valve Replacement in the Current Era,” Ann. Thorac. Surg., 8(3):845-850 (Sep. 2005). |
Fluency Vascular Stent Graft Instructions for Use, May 2014, 20 pages. |
Greeenberg, “Abdominal Aortic Endografting: Fixation and Sealing.” J. Am. Coll. Surg., 194(1):S79-S87 (Jan. 2002). |
Grossi A.E et al., “Impact of Minimally Invasive Valvular Heart Surgery: A Case-Control Study”, Ann. Thorac. Surg., 71:807-810 (Mar. 2001). |
Heinrich R.S., et al., “Experimental analysis of fluid mechanical energy losses in aortic valve stenosis: importance of pressure recovery”, Ann Biomed Eng., Nov.-Dec. 1996, vol. 24(6), pp. 685-694. |
Hijazi Z.M., “Transcatheter Valve Replacement: A New Era of Percutaneous Cardiac Intervention Begins”, J. of Am. College of Cardio., Nov. 6, 2004, vol. 43, No. 6, pp. 1088-1089. |
Hourihan M., et al., “Transcatheter Umbrella Closure of Valvular and Paravalvular Leaks”, JACC, Boston, Massachusetts, 20(6):1371-1377 (Nov. 1992). |
Huber H.C., et al., “Direct-Access Valve Replacement: A Novel Approach for Off-Pump Valve Implantation Using Valved Stents”, Journal of the American College of Cardiology, vol. 46, No. 2, Jul. 19, 2005, pp. 366-370. |
Huber H.C., et al., “Do Valved Stents Compromise Coronary Flow?”, European Journal of Cardio-thoracic Surgery, Jan. 23, 2004, vol. 25; pp. 754-759. |
Ing F., “Stents: What's Available to the Pediatric Interventional Cardiologist?” Catheterization and Cardiovascular Interventions, 57:374-386 (Jun. 2002). |
International Search Report dated Dec. 29, 2003 in Intl PCT Patent Appl. U.S. Appl. No. PCT/DE2003/002669. |
International Search Report and Written Opinion for PCT Application No. PCT/EP2009/052230 dated Jun. 29, 2009, 12 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/EP2010/052429 dated Jun. 14, 2010, 12 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/EP2011/002524 dated Apr. 23, 2012, 15 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/EP2011/052674 dated Jul. 5, 2011, 12 pages. |
International Search Report for PCT Application No. PCT/US1999/020736dated Jan. 28, 2000, 3 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/EP2009/050762 dated Jun. 23, 2009, 12 pages. |
International Search Report & Written Opiniondated Jul. 18, 2016 for PCT Patent Appl No. PCT/EP2016/059839, 10 pages. |
International Search Report and Written Opinion for Appl. No. PCT/EP2016/055783, dated May 30, 2016, 15 pages. |
International Search Report and Written Opinion for Application No. PCT/EP2013/057431 dated Jul. 26, 2013, 9 pages. |
International Search Report and Written Opinion for Application No. PCT/IB2018/050438 dated Apr. 12, 2018, 11 pages. |
International Search Report and Written Opinion for International Application No. PCT/EP2010/063306, dated Nov. 17, 2010, 9 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/EP2006/010519 dated Mar. 1, 2007, 13 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US06/36286 dated Jul. 9, 2007, 4 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2004/041513 dated Jun. 10, 2005, 4 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2004/043607 dated Mar. 20, 2006, 4 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2005/020947 dated Oct. 6, 2005, 5 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2006/038352 dated May 19, 2008, 4 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2006/043484 dated Jun. 25, 2008, 4 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2007/003992 dated Jan. 10, 2008, 5 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2007/02970 dated Oct. 19, 2007, 7 pages. |
International Search Report and Written Opinion for PCT Application No. PCT/US2009/060531 dated May 13, 2010, 6 pages. |
International Search Report and Written Opinion for PCT/DE2006/000056 dated Jun. 7, 2006, 11 pages. |
International Search Report and Written Opinion for PCT/EP2007/061117 dated May 20, 2008, 16 pages. |
International Search Report and Written Opinion for PCT/EP2008/003803 dated Aug. 20, 2008, 10 pages. |
International Search Report and Written Opinion for PCT/EP2009/055958 dated Oct. 21, 2009, 8 pages. |
International Search Report and Written Opinion for PCT/EP2010/056558 dated Oct. 7, 2010, 14 pages. |
International Search Report and Written Opinion for PCT/EP2012/067617 dated Dec. 19, 2012, 10 pages. |
International Search Report and Written Opinion for PCT/IL2007/001149 dated May 1, 2008, 4 pages. |
International Search Report and Written Opinion for PCT/US2011/027730 dated May 25, 2011, 9 pages. |
International Search Report and Written Opinion of the International Search Authority for International Application No. PCT/EP2008/064558, date of completion of report is Mar. 18, 2009, 14 pages. |
International Search Report for Application No. PCT/DE2001/000837, dated Aug. 7, 2001, 4 pages. |
International Search Report for Application No. PCT/EP2006/012455, dated Sep. 27, 2007, 5 pages. |
International Search Report for Application No. PCT/EP2010/057798, dated Sep. 12, 2010, 6 pages. |
International Search Report for Application No. PCT/EP2011/066677, dated Feb. 17, 2012, 7 pages. |
International Search Report for Application No. PCT/EP2012/067617 dated Dec. 19, 2012, 3 pages. |
International Search Report for Application No. PCT/EP2012/067714 dated Dec. 18, 2012, 3 pages. |
International Search Report for Application No. PCT/EP2013/073318, dated Apr. 17, 2014, 5 pages. |
International Search Report for Application No. PCT/EP2014/065817, dated Jan. 7, 2015, 6 pages. |
International Search Report for Application No. PCT/EP2016/055783, dated May 30, 2016, 5 pages. |
International Search Report for Application No. PCT/EP2016/058532, dated Jul. 11, 2016, 4 pages. |
International Search Report for Application No. PCT/IB2008/002180, dated Apr. 15, 2009, 7 pages. |
International Search Report for Application No. PCT/IB2018/050438 dated Apr. 12, 2018, 3 pages. |
International Search Report for PCT/DE2001/000836 dated Jun. 13, 2001, 6 pages. |
International Search Report for PCT/EP2006/010023 dated Mar. 30, 2007, 6 pages. |
International Search Report for PCT/EP2007/007413, dated Jan. 28, 2008, 4 pages. |
International Search Report for PCT/IB2017/052718, dated Sep. 5, 2017, 4 pages. |
Kato et al., “Traumatic Thoracic Aortic Aneurysm: Treatment with Endovascular Stent-Grafts.” Radiol., 205:657-662 (Dec. 1997). |
Khambadkone, “Nonsurgical Pulmonary Valve Replacement: Why, When, and How?” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiography & Interventions (United States), Jul. 2004, pp. 401-408. |
Knudsen et al., “Catheter-implanted prosthetic heart valves”, Intl J. of Art. Organs, 16(5):253-262, May 1993. |
Kort et al., “Minimally Invasive Aortic Valve Replacement: Echocardiographic and Clinical Results.” Am. Heart J., Sep. 2001, vol. 142(3), pp. 476-481. |
Kuzela L., et al., “Experimental evaluation of direct transventricular revascularization,” Journal of Thoracic and Cardiovascular Surgery, 57(6):770-773 (Jun. 1969). |
Laborde et al., “Percutaneous Implantation of the Corevalve Aortic Valve Prosthesis for Patients Presenting High Risk for Surgical Valve Replacement,” EuroIntervention, 1(4):472-474 (Feb. 2006). |
Lawrence et al., “Percutaneous Endovascular Graft: Experimental Evaluation”, Radiology, May 1987, vol. 163(2), pp. 357-360. |
Levi et al., “Future of Interventional Cardiology in Pediactrics.” Current Opinion in Cardiol., 18:79-90 (Mar. 2003). |
Levy, “Mycobacterium chelonei Infection of Porcine Heart Valves.” The New England Journal of Medicine, Washington DC, 297(12), Sep. 22, 1977, pp. 667-668. |
Lichtenstein et al., “Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience”, circulation, American Heart Association vol. 114, Jul. 31, 2006, pp. 591-596. |
Lichtenstein, S.V., “Closed heart surgery: Back to the future” The Journal of Thoracic and Cardiovascular Surgery, vol. 131(5), May 2006, pp. 941-943. |
Liu et al., “Effect of Fiber Orientation on the Stress Distribution within a Leaflet of a Polymer Composite Heart Valve in be Closed Position”, Journal of Biomechanics, 4:1099-1106 (Jan. 2007). |
Lonescu et al., “Prevalence and Clinical Significance of Incidental Paraprosthetic Valvar Regurgitation: A prospective study using transesophageal echocardiography.” Heart, 89:1316-21 (Oct. 2003). |
Love S.C. et al., The Autogenous Tissue Heart Valve: Current Status, Journal of Cardiac Surgery, , Mar. 1991, vol. 6(4), pp. 499-507. |
Lutter et al., “Percutaneous Aortic Valve Replacement: An Experimental Study. I. Studies on Implantation.” J. of Thoracic and Cardio. Surg., Apr. 2002, vol. 123(4), pp. 768-776. |
Lutter et al., “Percutaneous Valve Replacement: Current State and Future Prospects,” Annals of Thoracic Surgery, Netherlands Dec. 2004, pp. 2199-2206. |
Ma L., et al., “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio-Thoracic Surgery, vol. 28, No. 2, 2005, pp. 194-199. |
Mack, M.J., “Minimally invasive cardiac surgery”, Surg Endosc, 20:S488-S492 (Mar. 2006). |
Magovern et al., “Twenty-five-Year Review of the Magovern-Cromie Sutureless Aortic Valve”, Ann. Thorac. Surg., 48:S33-S334 (Jan. 1989). |
Maraj et al., Evaluation of Hemolysis in Patients with Prosthetic Heart Valves, Clin. Cardiol. 21:387-392 (Jun. 1998). |
Marcus RH et al., “Assessment of small-diameter aortic mechanical prostheses: physiological relevance of the Doppler gradient, utility of flow augmentation, and limitations of orifice area estimation,” Circulation, 98(9):866-872 (Sep. 1998). |
McKay G. R. et al., “The Mansfield Scientific Aortic Valvuloplasty Registry: Overview of Acute Hemodynamic Results and Procedural Complications.” J. Am. Coll. Cardiol., 17(2):485-491 (Feb. 1991). |
Mills N.L., et al., “Valvulotomy of valves in the saphenous vein graft before coronary artery bypass,” The Journal of Thoracic and Cardiovascular Surgery, 71 (6):878-879 (Jun. 1976). |
Mirich et al., “Percutaneously Placed Endovascular Grafts for Aortic Aneurysms: Feasibility Study”, Radiology, 170:1033-1037 (Mar. 1989). |
Moazami N et al. “Transluminal Aortic Valve Placement: a Fesibility Study with a Newly Designed Collapsible Aortic Valve”, ASAIO Journal, vol. 42, No. 2, Mar.-Apr. 1996. |
Moulopoulos et al., “Catheter-Mounted Aortic Valves,” Annals of Thoracic Surg., vol. 11, No. 5, May 1971, pp. 423-430. |
MUNRO 1., et al., “The possibility of myocardial revascularization by creation of a left ventriculocoronary artery fistula,” The Journal of Thoracic and Cardiovascular Surgery, 58(1):25-32 (Jul. 1969). |
Nath J., et al., Impact of Tricuspid Regurgitation on Long-term Survival, Journal of the American College of Cardiology, 43(3):405-406 (Feb. 2004). |
Nietlispach F., et al., “Current Balloon-Expandable Transcatheter Heart Valve and Delivery Systems”, Catheterization and Cardiovascular Interventions, 75:295-300 (Sep. 2009). |
Palacios., “Percutaneous Valve Replacement and Repair, Fiction or Reality?,” Journal of American College of Cardiology, 44(8):1662-1663 (Oct. 2004). |
Palmaz J.C., et al., “Expandable Intrahepatic Portacaval Shunt Stents: Early Experience in the Dog,” American Journal of Roentgenology, 145 (4):821-825 (Oct. 1985). |
Palmaz J.C., et al., “Expandable Intrahepatic Portacaval Shunt Stents in Dogs with Chronic Portal Hypertension,” American Journal of Roentgenology, 147(6):1251-1254 (Dec. 1986). |
Paniagua et al., “Percutaneous Heart Valve in the Chronic in Vitro Testing Model.” Circulation, Sep. 17, 2002, vol. 106: e51-e52. |
Parodi J.C., et al., “Transfemoral Intraluminal Graft Implantation for Abdominal Aortic Aneurysms”, Ann. Vasc. Surg., 5(6):491-499 (Nov. 1991). |
Partial European Search Report dated Feb. 28, 2012 in EP Patent Appl. Serial No. 11178135.7 (1257). |
Partial European Search Report for Application No. 10168525.3-1269 dated Sep. 20, 2010, 5 pages. |
Partial European Search Report for Application No. 07116242.4-2310 dated Jan. 14, 2008, 5 pages. |
Partial European Search Report for Application No. 11153142.2-1257 dated Apr. 4, 2011, 5 pages. |
Partial European Search Report for EP Patent Appl. Serial No. 07110318.8, dated Mar. 10, 2008, 6 pages. |
Partial European Search Report for EP Patent Appl. Serial No. 10163478.0, dated Nov. 2, 2010, 6 pages. |
Partial International Search Report for International Application No. PCT/EP2014/055044, filed Mar. 13, 2014, 7 pages. |
Pavcnik D., et al., “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement.” Radiology, 183:151-154 (Apr. 1992). |
Pavcnik et al., “Aortic and venous valve for percutaneous insertion,” Min. Invas. Ther. & Allied Technol, 9(3/4):287-292 (Jan. 2000). |
Pavcnik et al., “Percutaneous Bioprosthetic Venous Valve: A Long-term Study in Sheep,” Jounal of Vascular Surg., vol. 35, No. 3, Mar. 2002, pp. 598-603. |
Pawelec-Wojtalk M., “Closure of left ventricle perforation with the use of muscular VSD occluder,” European Journal of Cardia-Thoracic Surgery, 27(4):714-716 (Apr. 2005). |
Pelton A.R., et al., “Medical Uses of Nitinol”, Materials Science Forum, 327-328:63-70 (Jan. 2000). |
Phillips et al., “A Temporary Catheter-Tip Aortic Valve: Hemodynamic Effects on Experimental Acute Aortic Insufficiency”, Annals of Thoracic Surg., Feb. 1976, 21(2), pp. 134-136. |
Phillips S.J., et al., “Improvement in Forward Coronary Blood Flow by Using a Reversed Saphenous Vein with a Competent Valve,” The Annals of Thoracic Surgery, vol. 21 (1), Jan. 1976, pp. 12-15. |
Raillat et al., “Treatment of Iliac Artery Stenosis with the Wallstent Endoprosthesis.” AJR, Mar. 1990, vol. 154(3), pp. 613-616. |
Remadi et al., “Preliminary results of 130 aortic valve replacements with a new mechanical bileaflet prosthesis: The Edwards MIRA valve,” Interactive Cardiovasc. and Thorac. Surg., 2:80-83 (Mar. 2003). |
Rogers J.H., et al., “The Tricuspid Valve: Current Perspective and Evolving Management of Tricuspid Regurgitation,” Circulation, 119(20):2718-2725 (May 2009). |
Ruiz C.E.,“Transcatheter Aortic Valve Implantation and Mitral Valve Repair: State of the Art,” Pediatric Cardiology, 26(3):289-294 (Jun. 2005). |
Schurink et al., “Stent Attachment Site-related Endoleakage after Stent Graft Treatment: An in vitro study of the effects of graft size, stent type, and atherosclerotic wall changes”, J. Vasc. Surg., vol. 30(4), Oct. 1999, pp. 658-667. |
Search Report dated Oct. 15, 2003 from the European Patent Office for European Patent Application No. EP 02291953.4, 2 pages. |
Sochman et al., “Percutaneous Transcatheter Aortic Disc Valve Prosthesis Implantation: A Feasibility Study.” Cardiovasc. Intervent. Radiol., Sep. 2000, 23: 384-388. |
Stanley et al., “Evaluation of Patient Selection Guidelines for Endoluminal AAA Repair With the Zenith Stent Graft: The Australasian Experience.” J. Endovasc. Ther., 8:457-464 (Oct. 2001). |
Stassano., “Mid-term Results of the Valve-on-Valve Technique for Bioprosthetic Failure”, European Journal of Cardiothoracic Surgery, Oct. 2000, vol. 18, pp. 453-457. |
Stein D.P., et al., “Turbulent blood flow in the ascending aorta of humans with normal and diseased aortic valves”, Circulation Research by American Heart Association, 39:58-65 (Jul. 1976). |
Steinhoff et al., “Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits.” Circulation102 [suppl. III], pp. III-50-III-55 (Nov. 2000). |
Supplemental Search Report from EP Patent Office for EP Application No. 04813777.2, dated Aug. 19, 2011. |
Supplemental Search Report from EP Patent Office for EP Application No. 04815634.3, dated Aug. 19, 2011. |
Supplemental Search Report from EP Patent Office for EP Application No. 05758878.2, dated Oct. 24, 2011. |
Supplementary European Search Report dated Jan. 2, 2012 in EP Patent Appl. Serial No. 09820051.2. |
Thompson et al., “Endoluminal stent grafting of the thoracic aorta: Initial experience with the Gore Excluder,” Journal of Vascular Surgery, Jun. 2002, pp. 1163-1170. |
Topol, Eric., Textbook of Interventional Cardiology, 4th Ed; Chapter 24: “Endovascular Options for Peripheral Arterial Occlusive and Aneurysmal Disease,” Saunders, pp. 499-503, 949-953 (Dec. 2003). |
Triennial Review of the National Nanotechnology Initiative: “A Matter of Size”, The National Academies Press, Washington DC, V-13, Retrieved from the Internet: URL: http://www.nap.edu/catalog/11752/a-matter-of-size-triennial-review-of-the-national-nanotechnology, 200 pages (Mar. 2006) (Parts 1-5). |
Vahanian et al., “Percutaneous Approaches to Valvular Disease”, Circulation, Apr. 6, 2004, 109: 1572-1579. |
Van Herwerden et al., “Percutaneous Valve Implantation: Back to the Future?”, Euro. Heart J., Sep. 2002, 23(18):1415-1416. |
Walther et al., “Transapical approach for sutureless stent-fixed aortic valve implantation: experimental results”, European Journal of Cardio-thoracic Surgery 29, 703-708 (May 2006). |
Webb et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery”, Circulation, American Hea Association, vol. 113, Feb. 6, 2006, pp. 842-850. |
Weerasinghe A., et al., “First Redo Heart Valve Replacement: A 10-Year Analysis,” Circulation, 99(5):655-658 (Feb. 1999). |
Weyman AB et al., “Aortic Stenosis: Physics and Physiology—What Do the Numbers Really Mean?”, Rev Cardiovasc Med., 6(1):23-32 (Jan. 2005). |
White et al., “Endoleak as a Complication of Endoluminal Grafting of Abdominal Aortic Aneurysms: Classification, Incidence, Diagnosis, and Management,” J. Endovasc. Surg., 4:152-168 (May 1997). |
Written Opinion for Application No. PCT/EP2006/012455, dated Sep. 27, 2007, 11 pages. |
Written Opinion for Application No. PCT/EP2007/007413, dated Jan. 28, 2008, 5 pages. |
Written Opinion for Application No. PCT/EP2011/058506, dated Nov. 3, 2011, 5 pages. |
Written Opinion for Application No. PCT/EP2014/065817, dated Jan. 7, 2015, 7 pages. |
Written Opinion for PCT/EP2006/010023 dated Mar. 30, 2007, 10 Pages. |
Written Opinion for PCT/EP2012/067714 dated Dec. 18, 2012, 5 Pages. |
Yonga G.O., et al., “Percutaneous Transvenous Mitral Commissurotomy in Juvenile Mitral Stenosis”, East African Medical Journal, 80(4):172-174 (Apr. 2003). |
Yoshioka et al., “Self-Expanding Endovascular Graft: An Experimental Study in Dogs.” AJR 151, Oct. 1988, pp. 673-676. |
Zhou et al., “Self-expandable Valved Stent of Large Size: Off-Bypass Implantation in Pulmonary Position”, Eur. J. Cardiothorac, Aug. 2003, 24: 212-216. |
Aortenklappenbioprothese erfolgreich in der Entwicklung, May 16, 2003 (1 page). |
English translation of Aortenklappenbioprotheseerfolgreich in der Entwicklung (2 pages), (May 2003). |
Screen shots from http://www.fraunhofer.de/presse/filme/2006/index.jsp, 2006 (2 pages). |
Liang, Ma, et al., “Double-crowned valved stents for off-pump mitral valve replacement,” Eur. J. Cardio-Thoracic Surgery, vol. 28, pp. 194-198 (2005) (5 pages); Aug. 2005. |
Huber, Christoph H., et al. “Direct Access Valve Replacement (DAVR)—are we entering a new era in cardiac surgery?” Eur. J. Cardio-Thoracic Surgery, vol. 29, pp. 380-385 (2006) (6 pages); received Mar. 2006. |
English translation of DE 19 546 692 A1 (4 pages), (Jun. 1997). |
English translation of EP 1 469 797 B1 (16 pages), (Nov. 2005). |
Klein, Allan L. et al., “Age-related Prevalence of Valvular Regurgitation in Normal Subjects: A Comprehensive Color Flow Examination of 118 Volunteers,” J. Am. Soc. Echocardiography, vol. 3, No. 1, pp. 54-63 (1990) (10 pages), Jan.-Feb. 1990. |
Gummert, J.F et al., “Cardiac Surgery in Germany During 2007: A Report on Behalf of the German Society for Thoracic and Cardiovascular Surgery,” Thorac. Cardiov. Surg., vol. 56, pp. 328-336 (2008) (9 pages), Sep. 2008. |
Gummert, J.F et al., “Cardiac Surgery in Germany During 2006: A Report on Behalf of the German Society for Thoracic and Cardiovascular Surgery,” Thorac. Cardiov. Surg., vol. 55, pp. 343-350 (2007) (8 pages), Sep. 2007. |
International Search Report for PCT/EP2011/058506, dated Nov. 3, 2011 (3 pages). |
Number | Date | Country | |
---|---|---|---|
20200323629 A1 | Oct 2020 | US |
Number | Date | Country | |
---|---|---|---|
61348036 | May 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15658955 | Jul 2017 | US |
Child | 16794423 | US | |
Parent | 13114582 | May 2011 | US |
Child | 15658955 | US |